[{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":20,"end":24,"tag":"WDD"},{"start":59,"end":68,"tag":"diabetes"},{"start":133,"end":139,"tag":"Nov14"}],"mentions":[{"start":3,"end":18,"username":"IntDiabetesFed","id":"38393473"}],"urls":{},"annotations":{}},"conversation_id":"389757843072512000","possibly_sensitive":false,"created_at":"2013-10-14T14:21:25.000Z","referenced_tweets":[{"type":"retweeted","id":"389756187761074176"}],"id":"389757843072512000","text":"RT @IntDiabetesFed: #WDD 1 month to go! 1 in 2 people with #diabetes don't know they have it. New numbers for 2013 &amp; 2035 out on #Nov14","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":108,"end":130,"url":"http://t.co/QHZ54VejNo","expanded_url":"http://bit.ly/19GFVDT","display_url":"bit.ly/19GFVDT"}],"annotations":{}},"conversation_id":"389752875917656064","possibly_sensitive":false,"created_at":"2013-10-14T14:01:41.000Z","referenced_tweets":{},"id":"389752875917656064","text":"RT @LV_MPA: The benefits of combined oral contraceptives outweigh their risks, even after new investigation http://t.co/QHZ54VejNo","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":87,"end":98,"username":"eupatients","id":"465674067"}],"urls":{},"annotations":{}},"conversation_id":"389746174514565120","possibly_sensitive":false,"created_at":"2013-10-14T13:35:03.000Z","referenced_tweets":[{"type":"retweeted","id":"389741738308284416"}],"id":"389746174514565120","text":"RT @IMI_JU: Know of a successful partnership btw patients &amp; academia/industry? Our @eupatients project wants to hear from you http://t.co/z…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":47,"end":62,"tag":"clinicaltrials"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":86,"end":101,"username":"EP_Environment","id":"951333319"}],"urls":{},"annotations":{}},"conversation_id":"389745332801638400","possibly_sensitive":false,"created_at":"2013-10-14T13:31:43.000Z","referenced_tweets":[{"type":"retweeted","id":"389724402398425088"}],"id":"389745332801638400","text":"RT @HAIEurope: Read our joint press release on #clinicaltrials regulation,urging ENVI @EP_Environment to ensure data transparency: http://t…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/fm5KVrMvK0","expanded_url":"http://bit.ly/1akvPpd","display_url":"bit.ly/1akvPpd"}],"annotations":{}},"conversation_id":"389742290832334848","possibly_sensitive":false,"created_at":"2013-10-14T13:19:37.000Z","referenced_tweets":{},"id":"389742290832334848","text":"Follow the workshop on preventing product shortages due to manufacturing and quality problems, live on our website: http://t.co/fm5KVrMvK0","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":38,"end":53,"tag":"prostatecancer"},{"start":95,"end":103,"tag":"urology"},{"start":104,"end":113,"tag":"oncology"}],"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"urls":[{"start":72,"end":94,"url":"http://t.co/rXUqnGybjz","expanded_url":"http://bit.ly/19IY9AH","display_url":"bit.ly/19IY9AH"}],"annotations":{}},"conversation_id":"389719265579773952","possibly_sensitive":false,"created_at":"2013-10-14T11:48:08.000Z","referenced_tweets":[{"type":"retweeted","id":"389719111040647170"}],"id":"389719265579773952","text":"RT @Uroweb: New data on prediction of #prostatecancer treatment outcome http://t.co/rXUqnGybjz #urology #oncology","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"annotations":[{"start":40,"end":42,"probability":0.6006,"type":"Organization","normalized_text":"EMA"}]},"conversation_id":"389718474198487040","possibly_sensitive":false,"created_at":"2013-10-14T11:44:59.000Z","referenced_tweets":[{"type":"retweeted","id":"389718408339943424"}],"id":"389718474198487040","text":"RT @URPLWMiPB: Regulatory information - EMA encourages companies to submit quality type I variations for 2013 by end of November http://t.c…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":34,"tag":"WorldMentalHealthDay"}],"mentions":{},"urls":[{"start":46,"end":68,"url":"http://t.co/yIVi6wTbDi","expanded_url":"http://bit.ly/162bvrx","display_url":"bit.ly/162bvrx"}],"annotations":{}},"conversation_id":"389717071312846848","possibly_sensitive":false,"created_at":"2013-10-14T11:39:25.000Z","referenced_tweets":{},"id":"389717071312846848","text":"We supported #WorldMentalHealthDay last week: http://t.co/yIVi6wTbDi","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":[{"start":38,"end":40,"probability":0.6892,"type":"Organization","normalized_text":"EMA"}]},"conversation_id":"389716216937328640","possibly_sensitive":false,"created_at":"2013-10-14T11:36:01.000Z","referenced_tweets":[{"type":"retweeted","id":"389716077661257728"}],"id":"389716216937328640","text":"RT @GCessak: Regulatory information - EMA encourages companies to submit quality type I variations for 2013 by end of November http://t.co/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/iO8xVKwHZd","expanded_url":"http://bit.ly/15B9HZr","display_url":"bit.ly/15B9HZr"}],"annotations":{}},"conversation_id":"389708494582321152","possibly_sensitive":false,"created_at":"2013-10-14T11:05:20.000Z","referenced_tweets":{},"id":"389708494582321152","text":"We are encouraging companies to submit any quality type I variations for 2013 by end of November:  http://t.co/iO8xVKwHZd","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"urls":{},"annotations":{}},"conversation_id":"389705135917502464","possibly_sensitive":false,"created_at":"2013-10-14T10:51:59.000Z","referenced_tweets":{},"id":"389705135917502464","text":"RT @cancereu: Are you a rare-cancer patient group? We'd like to get to know you! Contact us at info@ecpc-online.org","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":67,"end":70,"tag":"EU"},{"start":71,"end":81,"tag":"chemicals"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":82,"end":104,"url":"http://t.co/x1NVMUHuXy","expanded_url":"http://bit.ly/17oUiZO","display_url":"bit.ly/17oUiZO"}],"annotations":{}},"conversation_id":"389703731526131712","possibly_sensitive":false,"created_at":"2013-10-14T10:46:24.000Z","referenced_tweets":[{"type":"retweeted","id":"389703613641003009"}],"id":"389703731526131712","text":"RT @EU_ECHA: This is our work programme for the years 2014 to 2018 #EU #chemicals http://t.co/x1NVMUHuXy","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"urls":[{"start":99,"end":121,"url":"http://t.co/8ptCmNyMyN","expanded_url":"http://www.nhs.uk/news/2013/10October/Pages/A-historic-breakthrough-in-Alzheimers-research.aspx","display_url":"nhs.uk/news/2013/10Oc…"}],"annotations":[{"start":15,"end":17,"probability":0.7393,"type":"Organization","normalized_text":"NHS"}]},"conversation_id":"389700961670676480","possibly_sensitive":false,"created_at":"2013-10-14T10:35:24.000Z","referenced_tweets":[{"type":"retweeted","id":"389700817457905665"}],"id":"389700961670676480","text":"RT @AlzDisInt: NHS Behind the Headlines provides further clarification on last week's Alz research http://t.co/8ptCmNyMyN","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":21,"end":25,"tag":"TGA"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":80,"end":102,"url":"http://t.co/5e7SW3RH3j","expanded_url":"http://lnkd.in/bMRBZXc","display_url":"lnkd.in/bMRBZXc"}],"annotations":{}},"conversation_id":"389698436938735616","possibly_sensitive":false,"created_at":"2013-10-14T10:25:22.000Z","referenced_tweets":[{"type":"retweeted","id":"389698249310732288"}],"id":"389698436938735616","text":"RT @FrancoisMaignen: #TGA Rotavirus vaccination and the risk of intussusception http://t.co/5e7SW3RH3j","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":119,"end":129,"tag":"medicines"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":30,"end":37,"username":"pfizer","id":"56488059"}],"urls":{},"annotations":[{"start":15,"end":28,"probability":0.985,"type":"Person","normalized_text":"Chris Dierickx"}]},"conversation_id":"389693625518391296","possibly_sensitive":false,"created_at":"2013-10-14T10:06:15.000Z","referenced_tweets":[{"type":"retweeted","id":"389693520228782081"}],"id":"389693625518391296","text":"RT @EAHPtweet: Chris Dierickx @pfizer We need a pan-European &amp; international approach to single unit bar coding of #medicines to achieve #b…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":86,"end":102,"tag":"bedsidescanning"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":30,"end":37,"username":"pfizer","id":"56488059"}],"urls":{},"annotations":[{"start":15,"end":28,"probability":0.9477,"type":"Person","normalized_text":"Chris Dierickx"}]},"conversation_id":"389693606220423168","possibly_sensitive":false,"created_at":"2013-10-14T10:06:10.000Z","referenced_tweets":[{"type":"retweeted","id":"389693235104202752"}],"id":"389693606220423168","text":"RT @EAHPtweet: Chris Dierickx @pfizer Adding bar code to single unit of medicines for #bedsidescanning not a simple process. Code informati…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":66,"end":76,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":77,"end":99,"url":"http://t.co/GL7xAztW2q","expanded_url":"http://bit.ly/19FQHue","display_url":"bit.ly/19FQHue"}],"annotations":{}},"conversation_id":"389693387793641472","possibly_sensitive":false,"created_at":"2013-10-14T10:05:18.000Z","referenced_tweets":{},"id":"389693387793641472","text":"RT @GCessak: Side effects reported to the Polish medicines agency @URPLWMiPB http://t.co/GL7xAztW2q","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":38,"end":60,"url":"http://t.co/XQpP2JSQOS","expanded_url":"http://bit.ly/19FQyqB","display_url":"bit.ly/19FQyqB"}],"annotations":{}},"conversation_id":"389693217450373120","possibly_sensitive":false,"created_at":"2013-10-14T10:04:37.000Z","referenced_tweets":{},"id":"389693217450373120","text":"RT @URPLWMiPB: Reporting side effects http://t.co/XQpP2JSQOS","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":73,"end":88,"tag":"contraceptives"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":116,"end":138,"url":"http://t.co/haCCZe1hja","expanded_url":"http://bit.ly/19FP27Q","display_url":"bit.ly/19FP27Q"}],"annotations":{}},"conversation_id":"389691159565451264","possibly_sensitive":false,"created_at":"2013-10-14T09:56:27.000Z","referenced_tweets":{},"id":"389691159565451264","text":"RT @Aifa_ufficiale: The PRAC has confirmed that the benefits of hormonal #contraceptives continue to outweigh risks http://t.co/haCCZe1hja","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":{},"annotations":{}},"conversation_id":"389689187235930112","possibly_sensitive":false,"created_at":"2013-10-14T09:48:36.000Z","referenced_tweets":[{"type":"retweeted","id":"389688174181482496"}],"id":"389689187235930112","text":"RT @FrancoisMaignen: PRAC confirms that benefits of all combined hormonal contraceptives (CHCs) continue to outweigh risks http://t.co/BBMV…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":118,"end":140,"url":"http://t.co/Y3A03KdhWX","expanded_url":"http://lnkd.in/bVuYkga","display_url":"lnkd.in/bVuYkga"}],"annotations":[{"start":49,"end":91,"probability":0.4935,"type":"Organization","normalized_text":"Pharmacovigilance Risk Assessment Committee"}]},"conversation_id":"389689123025338368","possibly_sensitive":false,"created_at":"2013-10-14T09:48:21.000Z","referenced_tweets":[{"type":"retweeted","id":"389688134625009664"}],"id":"389689123025338368","text":"RT @FrancoisMaignen: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 October 2013 http://t.co/Y3A03KdhWX","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":58,"end":80,"url":"http://t.co/w5ZhEmVC1y","expanded_url":"http://bit.ly/1akzeEH","display_url":"bit.ly/1akzeEH"}],"annotations":{}},"conversation_id":"389689031249768448","possibly_sensitive":false,"created_at":"2013-10-14T09:47:59.000Z","referenced_tweets":{},"id":"389689031249768448","text":"RT @FrancoisMaignen: Insulin: many avoidable usage errors http://t.co/w5ZhEmVC1y","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":97,"end":119,"url":"http://t.co/6IfT7Hr4bm","expanded_url":"http://bit.ly/1akyUWr","display_url":"bit.ly/1akyUWr"}],"annotations":{}},"conversation_id":"389688452704239616","possibly_sensitive":false,"created_at":"2013-10-14T09:45:41.000Z","referenced_tweets":{},"id":"389688452704239616","text":"RT @FrancoisMaignen: Multiple sclerosis: cardiac risks with fingolimod (Gilenya) being monitored http://t.co/6IfT7Hr4bm","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":61,"end":83,"url":"http://t.co/f7llffV9bO","expanded_url":"http://bit.ly/19FMGpC","display_url":"bit.ly/19FMGpC"}],"annotations":{}},"conversation_id":"389687889799307264","possibly_sensitive":false,"created_at":"2013-10-14T09:43:27.000Z","referenced_tweets":{},"id":"389687889799307264","text":"RT @FrancoisMaignen: Fentanyl patches: warning for children! http://t.co/f7llffV9bO","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":30,"end":34,"tag":"WDD"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"urls":[{"start":97,"end":119,"url":"http://t.co/8wYLaC986g","expanded_url":"http://www.idf.org/worlddiabetesday/activities","display_url":"idf.org/worlddiabetesd…"}],"annotations":{}},"conversation_id":"389687092529205248","possibly_sensitive":false,"created_at":"2013-10-14T09:40:17.000Z","referenced_tweets":[{"type":"retweeted","id":"389686660587212801"}],"id":"389687092529205248","text":"RT @WDD: 31 days to go until ##WDD! Check out the activities you could organise to mark the day. http://t.co/8wYLaC986g","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":101,"end":113,"tag":"rarecancers"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"urls":[{"start":117,"end":139,"url":"http://t.co/rc8AWjl0Cx","expanded_url":"http://fb.me/6yspAzoDZ","display_url":"fb.me/6yspAzoDZ"}],"annotations":[{"start":61,"end":66,"probability":0.9948,"type":"Place","normalized_text":"Europe"}]},"conversation_id":"389687048371572737","possibly_sensitive":false,"created_at":"2013-10-14T09:40:07.000Z","referenced_tweets":[{"type":"retweeted","id":"389686597631098880"}],"id":"389687048371572737","text":"RT @cancereu: Are you a rare cancer patients organisation in Europe? We would like to hear from you. #rarecancers... http://t.co/rc8AWjl0Cx","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":3,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":38,"end":60,"url":"http://t.co/6gJtigEXeR","expanded_url":"http://bit.ly/GRAiZG","display_url":"bit.ly/GRAiZG"}],"annotations":[{"start":29,"end":35,"probability":0.2262,"type":"Organization","normalized_text":"EudraCT"}]},"conversation_id":"389686660859826176","possibly_sensitive":false,"created_at":"2013-10-14T09:38:34.000Z","referenced_tweets":{},"id":"389686660859826176","text":"We launched a new version of EudraCT: http://t.co/6gJtigEXeR","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":21,"end":25,"tag":"HES"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/j4d9TdqxUn","expanded_url":"http://bit.ly/1biiReb","display_url":"bit.ly/1biiReb"}],"annotations":{}},"conversation_id":"389686489459593216","possibly_sensitive":false,"created_at":"2013-10-14T09:37:53.000Z","referenced_tweets":{},"id":"389686489459593216","text":"#PRAC confirmed that #HES should no longer be used in patients with sepsis, burn injuries or in the critically ill: http://t.co/j4d9TdqxUn","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":21,"end":31,"tag":"TheLancet"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":{},"annotations":{}},"conversation_id":"389686415585329152","possibly_sensitive":false,"created_at":"2013-10-14T09:37:36.000Z","referenced_tweets":[{"type":"retweeted","id":"389686261314629632"}],"id":"389686415585329152","text":"RT @FrancoisMaignen: #TheLancet Effect of Ca-based versus non-Ca-based phosphate binders on mortality in patients with chronic kidney dis…h…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":55,"end":70,"tag":"contraceptives"}],"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/bMQPVSIMIQ","expanded_url":"http://bit.ly/1aeOHWA","display_url":"bit.ly/1aeOHWA"}],"annotations":{}},"conversation_id":"389686285859696640","possibly_sensitive":false,"created_at":"2013-10-14T09:37:05.000Z","referenced_tweets":{},"id":"389686285859696640","text":"#PRAC confirmed that benefits of all combined hormonal #contraceptives continue to outweigh risks: http://t.co/bMQPVSIMIQ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":21,"end":31,"tag":"TheLancet"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":95,"end":117,"url":"http://t.co/sgAnmkSYaS","expanded_url":"http://lnkd.in/bEFCv9f","display_url":"lnkd.in/bEFCv9f"}],"annotations":[{"start":54,"end":59,"probability":0.9972,"type":"Place","normalized_text":"Europe"}]},"conversation_id":"389685463285391360","possibly_sensitive":false,"created_at":"2013-10-14T09:33:49.000Z","referenced_tweets":[{"type":"retweeted","id":"389685306552635393"}],"id":"389685463285391360","text":"RT @FrancoisMaignen: #TheLancet Regulatory science in Europe: the case of schizophrenia trials http://t.co/sgAnmkSYaS","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/GDR1CXpHVQ","expanded_url":"http://bit.ly/1akvPpd","display_url":"bit.ly/1akvPpd"}],"annotations":{}},"conversation_id":"389678190886924288","possibly_sensitive":false,"created_at":"2013-10-14T09:04:55.000Z","referenced_tweets":{},"id":"389678190886924288","text":"Watch the live broadcast of our workshop on preventing product shortages due to manufacturing and quality problems: http://t.co/GDR1CXpHVQ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":93,"end":115,"url":"http://t.co/NBsY7PEcYj","expanded_url":"http://lnkd.in/bWFdmXx","display_url":"lnkd.in/bWFdmXx"}],"annotations":{}},"conversation_id":"389677980198264832","possibly_sensitive":false,"created_at":"2013-10-14T09:04:05.000Z","referenced_tweets":[{"type":"retweeted","id":"389677439669895168"}],"id":"389677980198264832","text":"RT @FrancoisMaignen: BMJ. Endgames Statistical Question. What is a patient preference trial? http://t.co/NBsY7PEcYj","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":86,"end":108,"url":"http://t.co/zNW9IiAS5H","expanded_url":"http://lnkd.in/bDd8s6y","display_url":"lnkd.in/bDd8s6y"}],"annotations":{}},"conversation_id":"389676855168475136","possibly_sensitive":false,"created_at":"2013-10-14T08:59:36.000Z","referenced_tweets":[{"type":"retweeted","id":"389676364590104576"}],"id":"389676855168475136","text":"RT @FrancoisMaignen: Guidelines for collaboration with industry should be transparent http://t.co/zNW9IiAS5H","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":75,"end":97,"url":"http://t.co/pA3I7SvWp4","expanded_url":"http://lnkd.in/bpXt5Df","display_url":"lnkd.in/bpXt5Df"}],"annotations":{}},"conversation_id":"389675999811469313","possibly_sensitive":false,"created_at":"2013-10-14T08:56:12.000Z","referenced_tweets":[{"type":"retweeted","id":"389675600866050048"}],"id":"389675999811469313","text":"RT @FrancoisMaignen: BMJ Endgames statistical question. The nocebo effect. http://t.co/pA3I7SvWp4","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"urls":{},"annotations":[{"start":108,"end":114,"probability":0.997,"type":"Place","normalized_text":"Denmark"},{"start":120,"end":125,"probability":0.9609,"type":"Place","normalized_text":"Sweden"}]},"conversation_id":"389675671179378688","possibly_sensitive":false,"created_at":"2013-10-14T08:54:54.000Z","referenced_tweets":[{"type":"retweeted","id":"389675297139728385"}],"id":"389675671179378688","text":"RT @FrancoisMaignen: Adverse events after immunisation of adolescent girls with quadrivalent HPV vaccine in Denmark and Sweden http://t.co/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":31,"tag":"WorldArthritisDay"}],"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/D0KyjGpw30","expanded_url":"http://bit.ly/1c8212F","display_url":"bit.ly/1c8212F"}],"annotations":{}},"conversation_id":"389671392364355584","possibly_sensitive":false,"created_at":"2013-10-14T08:37:54.000Z","referenced_tweets":{},"id":"389671392364355584","text":"We supported #WorldArthritisDay on Saturday. Find out what we do in this area: http://t.co/D0KyjGpw30","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":78,"end":100,"url":"http://t.co/mbF4hgvJj8","expanded_url":"http://www.reuters.com/article/2013/10/10/us-study-enlists-idUSBRE99915S20131010","display_url":"reuters.com/article/2013/1…"}],"annotations":[{"start":18,"end":23,"probability":0.8322,"type":"Place","normalized_text":"Europe"}]},"conversation_id":"388696247663472640","possibly_sensitive":false,"created_at":"2013-10-11T16:03:01.000Z","referenced_tweets":[{"type":"retweeted","id":"388696098795044864"}],"id":"388696247663472640","text":"RT @DrugInfoAssn: Europe To Combat Antibiotic Overuse Through Child Education http://t.co/mbF4hgvJj8","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"annotations":{}},"conversation_id":"388690244725272576","possibly_sensitive":false,"created_at":"2013-10-11T15:39:10.000Z","referenced_tweets":{},"id":"388690244725272576","text":"RT @URPLWMiPB: Tomorrow at 7.30am on TVN 24 the president of the Polish agency will explain what the black triangle means among other things","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"urls":[{"start":111,"end":133,"url":"http://t.co/0ZgaUNZZZN","expanded_url":"http://bit.ly/184P3BW","display_url":"bit.ly/184P3BW"}],"annotations":{}},"conversation_id":"388687232137064448","possibly_sensitive":false,"created_at":"2013-10-11T15:27:12.000Z","referenced_tweets":{},"id":"388687232137064448","text":"RT @sanidadgob: Distribution of human medicines incorporating measures to prevent entry of falsified medicines http://t.co/0ZgaUNZZZN","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":21,"end":32,"tag":"antibiotic"},{"start":133,"end":138,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":[{"start":110,"end":132,"url":"http://t.co/daLUwiiQT7","expanded_url":"http://bit.ly/T44tLs","display_url":"bit.ly/T44tLs"}],"annotations":{}},"conversation_id":"388682585133436929","possibly_sensitive":false,"created_at":"2013-10-11T15:08:44.000Z","referenced_tweets":[{"type":"retweeted","id":"388682466216521728"}],"id":"388682585133436929","text":"RT @EAAD_EU: What is #antibiotic resistance? When antibiotics lose their ability to kill or stop the bacteria http://t.co/daLUwiiQT7 #EAAD","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"conversation_id":"388682187827982336","possibly_sensitive":false,"created_at":"2013-10-11T15:07:09.000Z","referenced_tweets":[{"type":"retweeted","id":"388681689922150400"}],"id":"388682187827982336","text":"RT @innovationunion: Beyond genetics: mining biological networks for new treatments for disease: Our genes define us and every other... htt…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":110,"end":132,"url":"http://t.co/Qe8WuuvDqr","expanded_url":"http://bit.ly/1c8KIhJ","display_url":"bit.ly/1c8KIhJ"}],"annotations":{}},"conversation_id":"388677782571466752","possibly_sensitive":false,"created_at":"2013-10-11T14:49:39.000Z","referenced_tweets":{},"id":"388677782571466752","text":"RT @LV_MPA: PRAC recommends that solutions containing hydroxyethyl starch (HES) no longer used in patients... http://t.co/Qe8WuuvDqr","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"urls":{},"annotations":{}},"conversation_id":"388677477414887424","possibly_sensitive":false,"created_at":"2013-10-11T14:48:26.000Z","referenced_tweets":[{"type":"retweeted","id":"388672599607107584"}],"id":"388677477414887424","text":"RT @FDAMedWatch: Inclusig (Ponatinib): Drug Safety Communication - Increased Reports Of Serious Blood Clots In Arteries And Veins http://t.…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":101,"end":123,"url":"http://t.co/LC50wQiaEf","expanded_url":"http://bit.ly/184FGST","display_url":"bit.ly/184FGST"}],"annotations":{}},"conversation_id":"388676932058894338","possibly_sensitive":false,"created_at":"2013-10-11T14:46:16.000Z","referenced_tweets":{},"id":"388676932058894338","text":"RT @AEMPSGOB: Publication of the monthly report from the Spanish medicines agency for September 2013 http://t.co/LC50wQiaEf","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":24,"tag":"India"},{"start":51,"end":56,"tag":"drug"},{"start":71,"end":83,"tag":"inspections"}],"mentions":[{"start":111,"end":126,"username":"InPharmaTechno","id":"106444052"}],"urls":[{"start":84,"end":106,"url":"http://t.co/fK8QtUrd9d","expanded_url":"http://www.in-pharmatechnologist.com/Regulatory-Safety/India-to-invest-3B-to-overhaul-drug-manufacturing-inspections?utm_source=AddThis&utm_medium=Twitter&utm_campaign=SocialMedia/#.Ulf4wy4pJvI.twitter","display_url":"in-pharmatechnologist.com/Regulatory-Saf…"}],"annotations":{}},"conversation_id":"388658967460581376","possibly_sensitive":false,"created_at":"2013-10-11T13:34:53.000Z","referenced_tweets":[{"type":"retweeted","id":"388657298916118529"}],"id":"388658967460581376","text":"RT @sailinsomnia: #India to invest $3B to overhaul #drug manufacturing #inspections http://t.co/fK8QtUrd9d via @InPharmaTechno","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":29,"end":37,"tag":"Ranbaxy"}],"mentions":{},"urls":[{"start":69,"end":91,"url":"http://t.co/PTdCIXZHSs","expanded_url":"http://www.fiercepharma.com/story/fda-signoff-ranbaxy-nj-plant-provides-drugmaker-relief/2013-10-10?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.Ulf4ICzmo8o.twitter","display_url":"fiercepharma.com/story/fda-sign…"}],"annotations":[{"start":41,"end":46,"probability":0.4026,"type":"Place","normalized_text":"US GMP"}]},"conversation_id":"388658281641570305","possibly_sensitive":false,"created_at":"2013-10-11T13:32:09.000Z","referenced_tweets":[{"type":"retweeted","id":"388652362388103170"}],"id":"388658281641570305","text":"RT @sailinsomnia: Relief for #Ranbaxy as US GMP woes appear to ease  http://t.co/PTdCIXZHSs","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":41,"end":63,"url":"http://t.co/WLX7Oz8YmY","expanded_url":"http://bit.ly/GRAiZG","display_url":"bit.ly/GRAiZG"}],"annotations":[{"start":32,"end":38,"probability":0.2158,"type":"Organization","normalized_text":"EudraCT"}]},"conversation_id":"388652303580164096","possibly_sensitive":false,"created_at":"2013-10-11T13:08:24.000Z","referenced_tweets":{},"id":"388652303580164096","text":"We've launched a new version of EudraCT: http://t.co/WLX7Oz8YmY","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":31,"end":40,"tag":"westnile"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":82,"end":104,"url":"http://t.co/mirD2Yo2yv","expanded_url":"http://bit.ly/16PkDQq","display_url":"bit.ly/16PkDQq"}],"annotations":[{"start":56,"end":61,"probability":0.9947,"type":"Place","normalized_text":"Europe"}]},"conversation_id":"388645687467864064","possibly_sensitive":false,"created_at":"2013-10-11T12:42:07.000Z","referenced_tweets":[{"type":"retweeted","id":"388643763293151232"}],"id":"388645687467864064","text":"RT @ECDC_EU: All the latest on #westnile fever cases in Europe, new maps online:  http://t.co/mirD2Yo2yv. There's infographic too http://t.…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":17,"end":35,"tag":"WorldArthritisDay"}],"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/2fef6gKgjr","expanded_url":"http://bit.ly/1c8212F","display_url":"bit.ly/1c8212F"}],"annotations":{}},"conversation_id":"388627116813996032","possibly_sensitive":false,"created_at":"2013-10-11T11:28:19.000Z","referenced_tweets":{},"id":"388627116813996032","text":"We're supporting #WorldArthritisDay tomorrow. Find out what we do in this area: http://t.co/2fef6gKgjr","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":20,"end":24,"tag":"HES"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/DdgEBbjT6y","expanded_url":"http://bit.ly/1biiReb","display_url":"bit.ly/1biiReb"}],"annotations":{}},"conversation_id":"388625965876006912","possibly_sensitive":false,"created_at":"2013-10-11T11:23:45.000Z","referenced_tweets":{},"id":"388625965876006912","text":"#PRAC confirms that #HES should no longer be used in patients with sepsis, burn injuries or in the critically ill: http://t.co/DdgEBbjT6y","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":54,"end":69,"tag":"contraceptives"}],"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/iJI3nN6aUv","expanded_url":"http://bit.ly/1aeOHWA","display_url":"bit.ly/1aeOHWA"}],"annotations":{}},"conversation_id":"388624417418649600","possibly_sensitive":false,"created_at":"2013-10-11T11:17:36.000Z","referenced_tweets":{},"id":"388624417418649600","text":"#PRAC confirms that benefits of all combined hormonal #contraceptives continue to outweigh risks: http://t.co/iJI3nN6aUv","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":50,"end":72,"url":"http://t.co/K0BGqXJFGJ","expanded_url":"http://bit.ly/15YE1Q3","display_url":"bit.ly/15YE1Q3"}],"annotations":{}},"conversation_id":"388623345287450624","possibly_sensitive":false,"created_at":"2013-10-11T11:13:20.000Z","referenced_tweets":{},"id":"388623345287450624","text":"We've just published the PRAC meeting highlights: http://t.co/K0BGqXJFGJ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":73,"end":84,"tag":"compliance"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/EE0sywjNYa","expanded_url":"http://bit.ly/1gZOrP7","display_url":"bit.ly/1gZOrP7"}],"annotations":{}},"conversation_id":"388620393163943937","possibly_sensitive":false,"created_at":"2013-10-11T11:01:36.000Z","referenced_tweets":{},"id":"388620393163943937","text":"Two weeks left to apply for our #vacancy for a clinical and non-clinical #compliance officer. Deadline is 25 October: http://t.co/EE0sywjNYa","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":47,"end":53,"tag":"legal"},{"start":128,"end":140,"tag":"recruitment"}],"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/JwtLUu05F8","expanded_url":"http://bit.ly/19DXfGq","display_url":"bit.ly/19DXfGq"}],"annotations":{}},"conversation_id":"388620309147836416","possibly_sensitive":false,"created_at":"2013-10-11T11:01:16.000Z","referenced_tweets":{},"id":"388620309147836416","text":"Two weeks left to apply for our #vacancy for a #legal officer. Deadline for applications is 25 October: http://t.co/JwtLUu05F8  #recruitment","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":30,"end":39,"username":"ppenttin","id":"35465163"}],"urls":[{"start":116,"end":138,"url":"http://t.co/rvDBvk44HF","expanded_url":"http://bit.ly/1cD2bSo","display_url":"bit.ly/1cD2bSo"}],"annotations":{}},"conversation_id":"388619836709806080","possibly_sensitive":false,"created_at":"2013-10-11T10:59:23.000Z","referenced_tweets":[{"type":"retweeted","id":"388619618807332865"}],"id":"388619836709806080","text":"RT @ECDC_Flu: Warm welcome to @ppenttin, new acting Head of ECDC Influenza and other Respiratory Viruses programme! http://t.co/rvDBvk44HF","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":79,"end":101,"url":"http://t.co/kUyfYHQqiO","expanded_url":"http://bit.ly/GSPlRP","display_url":"bit.ly/GSPlRP"}],"annotations":{}},"conversation_id":"388617138082029568","possibly_sensitive":false,"created_at":"2013-10-11T10:48:40.000Z","referenced_tweets":[{"type":"retweeted","id":"388616221131685888"}],"id":"388617138082029568","text":"RT @EFPIA: \"Stem cell breakthrough could set up future transplant therapies\" - http://t.co/kUyfYHQqiO","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":46,"end":56,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":68,"end":90,"url":"http://t.co/gQGvyKkxeF","expanded_url":"http://bit.ly/GL3UYp","display_url":"bit.ly/GL3UYp"}],"annotations":{}},"conversation_id":"388611951317614592","possibly_sensitive":false,"created_at":"2013-10-11T10:28:03.000Z","referenced_tweets":[{"type":"retweeted","id":"388611399502417921"}],"id":"388611951317614592","text":"RT @euparkinsons: Is there a need to redefine #Parkinson’s disease? http://t.co/gQGvyKkxeF","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":26,"end":32,"tag":"study"},{"start":83,"end":96,"tag":"mentalhealth"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":111,"end":120,"username":"EU2013LT","id":"2484749870"}],"urls":{},"annotations":{}},"conversation_id":"388611803057373185","possibly_sensitive":false,"created_at":"2013-10-11T10:27:28.000Z","referenced_tweets":[{"type":"retweeted","id":"388610526646763520"}],"id":"388611803057373185","text":"RT @EU_Health: #EU funded #study \"European profile of prevention and  promotion of #mentalhealth\" presented in @EU2013LT conference http://…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":68,"end":75,"tag":"Mental"},{"start":76,"end":83,"tag":"Health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":21,"end":29,"username":"borgton","id":"1605512862"},{"start":46,"end":55,"username":"EU2013LT","id":"2484749870"}],"urls":{},"annotations":[{"start":118,"end":124,"probability":0.9628,"type":"Place","normalized_text":"Vilnius"}]},"conversation_id":"388611669401694208","possibly_sensitive":false,"created_at":"2013-10-11T10:26:56.000Z","referenced_tweets":[{"type":"retweeted","id":"388609095118237696"}],"id":"388611669401694208","text":"RT @EU_Health: Cssr. @borgton participates in @EU2013LT conference \"#Mental #Health: Challenges and Possibilities\" in Vilnius http://t.co/W…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"urls":[{"start":57,"end":79,"url":"http://t.co/F1plZjHs3B","expanded_url":"http://www.alz.co.uk/adi/pdf/gp201310.pdf","display_url":"alz.co.uk/adi/pdf/gp2013…"}],"annotations":{}},"conversation_id":"388609362547073024","possibly_sensitive":false,"created_at":"2013-10-11T10:17:46.000Z","referenced_tweets":[{"type":"retweeted","id":"388607009332793344"}],"id":"388609362547073024","text":"RT @AlzDisInt: New issue of Global Perspectives is here! http://t.co/F1plZjHs3B","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":74,"end":83,"tag":"biocides"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":84,"end":106,"url":"http://t.co/8D19kVBngk","expanded_url":"http://bit.ly/GR6fRR","display_url":"bit.ly/GR6fRR"}],"annotations":[{"start":13,"end":46,"probability":0.5683,"type":"Organization","normalized_text":"ECHA's Biocidal Products Committee"}]},"conversation_id":"388606409891250176","possibly_sensitive":false,"created_at":"2013-10-11T10:06:02.000Z","referenced_tweets":[{"type":"retweeted","id":"388606217419227136"}],"id":"388606409891250176","text":"RT @GCessak: ECHA's Biocidal Products Committee is now ready for business #biocides http://t.co/8D19kVBngk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":59,"end":69,"tag":"chemicals"}],"mentions":[{"start":112,"end":120,"username":"EU_ECHA","id":"331604970"}],"urls":{},"annotations":{}},"conversation_id":"388605702312194048","possibly_sensitive":false,"created_at":"2013-10-11T10:03:14.000Z","referenced_tweets":[{"type":"retweeted","id":"388605486163320832"}],"id":"388605702312194048","text":"RT @eubookshop: New labelling system and classification of #chemicals will come into force in 2017. Interested? @EU_ECHA http://t.co/IE6wQS…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"urls":[{"start":115,"end":137,"url":"http://t.co/AtusbVNoTW","expanded_url":"http://bit.ly/18Uhfqs","display_url":"bit.ly/18Uhfqs"}],"annotations":[{"start":15,"end":44,"probability":0.3075,"type":"Organization","normalized_text":"Dutch Health Care Inspectorate"}]},"conversation_id":"388591391812509696","possibly_sensitive":false,"created_at":"2013-10-11T09:06:22.000Z","referenced_tweets":{},"id":"388591391812509696","text":"RT @igznl: The Dutch Health Care Inspectorate is looking for an enthusiastic / experienced functional manager &gt; http://t.co/AtusbVNoTW","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"urls":[{"start":102,"end":124,"url":"http://t.co/wh9fJUmgtQ","expanded_url":"http://bit.ly/16ULqAL","display_url":"bit.ly/16ULqAL"}],"annotations":[{"start":15,"end":44,"probability":0.3456,"type":"Organization","normalized_text":"Dutch Health Care Inspectorate"}]},"conversation_id":"388590471095668736","possibly_sensitive":false,"created_at":"2013-10-11T09:02:42.000Z","referenced_tweets":{},"id":"388590471095668736","text":"RT @igznl: The Dutch Health Care Inspectorate is looking for a good-manufacturing-practice inspector: http://t.co/wh9fJUmgtQ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":73,"end":84,"tag":"compliance"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/EE0sywjNYa","expanded_url":"http://bit.ly/1gZOrP7","display_url":"bit.ly/1gZOrP7"}],"annotations":{}},"conversation_id":"388578150768070657","possibly_sensitive":false,"created_at":"2013-10-11T08:13:45.000Z","referenced_tweets":{},"id":"388578150768070657","text":"Two more weeks to apply for our #vacancy for a clinical and non-clinical #compliance officer. Deadline is 25 October: http://t.co/EE0sywjNYa","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":47,"end":53,"tag":"legal"},{"start":127,"end":139,"tag":"recruitment"}],"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/JwtLUu05F8","expanded_url":"http://bit.ly/19DXfGq","display_url":"bit.ly/19DXfGq"}],"annotations":{}},"conversation_id":"388577976171769857","possibly_sensitive":false,"created_at":"2013-10-11T08:13:03.000Z","referenced_tweets":{},"id":"388577976171769857","text":"Two more weeks to apply for our #vacancy for a #legal officer. Deadline for applications is 25 October: http://t.co/JwtLUu05F8 #recruitment","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":40,"end":47,"tag":"ETPGAH"},{"start":54,"end":66,"tag":"DISCONTOOLS"}],"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/c38B7tb8OZ","expanded_url":"http://www.discontools.eu","display_url":"discontools.eu"},{"start":108,"end":130,"url":"http://t.co/JJgoCGbUbh","expanded_url":"http://www.etpgah.eu","display_url":"etpgah.eu"}],"annotations":[{"start":16,"end":29,"probability":0.984,"type":"Person","normalized_text":"Declan O'Brien"}]},"conversation_id":"388577171939147776","possibly_sensitive":false,"created_at":"2013-10-11T08:09:51.000Z","referenced_tweets":[{"type":"retweeted","id":"388577075017179136"}],"id":"388577171939147776","text":"RT @IFAHEurope: Declan O'Brien presents #ETPGAH &amp; #DISCONTOOLS at STAR-IDAZ - http://t.co/c38B7tb8OZ  - http://t.co/JJgoCGbUbh http://t.co/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":68,"end":81,"tag":"globalhealth"},{"start":83,"end":98,"tag":"counterfeiting"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":99,"end":106,"username":"EU_ESM","id":"1949283199"},{"start":107,"end":122,"username":"EuropeanCancer","id":"60871623"}],"urls":{},"annotations":{}},"conversation_id":"388576178203672576","possibly_sensitive":false,"created_at":"2013-10-11T08:05:54.000Z","referenced_tweets":[{"type":"retweeted","id":"388574853210468352"}],"id":"388576178203672576","text":"RT @EFPIA: NEW! Check out this week's EFPIA Newsletter with news on #globalhealth, #counterfeiting @EU_ESM @EuropeanCancer http://t.co/WoM8…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"},{"start":37,"end":46,"username":"EU_H2020","id":"920249612329504768"},{"start":75,"end":91,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":[{"start":61,"end":72,"probability":0.3216,"type":"Other","normalized_text":"Horizon 2020"}]},"conversation_id":"388343049073328128","possibly_sensitive":false,"created_at":"2013-10-10T16:39:32.000Z","referenced_tweets":[{"type":"retweeted","id":"388338835022569472"}],"id":"388343049073328128","text":"RT @EU_H2020: What's the difference? @EU_H2020 is just about Horizon 2020; @innovationunion covers a broader range of R&amp;I topics and news.","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":121,"end":131,"tag":"CCASummit"}],"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"urls":{},"annotations":{}},"conversation_id":"388342911382716417","possibly_sensitive":false,"created_at":"2013-10-10T16:38:59.000Z","referenced_tweets":[{"type":"retweeted","id":"388336546165690368"}],"id":"388342911382716417","text":"RT @USPharmacopeia: Fighting counterfeit medicine requires a broad coalition + commitment that extends far beyond policy #CCASummit","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":23,"end":35,"tag":"antibiotics"},{"start":39,"end":49,"tag":"hospitals"},{"start":115,"end":120,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"annotations":{}},"conversation_id":"388342602178654208","possibly_sensitive":false,"created_at":"2013-10-10T16:37:46.000Z","referenced_tweets":[{"type":"retweeted","id":"388330706423660545"}],"id":"388342602178654208","text":"RT @EAAD_EU: Misuse of #antibiotics in #hospitals and primary care is leading factor of antibiotic resistance. See #EAAD factsheet http://t…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":106,"end":118,"tag":"Horizon2020"},{"start":119,"end":130,"tag":"innovation"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":26,"end":33,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":[{"start":34,"end":47,"probability":0.929,"type":"Person","normalized_text":"Michel Goldman"}]},"conversation_id":"388342433500499968","possibly_sensitive":false,"created_at":"2013-10-10T16:37:05.000Z","referenced_tweets":[{"type":"retweeted","id":"388327144549388289"}],"id":"388342433500499968","text":"RT @EFPIA: Interview with @IMI_JU Michel Goldman on Innovative Medicines Initiative &amp; success stories #Horizon2020 #innovation http://t.co/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":73,"end":87,"tag":"schizophrenia"},{"start":94,"end":105,"tag":"depression"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":106,"end":128,"url":"http://t.co/ZbZ8gOH58l","expanded_url":"http://bit.ly/17hGEY8","display_url":"bit.ly/17hGEY8"}],"annotations":{}},"conversation_id":"388342209558233088","possibly_sensitive":false,"created_at":"2013-10-10T16:36:12.000Z","referenced_tweets":[{"type":"retweeted","id":"388323857322360832"}],"id":"388342209558233088","text":"RT @IMI_JU: IMI project NEWMEDS is paving the way for new treatments for #schizophrenia &amp; #depression http://t.co/ZbZ8gOH58l #WorldMentalHe…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":26,"end":41,"tag":"ClinicalTrials"}],"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/dbnDLSAvks","expanded_url":"http://medcitynews.com/2013/10/indias-clinical-trials-called-question-industry-watching/#.UlbBrAaWTk8.twitter","display_url":"medcitynews.com/2013/10/indias…"}],"annotations":[{"start":18,"end":22,"probability":0.9817,"type":"Place","normalized_text":"India"},{"start":90,"end":101,"probability":0.5176,"type":"Organization","normalized_text":"MedCity News"}]},"conversation_id":"388341593746325504","possibly_sensitive":false,"created_at":"2013-10-10T16:33:45.000Z","referenced_tweets":[{"type":"retweeted","id":"388320023967567873"}],"id":"388341593746325504","text":"RT @sailinsomnia: India's #ClinicalTrials called into question again, industry watching - MedCity News: http://t.co/dbnDLSAvks","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"conversation_id":"388341447167987712","possibly_sensitive":false,"created_at":"2013-10-10T16:33:10.000Z","referenced_tweets":[{"type":"retweeted","id":"388319676272365569"}],"id":"388341447167987712","text":"RT @innovationunion: On the lookout for the genes behind disease: Today's information age has provided the tools for biology to yield... ht…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":21,"end":24,"tag":"EU"},{"start":53,"end":61,"tag":"Science"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"conversation_id":"388341356600381440","possibly_sensitive":false,"created_at":"2013-10-10T16:32:49.000Z","referenced_tweets":[{"type":"retweeted","id":"388319669314011138"}],"id":"388341356600381440","text":"RT @innovationunion: #EU urges 'closer ties' between #Science and industry: Bridging the gap between research institutes and... http://t.co…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":27,"tag":"Dementia"},{"start":31,"end":41,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":92,"end":114,"url":"http://t.co/SWF4oVAiW8","expanded_url":"http://bit.ly/GL3xNv","display_url":"bit.ly/GL3xNv"}],"annotations":{}},"conversation_id":"388341059131936768","possibly_sensitive":false,"created_at":"2013-10-10T16:31:38.000Z","referenced_tweets":[{"type":"retweeted","id":"388318056994177024"}],"id":"388341059131936768","text":"RT @euparkinsons: #Dementia in #Parkinson's disease: Usefulness of the pill questionnaire - http://t.co/SWF4oVAiW8","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":16,"end":22,"tag":"Crohn"},{"start":65,"end":73,"tag":"eHealth"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"urls":[{"start":85,"end":107,"url":"http://t.co/XUfxVQ6fSP","expanded_url":"http://www.euronews.com/2013/07/01/crohn-s-disease-the-inside-story/","display_url":"euronews.com/2013/07/01/cro…"}],"annotations":{}},"conversation_id":"388307126805729280","possibly_sensitive":false,"created_at":"2013-10-10T14:16:48.000Z","referenced_tweets":[{"type":"retweeted","id":"388306990872555520"}],"id":"388307126805729280","text":"RT @EU_eHealth: #Crohn's disease: the inside story - new imaging #eHealth techniques http://t.co/XUfxVQ6fSP","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":70,"end":92,"url":"http://t.co/HX1hX3bNsF","expanded_url":"http://mobile.bbc.co.uk/news/health-24462699","display_url":"mobile.bbc.co.uk/news/health-24…"}],"annotations":[{"start":13,"end":15,"probability":0.756,"type":"Organization","normalized_text":"BBC"},{"start":19,"end":27,"probability":0.3609,"type":"Other","normalized_text":"Alzheimer"}]},"conversation_id":"388306173423673346","possibly_sensitive":false,"created_at":"2013-10-10T14:13:00.000Z","referenced_tweets":[{"type":"retweeted","id":"388306085092032513"}],"id":"388306173423673346","text":"RT @GCessak: BBC | Alzheimer's breakthrough hailed as 'turning point' http://t.co/HX1hX3bNsF","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":121,"end":143,"url":"http://t.co/lAn7Hytwck","expanded_url":"http://bit.ly/1g2jC0O","display_url":"bit.ly/1g2jC0O"}],"annotations":{}},"conversation_id":"388294966813806592","possibly_sensitive":false,"created_at":"2013-10-10T13:28:28.000Z","referenced_tweets":{},"id":"388294966813806592","text":"RT @URPLWMiPB: FSME-IMMUN 0.5 ml &amp; FSME-IMMUN 0.25 ml Junior; vaccine syringe with permanently attached needle leaks http://t.co/lAn7Hytwck","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"urls":[{"start":48,"end":70,"url":"http://t.co/7nDzSmrvxU","expanded_url":"http://www.alz.co.uk/news/research-identifies-new-compound-that-could-stop-neurodegeneration","display_url":"alz.co.uk/news/research-…"}],"annotations":{}},"conversation_id":"388294314893135872","possibly_sensitive":false,"created_at":"2013-10-10T13:25:53.000Z","referenced_tweets":[{"type":"retweeted","id":"388283778281402368"}],"id":"388294314893135872","text":"RT @AlzDisInt: Thoughts on today's Alz headline http://t.co/7nDzSmrvxU","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":66,"end":88,"url":"http://t.co/b0WWZeMgK9","expanded_url":"http://bbc.in/17giZrk","display_url":"bbc.in/17giZrk"}],"annotations":[{"start":12,"end":20,"probability":0.3787,"type":"Person","normalized_text":"Alzheimer"}]},"conversation_id":"388293877020389376","possibly_sensitive":false,"created_at":"2013-10-10T13:24:09.000Z","referenced_tweets":[{"type":"retweeted","id":"388281436593074176"}],"id":"388293877020389376","text":"RT @EFPIA: \"Alzheimer's breakthrough hailed as 'turning point'\" - http://t.co/b0WWZeMgK9","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":72,"end":82,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{}},"conversation_id":"388291404197146624","possibly_sensitive":false,"created_at":"2013-10-10T13:14:19.000Z","referenced_tweets":[{"type":"retweeted","id":"388272754488639488"}],"id":"388291404197146624","text":"RT @euparkinsons: Prevalence &amp; features of peripheral neuropathy in #Parkinson's disease patients under different therapeutic regimens: htt…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":31,"end":38,"tag":"tender"},{"start":63,"end":75,"tag":"consultancy"},{"start":101,"end":113,"tag":"procurement"}],"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/suUSdhvjp7","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"annotations":{}},"conversation_id":"388261368526163968","possibly_sensitive":false,"created_at":"2013-10-10T11:14:58.000Z","referenced_tweets":{},"id":"388261368526163968","text":"One week left to apply for our #tender for high-level business #consultancy: http://t.co/suUSdhvjp7  #procurement","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/2L38IQmcoP","expanded_url":"http://bit.ly/1acjgwa","display_url":"bit.ly/1acjgwa"}],"annotations":{}},"conversation_id":"388258176665399296","possibly_sensitive":false,"created_at":"2013-10-10T11:02:17.000Z","referenced_tweets":{},"id":"388258176665399296","text":"We're hosting a workshop on prevention of product shortages due to manufacturing and quality problems on 14 October: http://t.co/2L38IQmcoP","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":31,"end":41,"tag":"Parkinson"},{"start":67,"end":85,"tag":"neurodegenerative"},{"start":101,"end":111,"tag":"Alzheimer"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{}},"conversation_id":"388257770580869120","possibly_sensitive":false,"created_at":"2013-10-10T11:00:40.000Z","referenced_tweets":[{"type":"retweeted","id":"388257651634610177"}],"id":"388257770580869120","text":"RT @euparkinsons: Did u know...#Parkinson's is the 2nd most common #neurodegenerative disease (after #Alzheimer’s disease) http://t.co/oskw…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":48,"end":70,"url":"http://t.co/88ZX1ywCHO","expanded_url":"http://www.who.int/mental_health/en/","display_url":"who.int/mental_health/…"}],"annotations":[{"start":23,"end":45,"probability":0.8578,"type":"Other","normalized_text":"World Mental Health Day"}]},"conversation_id":"388249578601840640","possibly_sensitive":false,"created_at":"2013-10-10T10:28:07.000Z","referenced_tweets":[{"type":"retweeted","id":"388247163928461312"}],"id":"388249578601840640","text":"RT @GCessak: WHO about World Mental Health Day: http://t.co/88ZX1ywCHO","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":47,"end":69,"url":"http://t.co/nWXrByEud4","expanded_url":"http://bit.ly/18RiN4N","display_url":"bit.ly/18RiN4N"}],"annotations":[{"start":22,"end":44,"probability":0.8681,"type":"Other","normalized_text":"World Mental Health Day"}]},"conversation_id":"388249491196768256","possibly_sensitive":false,"created_at":"2013-10-10T10:27:46.000Z","referenced_tweets":{},"id":"388249491196768256","text":"RT @GCessak: Today is World Mental Health Day: http://t.co/nWXrByEud4","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":44,"end":47,"tag":"EU"},{"start":48,"end":56,"tag":"Mercury"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":65,"end":87,"url":"http://t.co/qydLHYXlJZ","expanded_url":"http://bit.ly/1g1UWps","display_url":"bit.ly/1g1UWps"}],"annotations":{}},"conversation_id":"388248963045785601","possibly_sensitive":false,"created_at":"2013-10-10T10:25:40.000Z","referenced_tweets":[{"type":"retweeted","id":"388245036879474688"}],"id":"388248963045785601","text":"RT @EU_Commission: Questions and answers on #EU #Mercury Policy: http://t.co/qydLHYXlJZ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":101,"end":124,"url":"https://t.co/OJ0ukwBxqZ","expanded_url":"https://www.evidence.nhs.uk/about-evidence-services/bulletins-and-alerts/eyes-on-evidence/eyes-on-evidence-2013","display_url":"evidence.nhs.uk/about-evidence…"}],"annotations":{}},"conversation_id":"388243856551972864","possibly_sensitive":false,"created_at":"2013-10-10T10:05:23.000Z","referenced_tweets":[{"type":"retweeted","id":"388243621360570368"}],"id":"388243856551972864","text":"RT @NICEcomms: For expert commentary on new evidence, read Eyes on Evidence. October edition out now https://t.co/OJ0ukwBxqZ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"annotations":[{"start":33,"end":55,"probability":0.8684,"type":"Other","normalized_text":"World Mental Health Day"}]},"conversation_id":"388238777686056960","possibly_sensitive":false,"created_at":"2013-10-10T09:45:12.000Z","referenced_tweets":[{"type":"retweeted","id":"388238516028596225"}],"id":"388238777686056960","text":"RT @URPLWMiPB: We are supporting World Mental Health Day today","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":48,"end":70,"url":"http://t.co/dmnssRdYwn","expanded_url":"http://bit.ly/1bJ22xg","display_url":"bit.ly/1bJ22xg"}],"annotations":[{"start":24,"end":46,"probability":0.8605,"type":"Other","normalized_text":"World Mental Health Day"}]},"conversation_id":"388238693007237120","possibly_sensitive":false,"created_at":"2013-10-10T09:44:52.000Z","referenced_tweets":{},"id":"388238693007237120","text":"RT @URPLWMiPB: Today is World Mental Health Day http://t.co/dmnssRdYwn","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":49,"end":71,"url":"http://t.co/9WWsV4w5Qt","expanded_url":"http://bit.ly/162bvrx","display_url":"bit.ly/162bvrx"}],"annotations":[{"start":18,"end":40,"probability":0.7646,"type":"Other","normalized_text":"World Mental Health Day"}]},"conversation_id":"388237370371612672","possibly_sensitive":false,"created_at":"2013-10-10T09:39:36.000Z","referenced_tweets":{},"id":"388237370371612672","text":"We are supporting World Mental Health Day today: http://t.co/9WWsV4w5Qt","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":107,"end":129,"url":"http://t.co/XE3A8wXrjp","expanded_url":"http://bit.ly/1beknhc","display_url":"bit.ly/1beknhc"}],"annotations":{}},"conversation_id":"388236525516779520","possibly_sensitive":false,"created_at":"2013-10-10T09:36:15.000Z","referenced_tweets":{},"id":"388236525516779520","text":"RT @GCessak: We have published our monthly newsletter on authorised medicinal products, for September 2013 http://t.co/XE3A8wXrjp","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":31,"end":38,"tag":"tender"},{"start":63,"end":75,"tag":"consultancy"},{"start":101,"end":113,"tag":"procurement"}],"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/suUSdhvjp7","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"annotations":{}},"conversation_id":"388234716786089985","possibly_sensitive":false,"created_at":"2013-10-10T09:29:04.000Z","referenced_tweets":{},"id":"388234716786089985","text":"One more week to apply for our #tender for high-level business #consultancy: http://t.co/suUSdhvjp7  #procurement","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":28,"tag":"Parkinson"},{"start":50,"end":55,"tag":"stem"},{"start":92,"end":102,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":112,"end":134,"url":"http://t.co/gs23SYv6Rr","expanded_url":"http://bit.ly/18OFEhl","display_url":"bit.ly/18OFEhl"}],"annotations":{}},"conversation_id":"388233683271835648","possibly_sensitive":false,"created_at":"2013-10-10T09:24:57.000Z","referenced_tweets":[{"type":"retweeted","id":"388227452025049088"}],"id":"388233683271835648","text":"RT @euparkinsons: #Parkinson disease &amp; use of #stem cells for therapeutic approaches of #Parkinson disease: http://t.co/gs23SYv6Rr","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":96,"end":118,"url":"http://t.co/Un1TNy2a9f","expanded_url":"http://bit.ly/1bJ0CCF","display_url":"bit.ly/1bJ0CCF"}],"annotations":{}},"conversation_id":"388233466409517056","possibly_sensitive":false,"created_at":"2013-10-10T09:24:06.000Z","referenced_tweets":{},"id":"388233466409517056","text":"RT @URPLWMiPB: We have published a monthly newsletter on medicinal products for September 2013  http://t.co/Un1TNy2a9f","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":80,"end":102,"url":"http://t.co/HAGxxqtU37","expanded_url":"http://bit.ly/16x4VNu","display_url":"bit.ly/16x4VNu"}],"annotations":{}},"conversation_id":"388229540125757440","possibly_sensitive":false,"created_at":"2013-10-10T09:08:29.000Z","referenced_tweets":{},"id":"388229540125757440","text":"Our SME workshop dedicated to veterinary topics takes place on 7 November 2013: http://t.co/HAGxxqtU37","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":19,"end":27,"tag":"WDC2013"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"urls":[{"start":106,"end":128,"url":"http://t.co/Z2HuBeZ8gZ","expanded_url":"http://bit.ly/12feGZn","display_url":"bit.ly/12feGZn"}],"annotations":{}},"conversation_id":"387939742437748736","possibly_sensitive":false,"created_at":"2013-10-09T13:56:56.000Z","referenced_tweets":[{"type":"retweeted","id":"387935249541234688"}],"id":"387939742437748736","text":"RT @WDD: Check the #WDC2013 programme overview... Scientific sessions, poster presentations and much more http://t.co/Z2HuBeZ8gZ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/8EbMYBP6cz","expanded_url":"http://bit.ly/16x4VNu","display_url":"bit.ly/16x4VNu"}],"annotations":{}},"conversation_id":"387932203231244288","possibly_sensitive":false,"created_at":"2013-10-09T13:26:59.000Z","referenced_tweets":{},"id":"387932203231244288","text":"We're organising an SME workshop dedicated to veterinary topics on 7 November 2013: http://t.co/8EbMYBP6cz","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":92,"end":103,"tag":"medication"},{"start":105,"end":114,"tag":"Clinical"},{"start":128,"end":138,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{}},"conversation_id":"387618700188086272","possibly_sensitive":false,"created_at":"2013-10-08T16:41:14.000Z","referenced_tweets":[{"type":"retweeted","id":"387615922606714880"}],"id":"387618700188086272","text":"RT @euparkinsons: Did u know.... it can take around 13 years 2 develop &amp; register a new #medication? #Clinical trials &amp; #Parkinson's http:/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":34,"end":41,"tag":"Patent"},{"start":90,"end":99,"tag":"Shutdown"},{"start":123,"end":134,"tag":"fdaLawBlog"}],"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/PeZLmxFzqL","expanded_url":"http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2013/10/the-shutdown-an-update-on-fda-activities.html","display_url":"fdalawblog.net/fda_law_blog_h…"}],"annotations":{}},"conversation_id":"387595565329965056","possibly_sensitive":false,"created_at":"2013-10-08T15:09:18.000Z","referenced_tweets":[{"type":"retweeted","id":"387587371371200513"}],"id":"387595565329965056","text":"RT @sailinsomnia: What Happens to #Patent Terms, 180-Day Exclusivity and ANDAs During the #Shutdown?http://t.co/PeZLmxFzqL #fdaLawBlog","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":52,"end":56,"tag":"FDA"},{"start":87,"end":96,"tag":"Shutdown"}],"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/A3B4a3wwIq","expanded_url":"http://www.fda.gov/ForIndustry/ucm370652.htm","display_url":"fda.gov/ForIndustry/uc…"}],"annotations":{}},"conversation_id":"387595446022975489","possibly_sensitive":false,"created_at":"2013-10-08T15:08:50.000Z","referenced_tweets":[{"type":"retweeted","id":"387586818117357568"}],"id":"387595446022975489","text":"RT @sailinsomnia: Everything You Need to Know About #FDA During the Federal Government #Shutdown http://t.co/A3B4a3wwIq","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":23,"tag":"CBER"},{"start":43,"end":52,"tag":"shutdown"}],"mentions":{},"urls":[{"start":53,"end":75,"url":"http://t.co/LZtOoCrjFX","expanded_url":"http://www.biocentury.com/dailynews/politics/2013-10-07/cber-workshop-victim-of-shutdown","display_url":"biocentury.com/dailynews/poli…"}],"annotations":{}},"conversation_id":"387573624581795840","possibly_sensitive":false,"created_at":"2013-10-08T13:42:07.000Z","referenced_tweets":[{"type":"retweeted","id":"387573538552442880"}],"id":"387573624581795840","text":"RT @sailinsomnia: #CBER workshop victim of #shutdown http://t.co/LZtOoCrjFX","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":22,"tag":"FDA"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/l1pDUCy1sZ","expanded_url":"http://onforb.es/1cnYRud","display_url":"onforb.es/1cnYRud"}],"annotations":{}},"conversation_id":"387573476405424128","possibly_sensitive":false,"created_at":"2013-10-08T13:41:32.000Z","referenced_tweets":[{"type":"retweeted","id":"387573133533655040"}],"id":"387573476405424128","text":"RT @sailinsomnia: #FDA Is Accused Of Attending \"Inappropriate\" Meetings, But Critics Are Missing Key Points  http://t.co/l1pDUCy1sZ via @fo…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":22,"tag":"FDA"},{"start":38,"end":50,"tag":"inspections"},{"start":61,"end":66,"tag":"drug"}],"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/ktHB800Vb9","expanded_url":"http://mintne.ws/1bTb9be","display_url":"mintne.ws/1bTb9be"}],"annotations":{}},"conversation_id":"387573192593641473","possibly_sensitive":false,"created_at":"2013-10-08T13:40:24.000Z","referenced_tweets":[{"type":"retweeted","id":"387572324813135872"}],"id":"387573192593641473","text":"RT @sailinsomnia: #FDA plans surprise #inspections at Indian #drug units http://t.co/ktHB800Vb9","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":63,"end":85,"url":"http://t.co/5qqekRVAWL","expanded_url":"http://bit.ly/1afAtpV","display_url":"bit.ly/1afAtpV"}],"annotations":{}},"conversation_id":"387569546434850816","possibly_sensitive":false,"created_at":"2013-10-08T13:25:55.000Z","referenced_tweets":{},"id":"387569546434850816","text":"We published yesterday our Management Board meeting's outcome: http://t.co/5qqekRVAWL","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":48,"end":55,"tag":"health"},{"start":56,"end":67,"tag":"regulatory"}],"mentions":[{"start":109,"end":125,"username":"wordpressdotcom","id":"823905"}],"urls":[{"start":82,"end":104,"url":"http://t.co/MVh9ONXK5V","expanded_url":"http://wp.me/p1OhIZ-rp","display_url":"wp.me/p1OhIZ-rp"}],"annotations":{}},"conversation_id":"387567473022607361","possibly_sensitive":false,"created_at":"2013-10-08T13:17:40.000Z","referenced_tweets":[{"type":"retweeted","id":"387567299873349633"}],"id":"387567473022607361","text":"RT @sailinsomnia: New tool to understand global #health #regulatory requirements  http://t.co/MVh9ONXK5V via @wordpressdotcom","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":44,"end":52,"tag":"tobacco"},{"start":85,"end":89,"tag":"TPD"}],"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"},{"start":69,"end":84,"username":"EP_Environment","id":"951333319"}],"urls":{},"annotations":{}},"conversation_id":"387558221700804608","possibly_sensitive":false,"created_at":"2013-10-08T12:40:55.000Z","referenced_tweets":[{"type":"retweeted","id":"387556655397097472"}],"id":"387558221700804608","text":"RT @Europarl_EN: For more information about #tobacco decision, check @EP_Environment #TPD","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":17,"end":25,"tag":"Tobacco"}],"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"}],"urls":{},"annotations":{}},"conversation_id":"387558166394699776","possibly_sensitive":false,"created_at":"2013-10-08T12:40:42.000Z","referenced_tweets":[{"type":"retweeted","id":"387556535020572672"}],"id":"387558166394699776","text":"RT @Europarl_EN: #Tobacco: 65 % of cigarette packs with warning, flavours banned,  e-cigarettes ONLY med. products if curative/preventive p…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":112,"end":134,"url":"http://t.co/PjjPw7WZqW","expanded_url":"http://bit.ly/15VGeGD","display_url":"bit.ly/15VGeGD"}],"annotations":{}},"conversation_id":"387544675843723264","possibly_sensitive":false,"created_at":"2013-10-08T11:47:05.000Z","referenced_tweets":{},"id":"387544675843723264","text":"RT @GCessak: Our campaign is encouraging patients to read package leaflets of medicines and report side effects http://t.co/PjjPw7WZqW","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":15,"end":24,"tag":"Hospital"},{"start":25,"end":37,"tag":"pharmacists"},{"start":65,"end":78,"tag":"transparency"},{"start":117,"end":134,"tag":"hospitalpharmacy"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":106,"end":116,"username":"PMLiVEcom","id":"45543166"}],"urls":[{"start":79,"end":101,"url":"http://t.co/K1pDm72Dcn","expanded_url":"http://www.pmlive.com/pharma_news/pharmacists_back_trial_transparency_in_europe_508317#.UlPmws5OX_I.twitter","display_url":"pmlive.com/pharma_news/ph…"}],"annotations":{}},"conversation_id":"387534461329354752","possibly_sensitive":false,"created_at":"2013-10-08T11:06:30.000Z","referenced_tweets":[{"type":"retweeted","id":"387534342924169217"}],"id":"387534461329354752","text":"RT @EAHPtweet: #Hospital #pharmacists back clinical trial result #transparency http://t.co/K1pDm72Dcn via @pmlivecom #hospitalpharmacy #ctd…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":111,"end":133,"url":"http://t.co/GW4g47cKhf","expanded_url":"http://bit.ly/19wpNH2","display_url":"bit.ly/19wpNH2"}],"annotations":{}},"conversation_id":"387524183627821056","possibly_sensitive":false,"created_at":"2013-10-08T10:25:39.000Z","referenced_tweets":{},"id":"387524183627821056","text":"RT @GCessak: Poster: READ PATIENT LEAFLET - shared iniative from Polish medicines agency and patient ombudsman http://t.co/GW4g47cKhf","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":19,"end":33,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":105,"end":127,"url":"http://t.co/jM3BIWje0W","expanded_url":"http://bit.ly/19wnhk0","display_url":"bit.ly/19wnhk0"}],"annotations":{}},"conversation_id":"387518368552480769","possibly_sensitive":false,"created_at":"2013-10-08T10:02:33.000Z","referenced_tweets":{},"id":"387518368552480769","text":"RT @URPLWMiPB: The #blacktriangle does not mean that the medicine is unsafe - joint information campaign http://t.co/jM3BIWje0W","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":27,"end":41,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":118,"end":140,"url":"http://t.co/r8wODAJ8QY","expanded_url":"http://bit.ly/GEJmjL","display_url":"bit.ly/GEJmjL"}],"annotations":{}},"conversation_id":"387515348246724609","possibly_sensitive":false,"created_at":"2013-10-08T09:50:33.000Z","referenced_tweets":{},"id":"387515348246724609","text":"RT @URPLWMiPB: What is the #blacktriangle? Read package leaflet: Polish medicines agency / patient ombudsman iniative http://t.co/r8wODAJ8QY","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Cw5jvVf1pU","expanded_url":"http://bit.ly/17Rfn2n","display_url":"bit.ly/17Rfn2n"}],"annotations":{}},"conversation_id":"387506965015838720","possibly_sensitive":false,"created_at":"2013-10-08T09:17:14.000Z","referenced_tweets":{},"id":"387506965015838720","text":"RT @URPLWMiPB: Read the package leaflet - shared initiative from Polish medicines agency and patients' ombudsman. http://t.co/Cw5jvVf1pU","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":25,"tag":"Antibiotics"},{"start":119,"end":124,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":[{"start":96,"end":118,"url":"http://t.co/bCoM2KvAtM","expanded_url":"http://bit.ly/15XE2hZ","display_url":"bit.ly/15XE2hZ"}],"annotations":{}},"conversation_id":"387502947120054272","possibly_sensitive":false,"created_at":"2013-10-08T09:01:16.000Z","referenced_tweets":{},"id":"387502947120054272","text":"RT @EAAD_EU: #Antibiotics are useless against colds and the flu. They must be taken responsibly http://t.co/bCoM2KvAtM #EAAD","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":88,"end":102,"tag":"nanocolloidal"}],"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/efnBwDyeNt","expanded_url":"http://bit.ly/GIE1HX","display_url":"bit.ly/GIE1HX"}],"annotations":{}},"conversation_id":"387495266552516609","possibly_sensitive":false,"created_at":"2013-10-08T08:30:45.000Z","referenced_tweets":{},"id":"387495266552516609","text":"Send us your comments on our draft reflection paper on data requirements for iron-based #nanocolloidal products: http://t.co/efnBwDyeNt","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"hashtags":[{"start":82,"end":86,"tag":"GMP"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/3Jn9RJRXbq","expanded_url":"http://bit.ly/16NYvM2","display_url":"bit.ly/16NYvM2"}],"annotations":[{"start":4,"end":5,"probability":0.5515,"type":"Organization","normalized_text":"EU"},{"start":11,"end":15,"probability":0.8619,"type":"Place","normalized_text":"Japan"}]},"conversation_id":"387495186265153536","possibly_sensitive":false,"created_at":"2013-10-08T08:30:26.000Z","referenced_tweets":{},"id":"387495186265153536","text":"The EU and Japan are now sharing more information on good manufacturing practice (#GMP) using the EudraGMDP database: http://t.co/3Jn9RJRXbq","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":19,"end":33,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"387494799525150720","possibly_sensitive":false,"created_at":"2013-10-08T08:28:54.000Z","referenced_tweets":{},"id":"387494799525150720","text":"Find out about the #blacktriangle and additional monitoring of medicines. See our video, factsheet and webpages: http://t.co/ZzDNIqm0Nk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":35,"tag":"drugsafety"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":104,"end":108,"username":"BMJ","id":"540569441"}],"urls":[{"start":109,"end":131,"url":"http://t.co/EB1n2sALbM","expanded_url":"http://bit.ly/GEEOtM","display_url":"bit.ly/GEEOtM"}],"annotations":{}},"conversation_id":"387493027238785024","possibly_sensitive":false,"created_at":"2013-10-08T08:21:51.000Z","referenced_tweets":[{"type":"retweeted","id":"387491624898396160"}],"id":"387493027238785024","text":"RT @HAIEurope: Canadian #drugsafety initiative wins global support in campaign to have funding restored @BMJ http://t.co/EB1n2sALbM","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":116,"end":138,"url":"http://t.co/o3klhEZjlA","expanded_url":"http://bit.ly/1e5zc7y","display_url":"bit.ly/1e5zc7y"}],"annotations":{}},"conversation_id":"387492290991640576","possibly_sensitive":false,"created_at":"2013-10-08T08:18:56.000Z","referenced_tweets":{},"id":"387492290991640576","text":"RT @URPLWMiPB: Info on implementation of Commission and Council decision on medicines containing ergot derivatives: http://t.co/o3klhEZjlA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":117,"end":139,"url":"http://t.co/ul6tIlPzTJ","expanded_url":"http://bit.ly/1e5z4oL","display_url":"bit.ly/1e5z4oL"}],"annotations":[{"start":43,"end":64,"probability":0.4584,"type":"Organization","normalized_text":"Commission and Council"}]},"conversation_id":"387491677494984705","possibly_sensitive":false,"created_at":"2013-10-08T08:16:29.000Z","referenced_tweets":{},"id":"387491677494984705","text":"RT @GCessak: Info on implementation of the Commission and Council decision on medicines containing ergot derivatives http://t.co/ul6tIlPzTJ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":107,"end":121,"tag":"nanocolloidal"}],"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":18,"end":27,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"conversation_id":"387239150509776898","possibly_sensitive":false,"created_at":"2013-10-07T15:33:02.000Z","referenced_tweets":[{"type":"retweeted","id":"387239033643880448"}],"id":"387239150509776898","text":"RT @EU_Consumer: .@EMA_News invites comments on draft reflection paper on data requirements for iron-based #nanocolloidal products: http://…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":90,"end":104,"tag":"nanocolloidal"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/PIP7RTvozv","expanded_url":"http://bit.ly/GIE1HX","display_url":"bit.ly/GIE1HX"}],"annotations":{}},"conversation_id":"387238801846050816","possibly_sensitive":false,"created_at":"2013-10-07T15:31:39.000Z","referenced_tweets":{},"id":"387238801846050816","text":"We're inviting comments on our draft reflection paper on data requirements for iron-based #nanocolloidal products: http://t.co/PIP7RTvozv","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":80,"end":85,"tag":"AGES"},{"start":86,"end":91,"tag":"BASG"},{"start":92,"end":112,"tag":"medicinesupervision"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":113,"end":135,"url":"http://t.co/spgYORW5qB","expanded_url":"http://bit.ly/17g5lU2","display_url":"bit.ly/17g5lU2"}],"annotations":[{"start":14,"end":36,"probability":0.387,"type":"Person","normalized_text":"Christa Wirthumer-Hoche"}]},"conversation_id":"387234667948019713","possibly_sensitive":false,"created_at":"2013-10-07T15:15:13.000Z","referenced_tweets":{},"id":"387234667948019713","text":"RT @agesnews: Christa Wirthumer-Hoche new head of the Austrian medicines agency #AGES #BASG #medicinesupervision http://t.co/spgYORW5qB","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":79,"end":83,"tag":"GMP"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/TUUH0M4IwF","expanded_url":"http://bit.ly/16NYvM2","display_url":"bit.ly/16NYvM2"}],"annotations":[{"start":0,"end":1,"probability":0.6833,"type":"Organization","normalized_text":"EU"},{"start":7,"end":11,"probability":0.7943,"type":"Place","normalized_text":"Japan"}]},"conversation_id":"387209549419388928","possibly_sensitive":false,"created_at":"2013-10-07T13:35:25.000Z","referenced_tweets":{},"id":"387209549419388928","text":"EU and Japan have improved information-sharing in good manufacturing practice (#GMP) using the EudraGMDP database: http://t.co/TUUH0M4IwF","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":63,"end":85,"url":"http://t.co/X9fLQS84Ma","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2013/10/WC500151487.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{}},"conversation_id":"387209121830694912","possibly_sensitive":false,"created_at":"2013-10-07T13:33:43.000Z","referenced_tweets":[{"type":"retweeted","id":"387208173779566592"}],"id":"387209121830694912","text":"RT @GCessak: EMA's Human medicines highlights - September 2013 http://t.co/X9fLQS84Ma","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":[{"start":13,"end":56,"probability":0.2877,"type":"Organization","normalized_text":"European Medicines Agency's Management Board"}]},"conversation_id":"387209078272823296","possibly_sensitive":false,"created_at":"2013-10-07T13:33:32.000Z","referenced_tweets":[{"type":"retweeted","id":"387207862855798784"}],"id":"387209078272823296","text":"RT @GCessak: European Medicines Agency's Management Board supports plan to publish agendas and minutes of all committees http://t.co/ccM6wW…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":23,"tag":"Labs"},{"start":34,"end":41,"tag":"safety"},{"start":57,"end":63,"tag":"drugs"}],"mentions":[{"start":111,"end":126,"username":"washingtonpost","id":"2467791"}],"urls":[{"start":84,"end":106,"url":"http://t.co/HJQekCQ8vH","expanded_url":"http://wapo.st/1e1zBaZ","display_url":"wapo.st/1e1zBaZ"}],"annotations":{}},"conversation_id":"387208588126474240","possibly_sensitive":false,"created_at":"2013-10-07T13:31:36.000Z","referenced_tweets":[{"type":"retweeted","id":"387200049437872128"}],"id":"387208588126474240","text":"RT @sailinsomnia: #Labs that test #safety of custom-made #drugs fall under scrutiny http://t.co/HJQekCQ8vH via @washingtonpost","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":25,"end":36,"tag":"Drugmakers"},{"start":59,"end":68,"tag":"Novartis"}],"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/EmC5UQwajd","expanded_url":"http://www.pharmalive.com/should-drugmakers-pay-punitive-damages-novartis-says-no","display_url":"pharmalive.com/should-drugmak…"}],"annotations":{}},"conversation_id":"387208387378696192","possibly_sensitive":false,"created_at":"2013-10-07T13:30:48.000Z","referenced_tweets":[{"type":"retweeted","id":"387199902704336896"}],"id":"387208387378696192","text":"RT @sailinsomnia: Should #Drugmakers Pay Punitive Damages? #Novartis Says No | Pharmalot http://t.co/EmC5UQwajd","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":61,"end":83,"url":"http://t.co/TwVhz7uXhZ","expanded_url":"http://bit.ly/1afAtpV","display_url":"bit.ly/1afAtpV"}],"annotations":{}},"conversation_id":"387206739000840192","possibly_sensitive":false,"created_at":"2013-10-07T13:24:15.000Z","referenced_tweets":{},"id":"387206739000840192","text":"We've just published our Management Board meeting's outcome: http://t.co/TwVhz7uXhZ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":26,"tag":"Ranbaxy"},{"start":37,"end":41,"tag":"FDA"}],"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/xLe48pErtV","expanded_url":"http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/ranbaxy-hunts-for-fda-okayed-plants-in-india/articleshow/23622618.cms","display_url":"economictimes.indiatimes.com/news/news-by-i…"}],"annotations":[{"start":59,"end":63,"probability":0.9995,"type":"Place","normalized_text":"India"}]},"conversation_id":"387198598561021952","possibly_sensitive":false,"created_at":"2013-10-07T12:51:54.000Z","referenced_tweets":[{"type":"retweeted","id":"387197504900440064"}],"id":"387198598561021952","text":"RT @sailinsomnia: #Ranbaxy hunts for #FDA-okayed plants in India to get Around Import Ban http://t.co/xLe48pErtV","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":66,"end":88,"url":"http://t.co/R9v7McEfsV","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&DOC=6&CAT=NEWS&QUERY=014192e10762:cb99:23c47268&RCN=36131","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"annotations":{}},"conversation_id":"387195525805527040","possibly_sensitive":false,"created_at":"2013-10-07T12:39:41.000Z","referenced_tweets":[{"type":"retweeted","id":"387192257226354689"}],"id":"387195525805527040","text":"RT @GCessak: EC | Understanding the brain to relieve chronic pain http://t.co/R9v7McEfsV","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":100,"end":122,"url":"http://t.co/FUL09U7FAv","expanded_url":"http://bit.ly/16t4Bz6","display_url":"bit.ly/16t4Bz6"}],"annotations":[{"start":29,"end":51,"probability":0.7433,"type":"Other","normalized_text":"Nordic Life Science Day"}]},"conversation_id":"387195401037553664","possibly_sensitive":false,"created_at":"2013-10-07T12:39:12.000Z","referenced_tweets":{},"id":"387195401037553664","text":"RT @LV_MPA: One week left to Nordic Life Science Day - Meet us, EMA and our Nordic colleagues there http://t.co/FUL09U7FAv","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":22,"tag":"Evarrest"},{"start":24,"end":35,"tag":"fibrinogen"},{"start":38,"end":47,"tag":"thrombin"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/AcVW3f8lWz","expanded_url":"http://bit.ly/198rF6G","display_url":"bit.ly/198rF6G"}],"annotations":{}},"conversation_id":"387173292391424000","possibly_sensitive":false,"created_at":"2013-10-07T11:11:20.000Z","referenced_tweets":{},"id":"387173292391424000","text":"The EPAR for #Evarrest (#fibrinogen / #thrombin) to help stop bleeding during surgery is available on our website: http://t.co/AcVW3f8lWz","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":23,"end":37,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"387172956381528064","possibly_sensitive":false,"created_at":"2013-10-07T11:10:00.000Z","referenced_tweets":{},"id":"387172956381528064","text":"Watch our video on the #blacktriangle and additional monitoring of medicines: http://t.co/ZzDNIqm0Nk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":58,"end":80,"url":"http://t.co/1pMEJFwFHz","expanded_url":"http://bit.ly/1gj74zN","display_url":"bit.ly/1gj74zN"}],"annotations":{}},"conversation_id":"387169423720583168","possibly_sensitive":false,"created_at":"2013-10-07T10:55:58.000Z","referenced_tweets":{},"id":"387169423720583168","text":"RT @INFARMED_IP: Third conference 'biosimilar medicines'  http://t.co/1pMEJFwFHz","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":70,"end":92,"url":"http://t.co/PjjPw7WZqW","expanded_url":"http://bit.ly/15VGeGD","display_url":"bit.ly/15VGeGD"}],"annotations":{}},"conversation_id":"387165088102096896","possibly_sensitive":false,"created_at":"2013-10-07T10:38:44.000Z","referenced_tweets":{},"id":"387165088102096896","text":"RT @GCessak: Service for reporting side effects by patients launched: http://t.co/PjjPw7WZqW","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":51,"tag":"Evarrest"},{"start":53,"end":64,"tag":"fibrinogen"},{"start":67,"end":76,"tag":"thrombin"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/U17RBeL0Ub","expanded_url":"http://bit.ly/198rF6G","display_url":"bit.ly/198rF6G"}],"annotations":{}},"conversation_id":"387163074924646400","possibly_sensitive":false,"created_at":"2013-10-07T10:30:44.000Z","referenced_tweets":{},"id":"387163074924646400","text":"We've published the assessment report for #Evarrest (#fibrinogen / #thrombin) to help stop bleeding during surgery: http://t.co/U17RBeL0Ub","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":16,"end":30,"tag":"fluprevention"}],"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"urls":[{"start":110,"end":132,"url":"http://t.co/5B2hPtFjpn","expanded_url":"http://bit.ly/15VEOvQ","display_url":"bit.ly/15VEOvQ"}],"annotations":{}},"conversation_id":"387159896686202880","possibly_sensitive":false,"created_at":"2013-10-07T10:18:07.000Z","referenced_tweets":{},"id":"387159896686202880","text":"RT @sanidadgob: #fluprevention Do not self-medicate; antibiotics are not effective against influenza viruses. http://t.co/5B2hPtFjpn","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"urls":[{"start":73,"end":95,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{}},"conversation_id":"387130470867017728","possibly_sensitive":false,"created_at":"2013-10-07T10:00:29.000Z","referenced_tweets":[{"type":"replied_to","id":"387134868431179776"}],"id":"387155461805309952","text":"@trinevillemann Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":104,"end":113,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/0vePf6FsRo","expanded_url":"https://twitter.com/JeanGeorgesAE/status/387150198410997760/photo/1","display_url":"pic.twitter.com/0vePf6FsRo"}],"annotations":{}},"conversation_id":"387151717076176896","possibly_sensitive":false,"created_at":"2013-10-07T09:45:36.000Z","referenced_tweets":[{"type":"retweeted","id":"387150198410997760"}],"id":"387151717076176896","text":"RT @JeanGeorgesAE: Nice souvenir of the last meeting of the Working Party with patient organisations at @EMA_News http://t.co/0vePf6FsRo","attachments":{"media_keys":["3_387150198415192064"]}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":[{"start":113,"end":135,"url":"http://t.co/NGpWzE4SwZ","expanded_url":"http://bit.ly/1gtlHhn","display_url":"bit.ly/1gtlHhn"}],"annotations":[{"start":34,"end":54,"probability":0.4515,"type":"Organization","normalized_text":"Regulatory Rapporteur"}]},"conversation_id":"387141019487064067","possibly_sensitive":false,"created_at":"2013-10-07T09:03:06.000Z","referenced_tweets":[{"type":"retweeted","id":"387140886154321920"}],"id":"387141019487064067","text":"RT @TOPRANEWS: October's issue of Regulatory Rapporteur looks at the impact of the pharmacovigilance legislation http://t.co/NGpWzE4SwZ #ph…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":45,"end":59,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":76,"end":98,"url":"http://t.co/KkyczDRQNf","expanded_url":"http://bit.ly/1fcdF04","display_url":"bit.ly/1fcdF04"},{"start":110,"end":132,"url":"http://t.co/yMYbBzO3uX","expanded_url":"http://bit.ly/15VyHb1","display_url":"bit.ly/15VyHb1"}],"annotations":{}},"conversation_id":"387140404182659073","possibly_sensitive":false,"created_at":"2013-10-07T09:00:39.000Z","referenced_tweets":{},"id":"387140404182659073","text":"RT @Aifa_ufficiale: Medicines: what does the #blacktriangle mean? Factsheet http://t.co/KkyczDRQNf  and video http://t.co/yMYbBzO3uX","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":112,"end":134,"url":"http://t.co/OYREO9rkgT","expanded_url":"http://bit.ly/15VyWTc","display_url":"bit.ly/15VyWTc"}],"annotations":{}},"conversation_id":"387140282682048513","possibly_sensitive":false,"created_at":"2013-10-07T09:00:10.000Z","referenced_tweets":{},"id":"387140282682048513","text":"RT @GCessak: Signing of agreement and joint briefing with the patient campaign for reporting of adverse events: http://t.co/OYREO9rkgT","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"},{"start":100,"end":109,"username":"marcwort","id":"284577403"}],"urls":[{"start":77,"end":99,"url":"http://t.co/wGuKOh1lKN","expanded_url":"http://2020health.wordpress.com/2013/10/04/alzheimers-a-journey-of-caring/","display_url":"2020health.wordpress.com/2013/10/04/alz…"}],"annotations":[{"start":53,"end":67,"probability":0.5016,"type":"Other","normalized_text":"World Alzheimer"}]},"conversation_id":"387139638831222784","possibly_sensitive":false,"created_at":"2013-10-07T08:57:37.000Z","referenced_tweets":[{"type":"retweeted","id":"387135367234613248"}],"id":"387139638831222784","text":"RT @AlzDisInt: Check out ADI's 2020health blog about World Alzheimer's Month http://t.co/wGuKOh1lKN @marcwort","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":23,"tag":"Inflectra"},{"start":25,"end":36,"tag":"infliximab"},{"start":41,"end":52,"tag":"biosimilar"},{"start":56,"end":65,"tag":"Remicade"}],"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/DMu1wHpcf5","expanded_url":"http://bit.ly/16JZcWX","display_url":"bit.ly/16JZcWX"}],"annotations":{}},"conversation_id":"387130922107035649","possibly_sensitive":false,"created_at":"2013-10-07T08:22:59.000Z","referenced_tweets":{},"id":"387130922107035649","text":"The EPAR for #Inflectra (#infliximab), a #biosimilar of #Remicade, is available on our website: http://t.co/DMu1wHpcf5","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":21,"tag":"Remsima"},{"start":23,"end":34,"tag":"infliximab"},{"start":39,"end":50,"tag":"biosimilar"},{"start":54,"end":63,"tag":"Remicade"}],"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/tk0hvaRcHv","expanded_url":"http://bit.ly/1a6mjak","display_url":"bit.ly/1a6mjak"}],"annotations":{}},"conversation_id":"387130820407742464","possibly_sensitive":false,"created_at":"2013-10-07T08:22:34.000Z","referenced_tweets":{},"id":"387130820407742464","text":"The EPAR for #Remsima (#infliximab), a #biosimilar of #Remicade, is available on our website: http://t.co/tk0hvaRcHv","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":21,"tag":"Xoterna"},{"start":22,"end":33,"tag":"Breezhaler"},{"start":35,"end":47,"tag":"indacaterol"},{"start":50,"end":65,"tag":"glycopyrronium"},{"start":79,"end":84,"tag":"COPD"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/7iZBXR8maQ","expanded_url":"http://bit.ly/19mtL53","display_url":"bit.ly/19mtL53"}],"annotations":{}},"conversation_id":"387130649213018112","possibly_sensitive":false,"created_at":"2013-10-07T08:21:53.000Z","referenced_tweets":{},"id":"387130649213018112","text":"The EPAR for #Xoterna #Breezhaler (#indacaterol / #glycopyrronium bromide) for #COPD is available on our website: http://t.co/7iZBXR8maQ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":68,"end":75,"tag":"safety"},{"start":76,"end":84,"tag":"signals"},{"start":110,"end":128,"tag":"pharmacovigilance"}],"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/4TcedOgAR9","expanded_url":"http://bit.ly/1ga3wzL","display_url":"bit.ly/1ga3wzL"}],"annotations":{}},"conversation_id":"387130470867017728","possibly_sensitive":false,"created_at":"2013-10-07T08:21:11.000Z","referenced_tweets":{},"id":"387130470867017728","text":"We're now publishing our recommendations based on the assessment of #safety #signals: http://t.co/4TcedOgAR9  #pharmacovigilance","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":65,"end":87,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"387130284593803264","possibly_sensitive":false,"created_at":"2013-10-07T08:20:27.000Z","referenced_tweets":{},"id":"387130284593803264","text":"What does the #blacktriangle on medicines mean? Watch our video: http://t.co/ZzDNIqm0Nk","attachments":{"media_keys":{}}},{"lang":"in","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":64,"end":71,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":41,"end":63,"url":"http://t.co/ltaRerbDTn","expanded_url":"http://bit.ly/18JkD7v","display_url":"bit.ly/18JkD7v"}],"annotations":{}},"conversation_id":"387129154484707328","possibly_sensitive":false,"created_at":"2013-10-07T08:15:57.000Z","referenced_tweets":{},"id":"387129154484707328","text":"RT @LV_MPA: Investigators in Herbal Unit http://t.co/ltaRerbDTn #newjob","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":49,"end":56,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":26,"end":48,"url":"http://t.co/n2oQZBBtZo","expanded_url":"http://bit.ly/GI8maF","display_url":"bit.ly/GI8maF"}],"annotations":{}},"conversation_id":"387128970623193088","possibly_sensitive":false,"created_at":"2013-10-07T08:15:13.000Z","referenced_tweets":{},"id":"387128970623193088","text":"RT @LV_MPA: Heads of Unit http://t.co/n2oQZBBtZo #newjob","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":22,"tag":"westnile"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":62,"end":63,"probability":0.8321,"type":"Place","normalized_text":"EU"}]},"conversation_id":"386186227374112768","possibly_sensitive":false,"created_at":"2013-10-04T17:49:06.000Z","referenced_tweets":[{"type":"retweeted","id":"386163431910293504"}],"id":"386186227374112768","text":"RT @ECDC_EU: #westnile fever update: 14 new cases reported in EU, 19 - in neighbouring countries in last week. See infographic: http://t.co…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"hashtags":[{"start":53,"end":63,"tag":"Inflectra"},{"start":65,"end":76,"tag":"infliximab"},{"start":81,"end":92,"tag":"biosimilar"},{"start":96,"end":105,"tag":"Remicade"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/DIpN62gCld","expanded_url":"http://bit.ly/16JZcWX","display_url":"bit.ly/16JZcWX"}],"annotations":{}},"conversation_id":"386155634766659584","possibly_sensitive":false,"created_at":"2013-10-04T15:47:32.000Z","referenced_tweets":{},"id":"386155634766659584","text":"@EMA_News: We've published the assessment report for #Inflectra (#infliximab), a #biosimilar of #Remicade: http://t.co/DIpN62gCld","in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":66,"end":75,"tag":"Geymonat"},{"start":84,"end":91,"tag":"safety"},{"start":92,"end":102,"tag":"medicines"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":104,"end":126,"url":"http://t.co/kOhYUxmEWq","expanded_url":"http://bit.ly/1f5nRYg","display_url":"bit.ly/1f5nRYg"}],"annotations":[{"start":20,"end":23,"probability":0.5193,"type":"Organization","normalized_text":"AIFA"}]},"conversation_id":"386139077747036162","possibly_sensitive":false,"created_at":"2013-10-04T14:41:44.000Z","referenced_tweets":{},"id":"386139077747036162","text":"RT @Aifa_ufficiale: AIFA suspends manufacturing authorisation for #Geymonat company #safety #medicines  http://t.co/kOhYUxmEWq","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":50,"tag":"Remsima"},{"start":52,"end":63,"tag":"infliximab"},{"start":68,"end":79,"tag":"biosimilar"},{"start":83,"end":92,"tag":"Remicade"}],"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/oNZQnLzsnm","expanded_url":"http://bit.ly/1a6mjak","display_url":"bit.ly/1a6mjak"}],"annotations":{}},"conversation_id":"386134078178996225","possibly_sensitive":false,"created_at":"2013-10-04T14:21:52.000Z","referenced_tweets":{},"id":"386134078178996225","text":"We've published the assessment report for #Remsima (#infliximab), a #biosimilar of #Remicade: http://t.co/oNZQnLzsnm","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":26,"tag":"Ranbaxy"},{"start":34,"end":38,"tag":"FDA"}],"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/oePdaDwVa1","expanded_url":"http://www.fiercepharmamanufacturing.com/story/ranbaxy-denies-fda-issues-will-lead-layoffs/2013-10-03?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.Uk7LY9IYGhw.twitter","display_url":"fiercepharmamanufacturing.com/story/ranbaxy-…"}],"annotations":[{"start":69,"end":94,"probability":0.8163,"type":"Organization","normalized_text":"FiercePharma Manufacturing"}]},"conversation_id":"386131224562905088","possibly_sensitive":false,"created_at":"2013-10-04T14:10:32.000Z","referenced_tweets":[{"type":"retweeted","id":"386130826783494144"}],"id":"386131224562905088","text":"RT @sailinsomnia: #Ranbaxy denies #FDA issues will lead to layoffs - FiercePharma Manufacturing: http://t.co/oePdaDwVa1","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":37,"end":51,"tag":"AdverseEvents"},{"start":55,"end":62,"tag":"Cancer"},{"start":69,"end":78,"tag":"Thalomid"},{"start":83,"end":92,"tag":"Revlimid"}],"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/S6pyC5PMz3","expanded_url":"http://www.adverseevents.com/monitor/2013/10/03/new-study-compares-adverse-events-of-cancer-drugs-thalomid-and-revlimid/","display_url":"adverseevents.com/monitor/2013/1…"}],"annotations":{}},"conversation_id":"386131006471684098","possibly_sensitive":false,"created_at":"2013-10-04T14:09:40.000Z","referenced_tweets":[{"type":"retweeted","id":"386130588685463552"}],"id":"386131006471684098","text":"RT @sailinsomnia: New Study Compares #AdverseEvents of #Cancer Drugs #Thalomid and #Revlimid http://t.co/S6pyC5PMz3 via @socializeWP","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":29,"tag":"Boehringer"},{"start":44,"end":49,"tag":"Labs"},{"start":85,"end":101,"tag":"QualityProblems"}],"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/aEqOcXKHsZ","expanded_url":"http://www.outsourcing-pharma.com/Contract-Manufacturing/Boehringer-CMO-Ben-Venue-Labs-to-close-permanently-layoff-1-100?utm_source=AddThis&utm_medium=Twitter&utm_campaign=SocialMedia/#.Uk7Kx9JXcvo.twitter","display_url":"outsourcing-pharma.com/Contract-Manuf…"}],"annotations":{}},"conversation_id":"386130866612600832","possibly_sensitive":false,"created_at":"2013-10-04T14:09:07.000Z","referenced_tweets":[{"type":"retweeted","id":"386129987532619776"}],"id":"386130866612600832","text":"RT @sailinsomnia: #Boehringer CMO Ben Venue #Labs to close permanently after endemic #QualityProblems http://t.co/aEqOcXKHsZ via @InPharmaT…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":77,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":99,"end":104,"tag":"MERS"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":59,"end":81,"url":"http://t.co/wtQwLe5mut","expanded_url":"http://goo.gl/RSQzMo","display_url":"goo.gl/RSQzMo"}],"annotations":[{"start":26,"end":36,"probability":0.2969,"type":"Place","normalized_text":"Middle East"}]},"conversation_id":"386128457840594944","possibly_sensitive":false,"created_at":"2013-10-04T13:59:32.000Z","referenced_tweets":[{"type":"retweeted","id":"386127308114763777"}],"id":"386128457840594944","text":"RT @WHO: Latest update on Middle East respiratory syndrome http://t.co/wtQwLe5mut (4 October 2013) #MERS","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":50,"tag":"Xoterna"},{"start":51,"end":62,"tag":"Breezhaler"},{"start":64,"end":76,"tag":"indacaterol"},{"start":79,"end":94,"tag":"glycopyrronium"},{"start":108,"end":113,"tag":"COPD"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/jD8ptJOAm9","expanded_url":"http://bit.ly/19mtL53","display_url":"bit.ly/19mtL53"}],"annotations":{}},"conversation_id":"386123373698625536","possibly_sensitive":false,"created_at":"2013-10-04T13:39:20.000Z","referenced_tweets":{},"id":"386123373698625536","text":"We've published the assessment report for #Xoterna #Breezhaler (#indacaterol / #glycopyrronium bromide) for #COPD: http://t.co/jD8ptJOAm9","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":31,"end":35,"tag":"WDD"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"urls":[{"start":99,"end":121,"url":"http://t.co/vy1wNKC0RR","expanded_url":"http://bit.ly/GAylA0","display_url":"bit.ly/GAylA0"}],"annotations":{}},"conversation_id":"386122590932041728","possibly_sensitive":false,"created_at":"2013-10-04T13:36:14.000Z","referenced_tweets":[{"type":"retweeted","id":"386122538461323264"}],"id":"386122590932041728","text":"RT @WDD: Only 40 days to go to #WDD !!! All you need to know is in the newsletter!  Happy reading! http://t.co/vy1wNKC0RR","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":{},"annotations":{}},"conversation_id":"386122383087521793","possibly_sensitive":false,"created_at":"2013-10-04T13:35:24.000Z","referenced_tweets":{},"id":"386122383087521793","text":"Our website is up and running again now. You may need to refresh your browser for the site to appear correctly.","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":27,"tag":"Levodopa"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{}},"conversation_id":"386116038594531328","possibly_sensitive":false,"created_at":"2013-10-04T13:10:11.000Z","referenced_tweets":[{"type":"retweeted","id":"386109794110541824"}],"id":"386116038594531328","text":"RT @euparkinsons: #Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway: http://t.co/dzMpg1Lt…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":{},"annotations":{}},"conversation_id":"386093396764262400","possibly_sensitive":false,"created_at":"2013-10-04T11:40:13.000Z","referenced_tweets":{},"id":"386093396764262400","text":"Our website is down at the moment due to technical problems. We're working on getting it back up as soon as possible. Apologies.","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":26,"end":39,"tag":"publichealth"},{"start":56,"end":67,"tag":"skincancer"},{"start":80,"end":86,"tag":"drugs"},{"start":87,"end":100,"tag":"mentalhealth"},{"start":101,"end":132,"tag":"Emergencyplanningandresilience"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":{},"annotations":{}},"conversation_id":"386092292991614976","possibly_sensitive":false,"created_at":"2013-10-04T11:35:50.000Z","referenced_tweets":[{"type":"retweeted","id":"386090219604156416"}],"id":"386092292991614976","text":"RT @NICEcomms: Poss. NICE #publichealth standards cont: #skincancer prevention, #drugs #mentalhealth #Emergencyplanningandresilience http:/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":25,"end":38,"tag":"publichealth"},{"start":57,"end":70,"tag":"sexualhealth"},{"start":71,"end":84,"tag":"immunisation"},{"start":85,"end":105,"tag":"environmentalhealth"},{"start":106,"end":117,"tag":"antibiotic"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":{},"annotations":{}},"conversation_id":"386092244094447616","possibly_sensitive":false,"created_at":"2013-10-04T11:35:38.000Z","referenced_tweets":[{"type":"retweeted","id":"386089220764205056"}],"id":"386092244094447616","text":"RT @NICEcomms: Potential #publichealth quality standards #sexualhealth #immunisation #environmentalhealth #antibiotic management http://t.c…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":45,"tag":"publichealth"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":88,"end":110,"url":"http://t.co/vdHvmydLC8","expanded_url":"http://www.nice.org.uk/newsroom/news/NewQualityStandardsPublicHealth.jsp","display_url":"nice.org.uk/newsroom/news/…"}],"annotations":{}},"conversation_id":"386092095389589505","possibly_sensitive":false,"created_at":"2013-10-04T11:35:03.000Z","referenced_tweets":[{"type":"retweeted","id":"386088036661866497"}],"id":"386092095389589505","text":"RT @NICEcomms: Have your say on #publichealth quality standards NICE will be developing http://t.co/vdHvmydLC8","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"urls":{},"annotations":[{"start":21,"end":57,"probability":0.2783,"type":"Other","normalized_text":"Alzheimer Europe September Newsletter"},{"start":100,"end":114,"probability":0.5578,"type":"Other","normalized_text":"World Alzheimer"}]},"conversation_id":"386090559162834944","possibly_sensitive":false,"created_at":"2013-10-04T11:28:57.000Z","referenced_tweets":[{"type":"retweeted","id":"386089741990780928"}],"id":"386090559162834944","text":"RT @AlzheimerEurope: Alzheimer Europe September Newsletter is now available online! With a focus on World Alzheimer's Day activities: http:…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":74,"end":84,"tag":"Alzheimer"},{"start":85,"end":89,"tag":"EPO"},{"start":90,"end":101,"tag":"Innovation"},{"start":102,"end":126,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":51,"end":73,"url":"http://t.co/OnudI3XOdU","expanded_url":"http://bit.ly/1dZg3UI","display_url":"bit.ly/1dZg3UI"}],"annotations":{}},"conversation_id":"386090443685236736","possibly_sensitive":false,"created_at":"2013-10-04T11:28:29.000Z","referenced_tweets":[{"type":"retweeted","id":"386089010751209472"}],"id":"386090443685236736","text":"RT @EFPIA: Out today : Efpia's latest newsletter - http://t.co/OnudI3XOdU #Alzheimer #EPO #Innovation #AntimicrobialResistance #blacktriang…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":22,"tag":"Voncento"},{"start":30,"end":42,"tag":"coagulation"},{"start":43,"end":54,"tag":"factorVIII"},{"start":57,"end":71,"tag":"vonWillebrand"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/jmSc5M07hM","expanded_url":"http://bit.ly/1g9QZfJ","display_url":"bit.ly/1g9QZfJ"}],"annotations":{}},"conversation_id":"386089417024098304","possibly_sensitive":false,"created_at":"2013-10-04T11:24:24.000Z","referenced_tweets":{},"id":"386089417024098304","text":"The EPAR for #Voncento (human #coagulation #factorVIII / #vonWillebrand factor) is available on our website: http://t.co/jmSc5M07hM","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":22,"tag":"Procysbi"},{"start":24,"end":37,"tag":"mercaptamine"},{"start":43,"end":56,"tag":"nephropathic"},{"start":57,"end":68,"tag":"cystinosis"}],"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/A1A3AzPnlg","expanded_url":"http://bit.ly/18X4IBB","display_url":"bit.ly/18X4IBB"}],"annotations":{}},"conversation_id":"386089291958341632","possibly_sensitive":false,"created_at":"2013-10-04T11:23:55.000Z","referenced_tweets":{},"id":"386089291958341632","text":"The EPAR for #Procysbi (#mercaptamine) for #nephropathic #cystinosis is available on our website: http://t.co/A1A3AzPnlg","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":32,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"386089083480457216","possibly_sensitive":false,"created_at":"2013-10-04T11:23:05.000Z","referenced_tweets":{},"id":"386089083480457216","text":"Find out what the #blacktriangle means and how additional monitoring works: http://t.co/ZzDNIqm0Nk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/7pbvWAzcZf","expanded_url":"http://bit.ly/15M3zjf","display_url":"bit.ly/15M3zjf"},{"start":117,"end":139,"url":"http://t.co/pytDRTjcJ1","expanded_url":"http://bit.ly/19m8Ajk","display_url":"bit.ly/19m8Ajk"}],"annotations":{}},"conversation_id":"386088790705459200","possibly_sensitive":false,"created_at":"2013-10-04T11:21:55.000Z","referenced_tweets":{},"id":"386088790705459200","text":"Our pharmacovigilance and veterinary committees are meeting next week; highlights on Friday: http://t.co/7pbvWAzcZf  http://t.co/pytDRTjcJ1","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":90,"end":108,"tag":"pharmacovigilance"}],"mentions":{},"urls":[{"start":66,"end":88,"url":"http://t.co/4TcedOgAR9","expanded_url":"http://bit.ly/1ga3wzL","display_url":"bit.ly/1ga3wzL"}],"annotations":{}},"conversation_id":"386088107361058816","possibly_sensitive":false,"created_at":"2013-10-04T11:19:12.000Z","referenced_tweets":{},"id":"386088107361058816","text":"We've started publishing recommendations based on safety signals: http://t.co/4TcedOgAR9  #pharmacovigilance","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":33,"end":42,"tag":"shutdown"},{"start":66,"end":77,"tag":"orphandrug"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":47,"end":54,"username":"US_FDA","id":"208120290"}],"urls":{},"annotations":[{"start":25,"end":26,"probability":0.9022,"type":"Place","normalized_text":"US"}]},"conversation_id":"386082943296626688","possibly_sensitive":false,"created_at":"2013-10-04T10:58:41.000Z","referenced_tweets":[{"type":"retweeted","id":"386082869380014080"}],"id":"386082943296626688","text":"RT @eurordis: Due to the US govt #shutdown the @US_FDA webcast on #orphandrug designation will be rescheduled for a future date. Tnx @oli_r…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":9,"username":"eurordis","id":"26993786"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"urls":{},"annotations":[{"start":81,"end":93,"probability":0.577,"type":"Place","normalized_text":"United States"}]},"conversation_id":"386077581256437760","possibly_sensitive":false,"created_at":"2013-10-04T10:40:43.000Z","referenced_tweets":[{"type":"replied_to","id":"386077581256437760"}],"id":"386078423409774592","text":"@eurordis @US_FDA This workshop is being rescheduled for another day because the United States federal government is closed.","in_reply_to_user_id":"26993786","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":35,"end":44,"tag":"diabetes"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":69,"end":91,"url":"http://t.co/23MwOPZhJj","expanded_url":"http://bit.ly/18wezzg","display_url":"bit.ly/18wezzg"}],"annotations":{}},"conversation_id":"386066328140132352","possibly_sensitive":false,"created_at":"2013-10-04T09:52:40.000Z","referenced_tweets":[{"type":"retweeted","id":"386066212154667008"}],"id":"386066328140132352","text":"RT @EFPIA: Biological link between #diabetes and heart disease found http://t.co/23MwOPZhJj","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":85,"end":107,"url":"http://t.co/VLuONIGqqX","expanded_url":"http://www.urpl.gov.pl/aktualnosci/81-posiedzenie-rady-zarzadzajacej-europejskiej-agencji-lekow","display_url":"urpl.gov.pl/aktualnosci/81…"}],"annotations":{}},"conversation_id":"386064255877136384","possibly_sensitive":false,"created_at":"2013-10-04T09:44:25.000Z","referenced_tweets":{},"id":"386064255877136384","text":"RT @URPLWMiPB: 81st meeting of the Management Board of the European Medicines Agency http://t.co/VLuONIGqqX","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":83,"end":105,"url":"http://t.co/ZsbyGl1qa9","expanded_url":"http://fb.me/2X1d0bg7y","display_url":"fb.me/2X1d0bg7y"}],"annotations":{}},"conversation_id":"386064175933698048","possibly_sensitive":false,"created_at":"2013-10-04T09:44:06.000Z","referenced_tweets":{},"id":"386064175933698048","text":"RT @GCessak: 81st meeting of the Management Board of the European Medicines Agency http://t.co/ZsbyGl1qa9","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":51,"tag":"Voncento"},{"start":59,"end":71,"tag":"coagulation"},{"start":72,"end":83,"tag":"factorVIII"},{"start":86,"end":100,"tag":"vonWillebrand"}],"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/8mEjaSMl6F","expanded_url":"http://bit.ly/1g9QZfJ","display_url":"bit.ly/1g9QZfJ"}],"annotations":{}},"conversation_id":"386062428884451328","possibly_sensitive":false,"created_at":"2013-10-04T09:37:10.000Z","referenced_tweets":{},"id":"386062428884451328","text":"We've published the assessment report for #Voncento (human #coagulation #factorVIII / #vonWillebrand factor): http://t.co/8mEjaSMl6F","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":94,"end":98,"tag":"AMR"},{"start":99,"end":116,"tag":"CHdrugresistance"}],"mentions":{},"urls":{},"annotations":{}},"conversation_id":"386058817483857920","possibly_sensitive":false,"created_at":"2013-10-04T09:22:49.000Z","referenced_tweets":[{"type":"retweeted","id":"386057454884102145"}],"id":"386058817483857920","text":"RT @IFAHEurope: Antibiotic resistance solutions for animals are different to those for humans #AMR #CHdrugresistance","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":65,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":43,"end":47,"tag":"WHO"},{"start":97,"end":102,"tag":"MERS"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{}},"conversation_id":"386057090613403648","possibly_sensitive":false,"created_at":"2013-10-04T09:15:57.000Z","referenced_tweets":[{"type":"retweeted","id":"386056626798473216"}],"id":"386057090613403648","text":"RT @WHO: Globally, from Sept 2012 to date, #WHO has been informed of 136 lab-confirmed cases of  #MERS-CoV, including 58 deaths.","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":95,"end":117,"url":"http://t.co/gJ61Fj9eT3","expanded_url":"http://dzialanianiepozadane.urpl.gov.pl/zgloszenia-dzialan-niepozadanych","display_url":"dzialanianiepozadane.urpl.gov.pl/zgloszenia-dzi…"}],"annotations":{}},"conversation_id":"386057037144420352","possibly_sensitive":false,"created_at":"2013-10-04T09:15:44.000Z","referenced_tweets":{},"id":"386057037144420352","text":"RT @URPLWMiPB: Please note that the service for reporting of adverse events is up and running: http://t.co/gJ61Fj9eT3","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":52,"end":64,"tag":"antibiotics"},{"start":95,"end":100,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"annotations":{}},"conversation_id":"386056724370964480","possibly_sensitive":false,"created_at":"2013-10-04T09:14:30.000Z","referenced_tweets":[{"type":"retweeted","id":"386054519601131520"}],"id":"386056724370964480","text":"RT @EAAD_EU: Interested in promoting prudent use of #antibiotics on social media? Download the #EAAD social media toolkit http://t.co/SLdEe…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"urls":[{"start":68,"end":90,"url":"http://t.co/NJXGQ5DcDv","expanded_url":"http://www.nhs.uk/news/pages/newsarticles.aspx?TopicId=Older+people","display_url":"nhs.uk/news/pages/new…"}],"annotations":{}},"conversation_id":"386054520532631552","possibly_sensitive":false,"created_at":"2013-10-04T09:05:44.000Z","referenced_tweets":[{"type":"retweeted","id":"386054138720575489"}],"id":"386054520532631552","text":"RT @AlzDisInt: What's the science behind dementia health headlines? http://t.co/NJXGQ5DcDv","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":52,"tag":"Parkinson"},{"start":67,"end":72,"tag":"EPDA"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":101,"end":123,"url":"http://t.co/AEjntHtIyX","expanded_url":"http://bit.ly/O15QOZ","display_url":"bit.ly/O15QOZ"}],"annotations":{}},"conversation_id":"386050648019836928","possibly_sensitive":false,"created_at":"2013-10-04T08:50:21.000Z","referenced_tweets":[{"type":"retweeted","id":"386049395541561345"}],"id":"386050648019836928","text":"RT @euparkinsons: Did u know that all the #Parkinson's info on the #EPDA website is free 2 access? - http://t.co/AEjntHtIyX","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":51,"tag":"Procysbi"},{"start":53,"end":66,"tag":"mercaptamine"},{"start":72,"end":85,"tag":"nephropathic"},{"start":86,"end":97,"tag":"cystinosis"}],"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/IleY28vcZW","expanded_url":"http://bit.ly/18X4IBB","display_url":"bit.ly/18X4IBB"}],"annotations":{}},"conversation_id":"386045603882762240","possibly_sensitive":false,"created_at":"2013-10-04T08:30:19.000Z","referenced_tweets":{},"id":"386045603882762240","text":"We've published the assessment report for #Procysbi (#mercaptamine) for #nephropathic #cystinosis: http://t.co/IleY28vcZW","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":21,"tag":"Ultibro"},{"start":22,"end":33,"tag":"Breezhaler"},{"start":35,"end":47,"tag":"indacaterol"},{"start":50,"end":65,"tag":"glycopyrronium"},{"start":79,"end":84,"tag":"COPD"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/ztwHbnSXs7","expanded_url":"http://bit.ly/16IuddC","display_url":"bit.ly/16IuddC"}],"annotations":{}},"conversation_id":"386044802942259200","possibly_sensitive":false,"created_at":"2013-10-04T08:27:08.000Z","referenced_tweets":{},"id":"386044802942259200","text":"The EPAR for #Ultibro #Breezhaler (#indacaterol / #glycopyrronium bromide) for #COPD is available on our website: http://t.co/ztwHbnSXs7","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":4,"end":18,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"386044426146959360","possibly_sensitive":false,"created_at":"2013-10-04T08:25:38.000Z","referenced_tweets":{},"id":"386044426146959360","text":"The #blacktriangle is an invitation for patients and healthcare professionals to report suspected side effects: http://t.co/ZzDNIqm0Nk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/7pbvWAzcZf","expanded_url":"http://bit.ly/15M3zjf","display_url":"bit.ly/15M3zjf"},{"start":117,"end":139,"url":"http://t.co/pytDRTjcJ1","expanded_url":"http://bit.ly/19m8Ajk","display_url":"bit.ly/19m8Ajk"}],"annotations":{}},"conversation_id":"386043966077931520","possibly_sensitive":false,"created_at":"2013-10-04T08:23:48.000Z","referenced_tweets":{},"id":"386043966077931520","text":"Next Friday we're publishing highlights from our pharmacovigilance and veterinary committees: http://t.co/7pbvWAzcZf http://t.co/pytDRTjcJ1","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":99,"end":107,"tag":"efsa_tc"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":75,"end":97,"url":"http://t.co/rxpuN84K8m","expanded_url":"http://www.efsa.europa.eu/en/events/event/131003.htm","display_url":"efsa.europa.eu/en/events/even…"}],"annotations":[{"start":32,"end":35,"probability":0.451,"type":"Organization","normalized_text":"EFSA"}]},"conversation_id":"385802052615823360","possibly_sensitive":false,"created_at":"2013-10-03T16:22:31.000Z","referenced_tweets":[{"type":"retweeted","id":"385801849850589184"}],"id":"385802052615823360","text":"RT @EFSA_EU: Presentations from EFSA's Transparency Conference now online: http://t.co/rxpuN84K8m  #efsa_tc","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":25,"tag":"Pharma"},{"start":35,"end":50,"tag":"ClinicalTrials"},{"start":93,"end":100,"tag":"Health"}],"mentions":[{"start":130,"end":137,"username":"Forbes","id":"91478624"}],"urls":[{"start":103,"end":125,"url":"http://t.co/5QSGx4Lmgj","expanded_url":"http://onforb.es/1c4bSsP","display_url":"onforb.es/1c4bSsP"}],"annotations":{}},"conversation_id":"385799371398594560","possibly_sensitive":false,"created_at":"2013-10-03T16:11:52.000Z","referenced_tweets":[{"type":"retweeted","id":"385797372820742144"}],"id":"385799371398594560","text":"RT @sailinsomnia: #Pharma Controls #ClinicalTrials Of Their Drugs. Is This Hazardous To Your #Health?  http://t.co/5QSGx4Lmgj via @forbes","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":28,"end":37,"tag":"Shutdown"}],"mentions":{},"urls":[{"start":67,"end":89,"url":"http://t.co/HVPGiygRhh","expanded_url":"http://www.bioworld.com/content/impact-shutdown-depends-how-long-it-lasts-0","display_url":"bioworld.com/content/impact…"}],"annotations":{}},"conversation_id":"385795377049649152","possibly_sensitive":false,"created_at":"2013-10-03T15:56:00.000Z","referenced_tweets":[{"type":"retweeted","id":"385795267749875712"}],"id":"385795377049649152","text":"RT @sailinsomnia: Impact of #Shutdown Depends on How Long It Lasts http://t.co/HVPGiygRhh","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":27,"tag":"Novartis"},{"start":59,"end":66,"tag":"Diovan"},{"start":67,"end":75,"tag":"scandal"}],"mentions":[{"start":104,"end":112,"username":"Reuters","id":"1652541"}],"urls":[{"start":77,"end":99,"url":"http://t.co/ilYuS9oY71","expanded_url":"http://reut.rs/1f26E1R","display_url":"reut.rs/1f26E1R"}],"annotations":[{"start":53,"end":57,"probability":0.9141,"type":"Place","normalized_text":"Japan"}]},"conversation_id":"385795308997070848","possibly_sensitive":false,"created_at":"2013-10-03T15:55:44.000Z","referenced_tweets":[{"type":"retweeted","id":"385795028527751168"}],"id":"385795308997070848","text":"RT @sailinsomnia: #Novartis sees limited impact from Japan #Diovan #scandal  http://t.co/ilYuS9oY71 via @reuters","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":29,"end":37,"tag":"Hospira"}],"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/SXL5jBj2zS","expanded_url":"http://www.raps.org/focus-online/news/news-article-view/article/4142/recalls-by-hospira-continue-to-mount-as-company-finds-hair-glass-steel-and-brass.aspx#.Uk2Sx8CA2zw.twitter","display_url":"raps.org/focus-online/n…"}],"annotations":{}},"conversation_id":"385794749288153088","possibly_sensitive":false,"created_at":"2013-10-03T15:53:30.000Z","referenced_tweets":[{"type":"retweeted","id":"385794621491527680"}],"id":"385794749288153088","text":"RT @sailinsomnia: Recalls by #Hospira Continue to Mount as Company Finds Hair, Glass, Steel and Brass http://t.co/SXL5jBj2zS","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":50,"tag":"Ultibro"},{"start":51,"end":62,"tag":"Breezhaler"},{"start":64,"end":76,"tag":"indacaterol"},{"start":79,"end":94,"tag":"glycopyrronium"},{"start":108,"end":113,"tag":"COPD"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/o6thpwFlFw","expanded_url":"http://bit.ly/16IuddC","display_url":"bit.ly/16IuddC"}],"annotations":{}},"conversation_id":"385786484655423488","possibly_sensitive":false,"created_at":"2013-10-03T15:20:40.000Z","referenced_tweets":{},"id":"385786484655423488","text":"We've published the assessment report for #Ultibro #Breezhaler (#indacaterol / #glycopyrronium bromide) for #COPD: http://t.co/o6thpwFlFw","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":28,"end":38,"tag":"Hepatitis"},{"start":123,"end":135,"tag":"Worldhepday"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":{}},"conversation_id":"385784092199235584","possibly_sensitive":false,"created_at":"2013-10-03T15:11:09.000Z","referenced_tweets":[{"type":"retweeted","id":"385757928273084416"}],"id":"385784092199235584","text":"RT @Hep_Alliance: Our World #Hepatitis Day 2013 wrap-up report has now been published! See all the events that went on for #Worldhepday htt…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":51,"end":55,"tag":"AMR"},{"start":57,"end":64,"tag":"EPRUMA"}],"mentions":[{"start":29,"end":42,"username":"ChathamHouse","id":"38630618"}],"urls":{},"annotations":{}},"conversation_id":"385781984876064768","possibly_sensitive":false,"created_at":"2013-10-03T15:02:47.000Z","referenced_tweets":[{"type":"retweeted","id":"385738564496920577"}],"id":"385781984876064768","text":"RT @IFAHEurope: Good debates @ChathamHouse conf on #AMR. #EPRUMA view on antibiotics: As little as possible as much as necessary #CHdrugres…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":36,"end":49,"tag":"rarediseases"},{"start":110,"end":122,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"annotations":[{"start":54,"end":78,"probability":0.6863,"type":"Organization","normalized_text":"World Academy of Sciences"}]},"conversation_id":"385723219195748352","possibly_sensitive":false,"created_at":"2013-10-03T11:09:16.000Z","referenced_tweets":[{"type":"retweeted","id":"385722603127992320"}],"id":"385723219195748352","text":"RT @eurordis: French Foundation for #rarediseases and World Academy of Sciences announce first joint call for #raredisease research http://…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":22,"tag":"Provenge"},{"start":27,"end":43,"tag":"advancedtherapy"},{"start":48,"end":63,"tag":"prostatecancer"}],"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/WZxeQlfvVH","expanded_url":"http://bit.ly/1hmYptV","display_url":"bit.ly/1hmYptV"}],"annotations":{}},"conversation_id":"385721871607422977","possibly_sensitive":false,"created_at":"2013-10-03T11:03:55.000Z","referenced_tweets":{},"id":"385721871607422977","text":"The EPAR for #Provenge, an #advancedtherapy for #prostatecancer is available on our website: http://t.co/WZxeQlfvVH","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":38,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"385721642694893568","possibly_sensitive":false,"created_at":"2013-10-03T11:03:00.000Z","referenced_tweets":{},"id":"385721642694893568","text":"Find out more about the #blacktriangle and additional monitoring with our video, factsheet and webpages: http://t.co/ZzDNIqm0Nk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":39,"tag":"tender"},{"start":64,"end":76,"tag":"consultancy"},{"start":101,"end":113,"tag":"procurement"}],"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/suUSdhvjp7","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"annotations":{}},"conversation_id":"385721194403479552","possibly_sensitive":false,"created_at":"2013-10-03T11:01:13.000Z","referenced_tweets":{},"id":"385721194403479552","text":"Two weeks left to apply for our #tender for high-level business #consultancy: http://t.co/suUSdhvjp7 #procurement","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":122,"end":130,"tag":"efsa_tc"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":[{"start":39,"end":42,"probability":0.4734,"type":"Organization","normalized_text":"EFSA"}]},"conversation_id":"385714927534886912","possibly_sensitive":false,"created_at":"2013-10-03T10:36:19.000Z","referenced_tweets":[{"type":"retweeted","id":"385714445076295680"}],"id":"385714927534886912","text":"RT @EFSA_EU: Stakeholder conference at EFSA: Break-out sessions on transparency in the scientific decision-making process #efsa_tc http://t…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":51,"tag":"Provenge"},{"start":56,"end":72,"tag":"advancedtherapy"},{"start":77,"end":92,"tag":"prostatecancer"}],"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/IyaUy16xNV","expanded_url":"http://bit.ly/1hmYptV","display_url":"bit.ly/1hmYptV"}],"annotations":{}},"conversation_id":"385710458524954624","possibly_sensitive":false,"created_at":"2013-10-03T10:18:34.000Z","referenced_tweets":{},"id":"385710458524954624","text":"We've published the assessment report for #Provenge, an #advancedtherapy for #prostatecancer: http://t.co/IyaUy16xNV","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":104,"end":126,"url":"http://t.co/AN8RlvWKCQ","expanded_url":"https://twitter.com/URPLWMiPB/status/385698382079352832/photo/1","display_url":"pic.twitter.com/AN8RlvWKCQ"}],"annotations":{}},"conversation_id":"385698750070784000","possibly_sensitive":false,"created_at":"2013-10-03T09:32:02.000Z","referenced_tweets":{},"id":"385698750070784000","text":"RT @URPLWMiPB: Polish medicines agency conference \"respiratory viruses with particular emphasis on flu\" http://t.co/AN8RlvWKCQ","attachments":{"media_keys":["3_385698381924167680"]}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":22,"tag":"Orphacol"},{"start":24,"end":35,"tag":"cholicacid"},{"start":79,"end":84,"tag":"bile"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/60aEZxIpCH","expanded_url":"http://bit.ly/1hkTbit","display_url":"bit.ly/1hkTbit"}],"annotations":{}},"conversation_id":"385684406792232960","possibly_sensitive":false,"created_at":"2013-10-03T08:35:02.000Z","referenced_tweets":{},"id":"385684406792232960","text":"The EPAR for #Orphacol (#cholicacid) for the treatment of inability to produce #bile is available on our website: http://t.co/60aEZxIpCH","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":65,"end":86,"tag":"conflictsofinterests"},{"start":112,"end":124,"tag":"coiworkshop"}],"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/yAXSlcN27o","expanded_url":"http://bit.ly/1730C94","display_url":"bit.ly/1730C94"}],"annotations":{}},"conversation_id":"385684292044476416","possibly_sensitive":false,"created_at":"2013-10-03T08:34:35.000Z","referenced_tweets":{},"id":"385684292044476416","text":"Yesterday we published the report and video from our workshop on #conflictsofinterests: http://t.co/yAXSlcN27o  #coiworkshop","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":32,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"385683934979166209","possibly_sensitive":false,"created_at":"2013-10-03T08:33:10.000Z","referenced_tweets":{},"id":"385683934979166209","text":"Not sure what the #blacktriangle and additional monitoring are? Watch our video: http://t.co/ZzDNIqm0Nk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":39,"tag":"tender"},{"start":64,"end":76,"tag":"consultancy"},{"start":102,"end":114,"tag":"procurement"}],"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/suUSdhvjp7","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"annotations":{}},"conversation_id":"385683327140651008","possibly_sensitive":false,"created_at":"2013-10-03T08:30:45.000Z","referenced_tweets":{},"id":"385683327140651008","text":"Two more weeks to apply for our #tender for high-level business #consultancy: http://t.co/suUSdhvjp7  #procurement","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":22,"tag":"EMA"},{"start":63,"end":73,"tag":"medicines"},{"start":126,"end":140,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":103,"end":125,"url":"http://t.co/LdE49k7dUV","expanded_url":"http://bit.ly/15Lh2Tl","display_url":"bit.ly/15Lh2Tl"}],"annotations":{}},"conversation_id":"385444532500054016","possibly_sensitive":false,"created_at":"2013-10-02T16:41:52.000Z","referenced_tweets":{},"id":"385444532500054016","text":"RT @euparkinsons: #EMA publishes a video explaining concept of #medicines under additional monitoring: http://t.co/LdE49k7dUV #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":52,"tag":"Menopause"}],"mentions":{},"urls":[{"start":97,"end":119,"url":"http://t.co/lbfe0ASMIB","expanded_url":"http://nyti.ms/15JnTfR","display_url":"nyti.ms/15JnTfR"}],"annotations":{}},"conversation_id":"385444415747416064","possibly_sensitive":false,"created_at":"2013-10-02T16:41:24.000Z","referenced_tweets":[{"type":"retweeted","id":"385439936905613312"}],"id":"385444415747416064","text":"RT @sailinsomnia: Study of Hormone Use in #Menopause Reaffirms Complex Mix of Risks and Benefits http://t.co/lbfe0ASMIB","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":22,"end":27,"tag":"Pill"},{"start":38,"end":49,"tag":"depression"}],"mentions":[{"start":91,"end":99,"username":"Reuters","id":"1652541"}],"urls":[{"start":64,"end":86,"url":"http://t.co/U11ZqMRNZJ","expanded_url":"http://reut.rs/16Upxup","display_url":"reut.rs/16Upxup"}],"annotations":{}},"conversation_id":"385430873245749248","possibly_sensitive":false,"created_at":"2013-10-02T15:47:35.000Z","referenced_tweets":[{"type":"retweeted","id":"385430499608363008"}],"id":"385430873245749248","text":"RT @sailinsomnia: The #Pill's link to #depression still unclear http://t.co/U11ZqMRNZJ via @reuters","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":23,"tag":"SPCs"},{"start":62,"end":72,"tag":"medicines"}],"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/63m80QrRqh","expanded_url":"http://www.pjonline.com/news/smpcs_contribute_little_to_effective_use_of_medicines#.Ukw0WRwdWfU.twitter","display_url":"pjonline.com/news/smpcs_con…"}],"annotations":{}},"conversation_id":"385430848222560257","possibly_sensitive":false,"created_at":"2013-10-02T15:47:29.000Z","referenced_tweets":[{"type":"retweeted","id":"385418317109788672"}],"id":"385430848222560257","text":"RT @sailinsomnia: #SPCs contribute little to effective use of #medicines | PJ Online http://t.co/63m80QrRqh","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":51,"tag":"Orphacol"},{"start":53,"end":64,"tag":"cholicacid"},{"start":108,"end":113,"tag":"bile"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/1vhi3jc8L6","expanded_url":"http://bit.ly/1hkTbit","display_url":"bit.ly/1hkTbit"}],"annotations":{}},"conversation_id":"385429583031726080","possibly_sensitive":false,"created_at":"2013-10-02T15:42:28.000Z","referenced_tweets":{},"id":"385429583031726080","text":"We've published the assessment report for #Orphacol (#cholicacid) for the treatment of inability to produce #bile: http://t.co/1vhi3jc8L6","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":{}},"conversation_id":"385428790929006592","possibly_sensitive":false,"created_at":"2013-10-02T15:39:19.000Z","referenced_tweets":[{"type":"retweeted","id":"385426535597211648"}],"id":"385428790929006592","text":"RT @IMI_JU: IMI is tackling areas of public health importance eg infectious disease (esp antibiotic resistance) and brain disorders #Innova…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":7,"username":"myESMO","id":"69232855"},{"start":8,"end":15,"username":"zorgnl","id":"19287403"},{"start":16,"end":21,"username":"uicc","id":"53023973"},{"start":22,"end":32,"username":"Jolienpon","id":"359313097"},{"start":33,"end":42,"username":"cancereu","id":"140344419"},{"start":43,"end":59,"username":"DrMiguelPerales","id":"1407780158"},{"start":60,"end":72,"username":"Nigel_Lloyd","id":"281988809"},{"start":73,"end":87,"username":"cancernurseEU","id":"439224883"},{"start":88,"end":99,"username":"liutprando","id":"51550238"}],"urls":{},"annotations":{}},"conversation_id":"385402911859421184","possibly_sensitive":false,"created_at":"2013-10-02T15:38:19.000Z","referenced_tweets":[{"type":"replied_to","id":"385402911859421184"}],"id":"385428541699289088","text":"@myESMO @zorgnl @UICC @Jolienpon @cancerEU @DrMiguelPerales @Nigel_Lloyd @cancernurseEU @liutprando You're welcome!","in_reply_to_user_id":"69232855","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":73,"end":83,"tag":"hepatitis"},{"start":91,"end":99,"tag":"Arzerra"},{"start":104,"end":112,"tag":"Rituxan"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":114,"end":136,"url":"http://t.co/O8fRN786H7","expanded_url":"http://1.usa.gov/18sWJNt","display_url":"1.usa.gov/18sWJNt"}],"annotations":{}},"conversation_id":"385415859877191680","possibly_sensitive":false,"created_at":"2013-10-02T14:47:56.000Z","referenced_tweets":{},"id":"385415859877191680","text":"RT @FDA_Drug_Info: Recommendations to reduce the risk of reactivation of #hepatitis B with #Arzerra and #Rituxan. http://t.co/O8fRN786H7","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":58,"end":79,"tag":"conflictsofinterests"},{"start":104,"end":116,"tag":"coiworkshop"}],"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/Adf9xeWmRF","expanded_url":"http://bit.ly/1730C94","display_url":"bit.ly/1730C94"}],"annotations":{}},"conversation_id":"385415294258544640","possibly_sensitive":false,"created_at":"2013-10-02T14:45:41.000Z","referenced_tweets":{},"id":"385415294258544640","text":"We've published the report and video from our workshop on #conflictsofinterests: http://t.co/Adf9xeWmRF #coiworkshop","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":87,"end":94,"tag":"ctdata"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":64,"end":86,"url":"http://t.co/2O7jeNrFPg","expanded_url":"http://www.eahp.eu/press-room/eahp-supports-ema-policy-clinical-trial-results","display_url":"eahp.eu/press-room/eah…"}],"annotations":[{"start":27,"end":29,"probability":0.4084,"type":"Organization","normalized_text":"EMA"}]},"conversation_id":"385409303844511744","possibly_sensitive":false,"created_at":"2013-10-02T14:21:53.000Z","referenced_tweets":{},"id":"385409303844511744","text":"RT @GCessak: EAHP supports EMA policy on clinical trial results http://t.co/2O7jeNrFPg #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":16,"username":"RiccardoGuidi87","id":"215396540"},{"start":17,"end":27,"username":"EAHPtweet","id":"203357203"}],"urls":{},"annotations":{}},"conversation_id":"385326249058381824","possibly_sensitive":false,"created_at":"2013-10-02T13:47:36.000Z","referenced_tweets":[{"type":"replied_to","id":"385387496319627264"}],"id":"385400678258311168","text":"@RiccardoGuidi87 @EAHPtweet You're welcome!","in_reply_to_user_id":"215396540","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":15,"end":20,"tag":"EAHP"},{"start":45,"end":58,"tag":"consultation"},{"start":85,"end":98,"tag":"transparency"},{"start":133,"end":140,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":110,"end":132,"url":"http://t.co/2O7jeNrFPg","expanded_url":"http://www.eahp.eu/press-room/eahp-supports-ema-policy-clinical-trial-results","display_url":"eahp.eu/press-room/eah…"}],"annotations":{}},"conversation_id":"385384879363735552","possibly_sensitive":false,"created_at":"2013-10-02T12:44:50.000Z","referenced_tweets":{},"id":"385384879363735552","text":"RT @EAHPtweet: #EAHP has responded to an EMA #consultation supporting clinical-trial #transparency prpoposals http://t.co/2O7jeNrFPg #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":81,"end":95,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":56,"end":78,"url":"http://t.co/ZHpQ2HUKng","expanded_url":"http://www.aemps.gob.es/vigilancia/medicamentosUsoHumano/seguimiento_adicional.htm","display_url":"aemps.gob.es/vigilancia/med…"}],"annotations":{}},"conversation_id":"385382549746245632","possibly_sensitive":false,"created_at":"2013-10-02T12:35:34.000Z","referenced_tweets":{},"id":"385382549746245632","text":"RT @AEMPSGOB: Video: what does the black triangle mean? http://t.co/ZHpQ2HUKng … #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":90,"end":104,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":67,"end":89,"url":"http://t.co/JPOyYclwh1","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/ciudadanos/2013/NI-MUH_FV_26-2013-seguimiento_adicional.htm","display_url":"aemps.gob.es/informa/notasI…"}],"annotations":{}},"conversation_id":"385382179251175424","possibly_sensitive":false,"created_at":"2013-10-02T12:34:06.000Z","referenced_tweets":{},"id":"385382179251175424","text":"RT @AEMPSGOB: Information on medicines under additional monitoring http://t.co/JPOyYclwh1 #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":4,"end":18,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"385372284547891200","possibly_sensitive":false,"created_at":"2013-10-02T11:54:47.000Z","referenced_tweets":{},"id":"385372284547891200","text":"The #blacktriangle is an invitation to report side effects. It does not mean that the medicine is unsafe: http://t.co/ZzDNIqm0Nk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":20,"end":34,"tag":"Blacktriangle"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":116,"end":138,"url":"http://t.co/lPZXxdADuN","expanded_url":"http://bit.ly/1eZjCx7","display_url":"bit.ly/1eZjCx7"}],"annotations":{}},"conversation_id":"385371598628601857","possibly_sensitive":false,"created_at":"2013-10-02T11:52:03.000Z","referenced_tweets":{},"id":"385371598628601857","text":"RT @Legemiddelinfo: #Blacktriangle in the summary of product characteristics - what does it mean? Read our website: http://t.co/lPZXxdADuN","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":129,"end":134,"tag":"jobs"},{"start":135,"end":138,"tag":"EU"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":104,"end":126,"url":"http://t.co/fZlbqZKiS0","expanded_url":"http://bit.ly/15xbvBD","display_url":"bit.ly/15xbvBD"}],"annotations":[{"start":13,"end":16,"probability":0.5542,"type":"Organization","normalized_text":"ECHA"},{"start":68,"end":80,"probability":0.4042,"type":"Place","normalized_text":"Ecotoxicology"}]},"conversation_id":"385371018757689344","possibly_sensitive":false,"created_at":"2013-10-02T11:49:45.000Z","referenced_tweets":[{"type":"retweeted","id":"385358756051046400"}],"id":"385371018757689344","text":"RT @EU_ECHA: ECHA is recruiting Scientific Officers in the field of Ecotoxicology. Apply by 4 November. http://t.co/fZlbqZKiS0   #jobs #EU","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":52,"end":64,"tag":"antibiotics"},{"start":108,"end":113,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":[{"start":85,"end":107,"url":"http://t.co/suD5lynbh8","expanded_url":"http://bit.ly/1eZeyZG","display_url":"bit.ly/1eZeyZG"}],"annotations":{}},"conversation_id":"385370809906495488","possibly_sensitive":false,"created_at":"2013-10-02T11:48:55.000Z","referenced_tweets":{},"id":"385370809906495488","text":"RT @EAAD_EU: Every single person is responsible for #antibiotics remaining effective http://t.co/suD5lynbh8 #EAAD","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":29,"tag":"Biomedical"},{"start":57,"end":63,"tag":"human"},{"start":76,"end":81,"tag":"stem"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":114,"end":136,"url":"http://t.co/Jj6EgVictz","expanded_url":"http://bit.ly/15If9fp","display_url":"bit.ly/15If9fp"}],"annotations":{}},"conversation_id":"385351114604183552","possibly_sensitive":false,"created_at":"2013-10-02T10:30:39.000Z","referenced_tweets":[{"type":"retweeted","id":"385350973947785216"}],"id":"385351114604183552","text":"RT @euparkinsons: #Biomedical &amp; clinical promises of #human pluripotent #stem cells 4 neurological disorders: http://t.co/Jj6EgVictz","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":[{"start":33,"end":51,"probability":0.5591,"type":"Organization","normalized_text":"EMA Managment Board"}]},"conversation_id":"385334651197595648","possibly_sensitive":false,"created_at":"2013-10-02T09:25:14.000Z","referenced_tweets":[{"type":"retweeted","id":"385334586403979264"}],"id":"385334651197595648","text":"RT @GCessak: The next meeting of EMA Managment Board will start tomorrow.\nMain outcomes will be published after the meeting: http://t.co/On…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":130,"end":137,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":35,"end":51,"username":"RiccardoGuidi87","id":"215396540"}],"urls":[{"start":107,"end":129,"url":"http://t.co/LX4qyNthYE","expanded_url":"http://www.scienceplug.com/2013/10/01/letter-to-the-european-medical-agency-release-clinical-trials-data/","display_url":"scienceplug.com/2013/10/01/let…"}],"annotations":{}},"conversation_id":"385326840434675712","possibly_sensitive":false,"created_at":"2013-10-02T08:54:12.000Z","referenced_tweets":{},"id":"385326840434675712","text":"RT @EAHPtweet: Interesting blog by @RiccardoGuidi87 on his response to consultation on clinical-trial data http://t.co/LX4qyNthYE #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":119,"end":126,"tag":"ctdata"}],"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/R53IfCE4uP","expanded_url":"http://bit.ly/19kg80a","display_url":"bit.ly/19kg80a"}],"annotations":{}},"conversation_id":"385318535137751040","possibly_sensitive":false,"created_at":"2013-10-02T08:21:12.000Z","referenced_tweets":{},"id":"385318535137751040","text":"Our public consultation on the publication and access to clinical-trial data closed on Monday: http://t.co/R53IfCE4uP  #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/llL8pEi40A","expanded_url":"http://bit.ly/15I7Miy","display_url":"bit.ly/15I7Miy"}],"annotations":{}},"conversation_id":"385318196477063168","possibly_sensitive":false,"created_at":"2013-10-02T08:19:51.000Z","referenced_tweets":{},"id":"385318196477063168","text":"Send us your comments on our concept paper on demonstrating equivalence for local medicines in the GI tract: http://t.co/llL8pEi40A","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":27,"end":36,"tag":"teaching"},{"start":43,"end":55,"tag":"antibiotics"},{"start":126,"end":131,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":[{"start":103,"end":125,"url":"http://t.co/OULqMZPxNI","expanded_url":"http://bit.ly/MXohSC","display_url":"bit.ly/MXohSC"}],"annotations":{}},"conversation_id":"385317770717831168","possibly_sensitive":false,"created_at":"2013-10-02T08:18:10.000Z","referenced_tweets":[{"type":"retweeted","id":"385317524465664000"}],"id":"385317770717831168","text":"RT @EAAD_EU: Interested in #teaching about #antibiotics? Participate to this year’s e-bug competition: http://t.co/OULqMZPxNI #EAAD","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":12,"end":26,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/Mq1KF9kPri","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"385317215803047936","possibly_sensitive":false,"created_at":"2013-10-02T08:15:57.000Z","referenced_tweets":{},"id":"385317215803047936","text":"What is the #blacktriangle? Find out more about additional monitoring of medicines: http://t.co/Mq1KF9kPri","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":47,"end":60,"tag":"rarediseases"},{"start":126,"end":138,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":61,"end":83,"url":"http://t.co/OR0psqav0Y","expanded_url":"http://ow.ly/ppAIG","display_url":"ow.ly/ppAIG"}],"annotations":[{"start":14,"end":20,"probability":0.9848,"type":"Place","normalized_text":"Germany"}]},"conversation_id":"385316629854552064","possibly_sensitive":false,"created_at":"2013-10-02T08:13:38.000Z","referenced_tweets":[{"type":"retweeted","id":"385316466406731776"}],"id":"385316629854552064","text":"RT @eurordis: Germany adopts national plan for #rarediseases http://t.co/OR0psqav0Y  Estimated 4 million people living with a #raredisease …","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":38,"tag":"animaltesting"},{"start":97,"end":101,"tag":"fp7"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":74,"end":96,"url":"http://t.co/vZfeWj6QYL","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=36113","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"annotations":{}},"conversation_id":"385316518093139968","possibly_sensitive":false,"created_at":"2013-10-02T08:13:11.000Z","referenced_tweets":[{"type":"retweeted","id":"385315183586865152"}],"id":"385316518093139968","text":"RT @myCORDIS: Replacing #animaltesting with accurate in vitro innovations http://t.co/vZfeWj6QYL #fp7","attachments":{"media_keys":{}}},{"lang":"da","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":78,"end":92,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":55,"end":77,"url":"http://t.co/tj7fINjLep","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_NOVIDADES/DETALHE_NOVIDADE?itemid=7462655","display_url":"infarmed.pt/portal/page/po…"}],"annotations":{}},"conversation_id":"385078888088756224","possibly_sensitive":false,"created_at":"2013-10-01T16:28:56.000Z","referenced_tweets":{},"id":"385078888088756224","text":"RT @INFARMED_IP: Medicines under additional monitoring http://t.co/tj7fINjLep #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":115,"end":122,"tag":"ctdata"}],"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/sCj7ZRiHjM","expanded_url":"http://bit.ly/19kg80a","display_url":"bit.ly/19kg80a"}],"annotations":{}},"conversation_id":"385078408591708160","possibly_sensitive":false,"created_at":"2013-10-01T16:27:01.000Z","referenced_tweets":{},"id":"385078408591708160","text":"Our public consultation on the publication and access to clinical-trial data is now closed: http://t.co/sCj7ZRiHjM #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":20,"end":34,"tag":"BlackTriangle"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":122,"end":144,"url":"http://t.co/GLd4DbnMar","expanded_url":"http://govuk.info/2xGu","display_url":"govuk.info/2xGu"}],"annotations":[{"start":50,"end":51,"probability":0.6871,"type":"Place","normalized_text":"EU"}]},"conversation_id":"385078014356512768","possibly_sensitive":false,"created_at":"2013-10-01T16:25:27.000Z","referenced_tweets":{},"id":"385078014356512768","text":"RT @GCessak: MHRA | #BlackTriangle implemented in EU, patient leaflet to have symbol &amp; info on reporting side effects http://t.co/GLd4DbnMar","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":19,"end":23,"tag":"FDA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":78,"end":100,"url":"http://t.co/UeEWBXfnKn","expanded_url":"http://1.usa.gov/GzICfv","display_url":"1.usa.gov/GzICfv"}],"annotations":{}},"conversation_id":"385070913534058496","possibly_sensitive":false,"created_at":"2013-10-01T15:57:14.000Z","referenced_tweets":[{"type":"retweeted","id":"385068861403701248"}],"id":"385070913534058496","text":"RT @FDA_Drug_Info: #FDA approves new drug to treat major depressive disorder. http://t.co/UeEWBXfnKn","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":45,"end":67,"url":"http://t.co/olc1K0rXjs","expanded_url":"http://ecdc2007.ecdc.europa.eu/en/eaad/antibiotics/Pages/messagesForPublic.aspx","display_url":"ecdc2007.ecdc.europa.eu/en/eaad/antibi…"}],"annotations":{}},"conversation_id":"385070872023031808","possibly_sensitive":false,"created_at":"2013-10-01T15:57:04.000Z","referenced_tweets":[{"type":"retweeted","id":"385070217757741056"}],"id":"385070872023031808","text":"RT @GCessak: When should I take antibiotics? http://t.co/olc1K0rXjs","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":19,"end":33,"tag":"BlackTriangle"}],"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":121,"end":143,"url":"http://t.co/GLd4DbnMar","expanded_url":"http://govuk.info/2xGu","display_url":"govuk.info/2xGu"}],"annotations":[{"start":49,"end":50,"probability":0.7174,"type":"Place","normalized_text":"EU"}]},"conversation_id":"385070660508471296","possibly_sensitive":false,"created_at":"2013-10-01T15:56:14.000Z","referenced_tweets":{},"id":"385070660508471296","text":"RT @MHRAmedicines: #BlackTriangle implemented in EU, patient leaflet to have symbol &amp; info on reporting side effects http://t.co/GLd4DbnMar","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":72,"end":86,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":27,"end":36,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/uKy1J3oPoi","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"annotations":{}},"conversation_id":"385045050381856768","possibly_sensitive":false,"created_at":"2013-10-01T14:14:28.000Z","referenced_tweets":[{"type":"retweeted","id":"385044814166626305"}],"id":"385045050381856768","text":"RT @EU_Consumer: Check out @EMA_News video and factsheet explaining the #blacktriangle &amp; additional monitoring http://t.co/uKy1J3oPoi","attachments":{"media_keys":{}}},{"lang":"fr","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":17,"end":25,"username":"YouTube","id":"10228272"}],"urls":{},"annotations":{}},"conversation_id":"385037019241406464","possibly_sensitive":false,"created_at":"2013-10-01T13:59:41.000Z","referenced_tweets":[{"type":"replied_to","id":"385037019241406464"}],"id":"385041330411675648","text":"@StephLavaudMeds @youtube Le triangle noir ne sera pas sur les boites de medicaments; seulement sur les notices.","in_reply_to_user_id":"773698945","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":119,"end":133,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":96,"end":118,"url":"http://t.co/aZ6R11EnPM","expanded_url":"http://ow.ly/pnKDA","display_url":"ow.ly/pnKDA"}],"annotations":[{"start":14,"end":28,"probability":0.9928,"type":"Person","normalized_text":"Francois Houyez"}]},"conversation_id":"385040456393830400","possibly_sensitive":false,"created_at":"2013-10-01T13:56:13.000Z","referenced_tweets":{},"id":"385040456393830400","text":"RT @eurordis: Francois Houyez speaks in EMA video on medicines in need of additional monitoring http://t.co/aZ6R11EnPM #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":83,"end":97,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":40,"end":49,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"conversation_id":"385035899496845312","possibly_sensitive":false,"created_at":"2013-10-01T13:38:06.000Z","referenced_tweets":[{"type":"retweeted","id":"385035833905926145"}],"id":"385035899496845312","text":"RT @JeanGeorgesAE: Very useful video of @EMA_News to explain what newly introduced #blacktriangle means in package leaflets of medicines ht…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":8,"username":"EPHA_EU","id":"184756856"}],"urls":{},"annotations":{}},"conversation_id":"384971025286307840","possibly_sensitive":false,"created_at":"2013-10-01T13:34:49.000Z","referenced_tweets":[{"type":"replied_to","id":"385027451706802177"}],"id":"385035071520243713","text":"@EPHA_EU Thanks. We appreciate it!","in_reply_to_user_id":"184756856","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":4,"quote_count":0},"entities":{"hashtags":[{"start":27,"end":41,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":48,"end":70,"url":"http://t.co/qybC42RFtb","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/09/WC500150608.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"},{"start":71,"end":93,"url":"http://t.co/K2ImcFfQoz","expanded_url":"https://twitter.com/GCessak/status/385031341013618689/photo/1","display_url":"pic.twitter.com/K2ImcFfQoz"}],"annotations":{}},"conversation_id":"385031787141148672","possibly_sensitive":false,"created_at":"2013-10-01T13:21:46.000Z","referenced_tweets":{},"id":"385031787141148672","text":"RT @GCessak: What does the #blacktriangle mean? http://t.co/qybC42RFtb http://t.co/K2ImcFfQoz","attachments":{"media_keys":["3_385031341022007296"]}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":{},"annotations":{}},"conversation_id":"385031602373681152","possibly_sensitive":false,"created_at":"2013-10-01T13:21:02.000Z","referenced_tweets":[{"type":"retweeted","id":"385028754898055169"}],"id":"385031602373681152","text":"RT @EAHPtweet: Deadline to submit abstracts to EAHP's Congress closes in 2 wks! 4 inspiration &amp; encouragement heres the 2013 winners http:/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":15,"end":22,"tag":"EUPets"},{"start":41,"end":49,"tag":"welfare"},{"start":53,"end":58,"tag":"dogs"},{"start":63,"end":68,"tag":"cats"},{"start":76,"end":79,"tag":"EU"},{"start":81,"end":90,"tag":"Brussels"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":98,"end":120,"url":"http://t.co/IZfArWNDoO","expanded_url":"http://bit.ly/13t7s8M/","display_url":"bit.ly/13t7s8M/"}],"annotations":{}},"conversation_id":"385030792977874944","possibly_sensitive":false,"created_at":"2013-10-01T13:17:49.000Z","referenced_tweets":[{"type":"retweeted","id":"385020391707537409"}],"id":"385030792977874944","text":"RT @EU_Health: #EUPets 1st conference on #welfare of #dogs and #cats in the #EU, #Brussels, 28.10 http://t.co/IZfArWNDoO Registration closi…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":52,"end":56,"tag":"flu"},{"start":69,"end":81,"tag":"antibiotics"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"annotations":{}},"conversation_id":"385011745569660928","possibly_sensitive":false,"created_at":"2013-10-01T12:02:07.000Z","referenced_tweets":[{"type":"retweeted","id":"385011320468160512"}],"id":"385011745569660928","text":"RT @EAAD_EU: Antibiotics don’t work against cold or #flu. Learn when #antibiotics are needed and how you should take them: http://t.co/WWNa…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":113,"end":117,"tag":"cvd"},{"start":118,"end":129,"tag":"prevention"}],"mentions":[{"start":3,"end":12,"username":"ehnheart","id":"407008173"},{"start":46,"end":54,"username":"borgton","id":"1605512862"}],"urls":[{"start":90,"end":112,"url":"http://t.co/StH4xs0lA9","expanded_url":"http://ec.europa.eu/commission_2010-2014/borg/personally_speaking/index_en.htm","display_url":"ec.europa.eu/commission_201…"}],"annotations":[{"start":27,"end":44,"probability":0.5147,"type":"Person","normalized_text":"Commissionner Borg"},{"start":74,"end":88,"probability":0.7175,"type":"Other","normalized_text":"World Heart Day"}]},"conversation_id":"385009076830482432","possibly_sensitive":false,"created_at":"2013-10-01T11:51:31.000Z","referenced_tweets":[{"type":"retweeted","id":"385009016167882752"}],"id":"385009076830482432","text":"RT @ehnheart: Message from Commissionner Borg @borgton on the occasion of World Heart Day http://t.co/StH4xs0lA9\n#cvd #prevention","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/ysOtErqTdy","expanded_url":"http://bit.ly/15I7Miy","display_url":"bit.ly/15I7Miy"}],"annotations":{}},"conversation_id":"385006338927255552","possibly_sensitive":false,"created_at":"2013-10-01T11:40:38.000Z","referenced_tweets":{},"id":"385006338927255552","text":"We've published a paper on demonstrating equivalence for local medicines in the GI tract for public consultation: http://t.co/ysOtErqTdy","attachments":{"media_keys":{}}},{"lang":"es","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":105,"end":115,"tag":"medicines"},{"start":116,"end":134,"tag":"pharmacovigilance"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":64,"end":73,"username":"EMA_News","id":"116716199"}],"urls":[{"start":82,"end":104,"url":"http://t.co/Aq3oANc9GK","expanded_url":"http://www.youtube.com/watch?v=wlcOZ7eHuQI","display_url":"youtube.com/watch?v=wlcOZ7…"}],"annotations":{}},"conversation_id":"385005113573928960","possibly_sensitive":false,"created_at":"2013-10-01T11:35:46.000Z","referenced_tweets":[{"type":"retweeted","id":"385005055910227968"}],"id":"385005113573928960","text":"RT @EAHPtweet: ¿Qué significa el triángulo negro? Este video de @EMA_News explica http://t.co/Aq3oANc9GK #medicines #pharmacovigilance #bla…","attachments":{"media_keys":{}}},{"lang":"it","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":105,"end":123,"tag":"pharmacovigilance"},{"start":124,"end":134,"tag":"medicines"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":65,"end":74,"username":"EMA_News","id":"116716199"}],"urls":[{"start":82,"end":104,"url":"http://t.co/27W2XWqH9w","expanded_url":"http://www.youtube.com/watch?v=1eR1ZpEljmQ","display_url":"youtube.com/watch?v=1eR1Zp…"}],"annotations":{}},"conversation_id":"385004455290486784","possibly_sensitive":false,"created_at":"2013-10-01T11:33:09.000Z","referenced_tweets":[{"type":"retweeted","id":"385004388315451392"}],"id":"385004455290486784","text":"RT @EAHPtweet: Cosa significa il triangolo nero? Questo video da @EMA_News spiega http://t.co/27W2XWqH9w #pharmacovigilance #medicines #bla…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":10,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":52,"end":74,"url":"http://t.co/ruWSTft4Pz","expanded_url":"http://bit.ly/15GpNDs","display_url":"bit.ly/15GpNDs"}],"annotations":{}},"conversation_id":"385003805969891328","possibly_sensitive":false,"created_at":"2013-10-01T11:32:45.000Z","referenced_tweets":[{"type":"replied_to","id":"385003805969891328"}],"id":"385004354656563200","text":"@EAHPtweet The link to the Spanish video should be: http://t.co/ruWSTft4Pz","in_reply_to_user_id":"203357203","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":10,"username":"EAHPtweet","id":"203357203"}],"urls":{},"annotations":{}},"conversation_id":"385001360569024512","possibly_sensitive":false,"created_at":"2013-10-01T11:29:20.000Z","referenced_tweets":[{"type":"replied_to","id":"385001360569024512"}],"id":"385003494518042624","text":"@EAHPtweet Thanks for sharing this. However your Italian tweet links to the French video...","in_reply_to_user_id":"203357203","attachments":{"media_keys":{}}},{"lang":"fr","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":103,"end":117,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":61,"end":70,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/fQP7z8B8xz","expanded_url":"http://www.youtube.com/watch?v=7ZpSorhErss","display_url":"youtube.com/watch?v=7ZpSor…"}],"annotations":{}},"conversation_id":"385002645548965888","possibly_sensitive":false,"created_at":"2013-10-01T11:25:58.000Z","referenced_tweets":{},"id":"385002645548965888","text":"RT @EAHPtweet: Que signifie le triangle noir? Cette vidéo de @EMA_News explique http://t.co/fQP7z8B8xz #blacktriangle","attachments":{"media_keys":{}}},{"lang":"de","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":108,"end":122,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":67,"end":76,"username":"EMA_News","id":"116716199"}],"urls":[{"start":85,"end":107,"url":"http://t.co/33tM31H6oM","expanded_url":"http://www.youtube.com/watch?v=2dPGLjiK8d0","display_url":"youtube.com/watch?v=2dPGLj…"}],"annotations":{}},"conversation_id":"385002488556167169","possibly_sensitive":false,"created_at":"2013-10-01T11:25:20.000Z","referenced_tweets":{},"id":"385002488556167169","text":"RT @EAHPtweet: Was bedeutet das schwarze Dreieck? Dieses Video von @EMA_News erklärt http://t.co/33tM31H6oM #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":[{"start":42,"end":44,"probability":0.5777,"type":"Other","normalized_text":"HIV"}]},"conversation_id":"385000285963579392","possibly_sensitive":false,"created_at":"2013-10-01T11:16:35.000Z","referenced_tweets":[{"type":"retweeted","id":"384998326342393856"}],"id":"385000285963579392","text":"RT @innovationunion: Linking arms against HIV: For decades, scientists have been working in different fields to combat the pandemic... http…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":25,"end":39,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":77,"end":99,"url":"http://t.co/cZu3X97hlb","expanded_url":"http://www.ema.europa.eu/docs/pl_PL/document_library/Other/2013/09/WC500150608.pdf","display_url":"ema.europa.eu/docs/pl_PL/doc…"},{"start":100,"end":122,"url":"http://t.co/HQ4TIeuIIw","expanded_url":"https://twitter.com/GCessak/status/384996717176696833/photo/1","display_url":"pic.twitter.com/HQ4TIeuIIw"}],"annotations":{}},"conversation_id":"385000154400845824","possibly_sensitive":false,"created_at":"2013-10-01T11:16:04.000Z","referenced_tweets":{},"id":"385000154400845824","text":"RT @GCessak: What is the #blacktriangle on the package leaflet of medicines?\nhttp://t.co/cZu3X97hlb http://t.co/HQ4TIeuIIw","attachments":{"media_keys":["3_384996717185085440"]}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"entities":{"hashtags":[{"start":39,"end":53,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":121,"end":143,"url":"http://t.co/WeoH36QuED","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"annotations":{}},"conversation_id":"384996429652963328","possibly_sensitive":false,"created_at":"2013-10-01T11:01:16.000Z","referenced_tweets":{},"id":"384996429652963328","text":"Our video and factsheet explaining the #blacktriangle &amp; additional monitoring in all EU languages are now available: http://t.co/WeoH36QuED","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":120,"end":134,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":97,"end":119,"url":"http://t.co/12Hm6hkslo","expanded_url":"http://fb.me/2UOduCb4j","display_url":"fb.me/2UOduCb4j"}],"annotations":{}},"conversation_id":"384993292376887296","possibly_sensitive":false,"created_at":"2013-10-01T10:48:48.000Z","referenced_tweets":{},"id":"384993292376887296","text":"RT @GCessak: Information dated 01/10/2013 on the campaign on additional monitoring of medicines: http://t.co/12Hm6hkslo #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"hashtags":[{"start":29,"end":43,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":50,"end":72,"url":"http://t.co/cZu3X97hlb","expanded_url":"http://www.ema.europa.eu/docs/pl_PL/document_library/Other/2013/09/WC500150608.pdf","display_url":"ema.europa.eu/docs/pl_PL/doc…"}],"annotations":{}},"conversation_id":"384992018323480576","possibly_sensitive":false,"created_at":"2013-10-01T10:43:44.000Z","referenced_tweets":{},"id":"384992018323480576","text":"RT @URPLWMiPB: What does the #blacktriangle mean? http://t.co/cZu3X97hlb","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":114,"end":128,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":91,"end":113,"url":"http://t.co/91p695OPJB","expanded_url":"http://www.youtube.com/watch?v=qzM4NKPoovM","display_url":"youtube.com/watch?v=qzM4NK…"}],"annotations":{}},"conversation_id":"384991852119994368","possibly_sensitive":false,"created_at":"2013-10-01T10:43:05.000Z","referenced_tweets":{},"id":"384991852119994368","text":"RT @URPLWMiPB: The black triangle does not mean that the medicine is unsafe - EMA campaign http://t.co/91p695OPJB #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":116,"end":130,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":93,"end":115,"url":"http://t.co/K3SIrsSdwG","expanded_url":"http://urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-1-pazdziernika-2013-roku-o-kampanii-informacyjnej-poswieconej-dodatkowemu-monitorowaniu-produktow-leczniczych-2","display_url":"urpl.gov.pl/aktualnosci/in…"}],"annotations":{}},"conversation_id":"384991401987280896","possibly_sensitive":false,"created_at":"2013-10-01T10:41:17.000Z","referenced_tweets":{},"id":"384991401987280896","text":"RT @URPLWMiPB: Information about the campaign on additional monitoring of medicinal products http://t.co/K3SIrsSdwG #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":30,"end":44,"tag":"blacktriangle"}],"mentions":[{"start":0,"end":15,"username":"AIM_Healthcare","id":"784869524"},{"start":16,"end":25,"username":"cancereu","id":"140344419"}],"urls":{},"annotations":{}},"conversation_id":"384982169866625024","possibly_sensitive":false,"created_at":"2013-10-01T10:32:56.000Z","referenced_tweets":[{"type":"replied_to","id":"384982169866625024"}],"id":"384989301676974081","text":"@AIM_Healthcare @cancereu The #blacktriangle is not a warning, but an invitation to report suspected side effects to the regulators.","in_reply_to_user_id":"784869524","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":19,"end":33,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/Mq1KF9kPri","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"annotations":{}},"conversation_id":"384963559614316544","possibly_sensitive":false,"created_at":"2013-10-01T10:32:11.000Z","referenced_tweets":[{"type":"replied_to","id":"384980031728279552"}],"id":"384989111255572480","text":"@ClinicaAmanda The #blacktriangle is only for medicines; a deliverable of the 2010 pharmacovigilance legislation: http://t.co/Mq1KF9kPri","in_reply_to_user_id":"183177433","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":27,"end":41,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":[{"start":115,"end":137,"url":"http://t.co/p7SvowvIKA","expanded_url":"http://bit.ly/1fZvyxR","display_url":"bit.ly/1fZvyxR"}],"annotations":{}},"conversation_id":"384987434356056064","possibly_sensitive":false,"created_at":"2013-10-01T10:25:31.000Z","referenced_tweets":{},"id":"384987434356056064","text":"RT @HAIEurope: Now in use: #blacktriangle labels medicines under additional monitoring by reg. authorities: video: http://t.co/p7SvowvIKA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":80,"end":94,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":102,"end":124,"url":"http://t.co/fqyjKYHFxJ","expanded_url":"http://youtu.be/qzM4NKPoovM","display_url":"youtu.be/qzM4NKPoovM","status":200,"unwound_url":"https://www.youtube.com/watch?v=qzM4NKPoovM&feature=youtu.be"}],"annotations":[{"start":17,"end":41,"probability":0.5544,"type":"Organization","normalized_text":"European Medicines Agency"}]},"conversation_id":"384987193624002560","possibly_sensitive":false,"created_at":"2013-10-01T10:24:34.000Z","referenced_tweets":{},"id":"384987193624002560","text":"RT @GCessak: The European Medicines Agency has published a video: What does the #blacktriangle mean?: http://t.co/fqyjKYHFxJ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":14,"end":18,"tag":"ΕΜΑ"},{"start":125,"end":139,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"urls":[{"start":102,"end":124,"url":"http://t.co/2rMUrMA3RT","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fnews_and_events%2Fnews%2F2013%2F09%2Fnews_detail_001900.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{}},"conversation_id":"384987140670906368","possibly_sensitive":false,"created_at":"2013-10-01T10:24:21.000Z","referenced_tweets":{},"id":"384987140670906368","text":"RT @cancereu: #ΕΜΑ publishes a video explaining the concept of medicines under additional monitoring  http://t.co/2rMUrMA3RT #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":38,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"},{"start":120,"end":129,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"conversation_id":"384986338480898048","possibly_sensitive":false,"created_at":"2013-10-01T10:21:10.000Z","referenced_tweets":[{"type":"retweeted","id":"384978219419455489"}],"id":"384986338480898048","text":"RT @beuctweet: \"The new #blacktriangle on drugs is an invitation to health pros &amp; also patients to report problems\" @EMA_News Watch http://…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"mentions":[{"start":0,"end":9,"username":"cancereu","id":"140344419"}],"urls":{},"annotations":{}},"conversation_id":"384976819457622016","possibly_sensitive":false,"created_at":"2013-10-01T10:20:40.000Z","referenced_tweets":[{"type":"replied_to","id":"384976819457622016"}],"id":"384986213322883072","text":"@cancereu The #blacktriangle is not a warning, but an invitation to report suspected side effects to the regulatory authorities.","in_reply_to_user_id":"140344419","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":101,"end":123,"url":"http://t.co/jefoDs6l4b","expanded_url":"http://fb.me/203LAYfve","display_url":"fb.me/203LAYfve"}],"annotations":[{"start":28,"end":30,"probability":0.5558,"type":"Organization","normalized_text":"EMA"}]},"conversation_id":"384985776230256640","possibly_sensitive":false,"created_at":"2013-10-01T10:18:56.000Z","referenced_tweets":{},"id":"384985776230256640","text":"RT @GCessak: Video from the EMA information campaign on additional monitoring of medicinal products: http://t.co/jefoDs6l4b","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":117,"end":139,"url":"http://t.co/S1FRNgCKlI","expanded_url":"http://fb.me/112ehGZ7g","display_url":"fb.me/112ehGZ7g"}],"annotations":{}},"conversation_id":"384985128914939904","possibly_sensitive":false,"created_at":"2013-10-01T10:16:22.000Z","referenced_tweets":{},"id":"384985128914939904","text":"RT @GCessak: Invitation from Polish agency to press conference: respiratory viruses with particular emphasis on flu: http://t.co/S1FRNgCKlI","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":27,"tag":"blacktriangle"}],"mentions":[{"start":0,"end":8,"username":"EPHA_EU","id":"184756856"}],"urls":{},"annotations":{}},"conversation_id":"384971025286307840","possibly_sensitive":false,"created_at":"2013-10-01T10:13:46.000Z","referenced_tweets":[{"type":"replied_to","id":"384971025286307840"}],"id":"384984474796457984","text":"@EPHA_EU The #blacktriangle is not a warning, but an invitation to report suspected side effects.","in_reply_to_user_id":"184756856","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":119,"end":133,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":8,"username":"PGEU","id":"459292439"}],"urls":[{"start":96,"end":118,"url":"http://t.co/2rMUrMA3RT","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fnews_and_events%2Fnews%2F2013%2F09%2Fnews_detail_001900.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":10,"end":12,"probability":0.452,"type":"Organization","normalized_text":"EMA"}]},"conversation_id":"384984123401854976","possibly_sensitive":false,"created_at":"2013-10-01T10:12:22.000Z","referenced_tweets":{},"id":"384984123401854976","text":"RT @PGEU: EMA publishes a video explaining the concept of medicines under additional monitoring http://t.co/2rMUrMA3RT #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":122,"end":136,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":99,"end":121,"url":"http://t.co/7pelCPjWTE","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/09/news_detail_001900.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":13,"end":15,"probability":0.3621,"type":"Organization","normalized_text":"EMA"}]},"conversation_id":"384983978450911232","possibly_sensitive":false,"created_at":"2013-10-01T10:11:47.000Z","referenced_tweets":{},"id":"384983978450911232","text":"RT @GCessak: EMA published a video explaining the concept of medicines under additional monitoring http://t.co/7pelCPjWTE #blacktriangle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":73,"end":87,"tag":"blacktriangle"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/YWsuLDhWrE","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"annotations":{}},"conversation_id":"384963559614316544","possibly_sensitive":false,"created_at":"2013-10-01T08:50:39.000Z","referenced_tweets":{},"id":"384963559614316544","text":"We've published a video and factsheet in all EU languages explaining the #blacktriangle and additional monitoring: http://t.co/YWsuLDhWrE","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":61,"end":65,"tag":"HIV"}],"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/Y1XRIUrIxz","expanded_url":"http://bit.ly/16D1ruT","display_url":"bit.ly/16D1ruT"}],"annotations":{}},"conversation_id":"384959224112898048","possibly_sensitive":false,"created_at":"2013-10-01T08:33:25.000Z","referenced_tweets":{},"id":"384959224112898048","text":"Send us your comments on our updated guideline on developing #HIV medicines: http://t.co/Y1XRIUrIxz","attachments":{"media_keys":{}}},{"lang":"ro","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":81,"end":103,"url":"http://t.co/i4AzSzryQr","expanded_url":"http://1.usa.gov/1fD2FKq","display_url":"1.usa.gov/1fD2FKq"}],"annotations":{}},"conversation_id":"384713140287864832","possibly_sensitive":false,"created_at":"2013-09-30T16:15:34.000Z","referenced_tweets":[{"type":"retweeted","id":"384712998671376384"}],"id":"384713140287864832","text":"RT @FDA_Drug_Info: FDA approves Perjeta for neoadjuvant breast cancer treatment. http://t.co/i4AzSzryQr","attachments":{"media_keys":{}}},{"lang":"ro","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":73,"end":95,"url":"http://t.co/8pcqWDzs8z","expanded_url":"http://1.usa.gov/18G4gr5","display_url":"1.usa.gov/18G4gr5"}],"annotations":{}},"conversation_id":"384713103709323265","possibly_sensitive":false,"created_at":"2013-09-30T16:15:26.000Z","referenced_tweets":[{"type":"retweeted","id":"384712790444765184"}],"id":"384713103709323265","text":"RT @US_FDA: FDA approves Perjeta for neoadjuvant breast cancer treatment http://t.co/8pcqWDzs8z","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":93,"end":115,"url":"http://t.co/YRgY2znAqB","expanded_url":"http://bit.ly/17jesY7","display_url":"bit.ly/17jesY7"}],"annotations":{}},"conversation_id":"384696628927807488","possibly_sensitive":false,"created_at":"2013-09-30T15:09:58.000Z","referenced_tweets":{},"id":"384696628927807488","text":"RT @Legemiddelinfo: Physicians should advise on risk for psychiatric side effects of Lariam: http://t.co/YRgY2znAqB","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":23,"end":27,"tag":"FDA"},{"start":77,"end":85,"tag":"Tygacil"},{"start":87,"end":99,"tag":"tigecycline"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":102,"end":124,"url":"http://t.co/tqjmTBamDn","expanded_url":"http://1.usa.gov/16ZgV6Q","display_url":"1.usa.gov/16ZgV6Q"}],"annotations":{}},"conversation_id":"384696470953549824","possibly_sensitive":false,"created_at":"2013-09-30T15:09:20.000Z","referenced_tweets":{},"id":"384696470953549824","text":"RT @FDA_Drug_Info: The #FDA warns of increased risk of death with antibiotic #Tygacil (#tigecycline). http://t.co/tqjmTBamDn","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":[{"start":17,"end":41,"probability":0.393,"type":"Organization","normalized_text":"81st EMA Management Board"}]},"conversation_id":"384690146282844160","possibly_sensitive":false,"created_at":"2013-09-30T14:44:12.000Z","referenced_tweets":[{"type":"retweeted","id":"384684659071664129"}],"id":"384690146282844160","text":"RT @GCessak: The 81st EMA Management Board meeting will be held on Thursday. Main outcomes will be published after the meeting: http://t.co…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":80,"end":102,"url":"http://t.co/1ZHmZHHqS1","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/2013/NI-AEMPS_14-2013-jornada-farmacovigilancia.htm","display_url":"aemps.gob.es/informa/notasI…"}],"annotations":{}},"conversation_id":"384682173443604480","possibly_sensitive":false,"created_at":"2013-09-30T14:12:31.000Z","referenced_tweets":{},"id":"384682173443604480","text":"RT @AEMPSGOB: Information day on developments in pharmacovigilance of medicines http://t.co/1ZHmZHHqS1","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"urls":{},"annotations":{}},"conversation_id":"384681981487095808","possibly_sensitive":false,"created_at":"2013-09-30T14:11:46.000Z","referenced_tweets":[{"type":"retweeted","id":"384679272050610176"}],"id":"384681981487095808","text":"RT @borgton: Commission' s goal is to reduce the incidence of cancer by 15% by 2020. Cancer killed 1.3million people in the EU last year","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":56,"end":80,"tag":"antimicrobialresistance"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{}},"conversation_id":"384681904760692736","possibly_sensitive":false,"created_at":"2013-09-30T14:11:27.000Z","referenced_tweets":[{"type":"retweeted","id":"384678466710675457"}],"id":"384681904760692736","text":"RT @ECDC_EU: Do you have promotional materials to fight #antimicrobialresistance? We can help promote it! Post it on our FB http://t.co/WBt…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":95,"end":117,"url":"http://t.co/taJfjq1oYL","expanded_url":"http://bit.ly/1bMe0oP","display_url":"bit.ly/1bMe0oP"}],"annotations":[{"start":27,"end":41,"probability":0.5976,"type":"Other","normalized_text":"World Heart Day"}]},"conversation_id":"384675310073286656","possibly_sensitive":false,"created_at":"2013-09-30T13:45:15.000Z","referenced_tweets":[{"type":"retweeted","id":"384675227583537152"}],"id":"384675310073286656","text":"RT @GCessak: EMA supported World Heart Day yesterday - more guidance for medicines developers: http://t.co/taJfjq1oYL","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":68,"end":90,"url":"http://t.co/e1k1K9gl6V","expanded_url":"http://www.pharmafile.com/news/181146/future-data-disclosure-europe#.Ukl8TkncC2M.twitter","display_url":"pharmafile.com/news/181146/fu…"}],"annotations":[{"start":48,"end":53,"probability":0.9904,"type":"Place","normalized_text":"Europe"}]},"conversation_id":"384671376642420736","possibly_sensitive":false,"created_at":"2013-09-30T13:29:37.000Z","referenced_tweets":[{"type":"retweeted","id":"384670949976469505"}],"id":"384671376642420736","text":"RT @EAHPtweet: The future of data disclosure in Europe | Pharmafile http://t.co/e1k1K9gl6V","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":29,"end":41,"tag":"LegalPolicy"},{"start":62,"end":66,"tag":"FDA"}],"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/5OV8a1eDit","expanded_url":"http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2013/09/center-for-legal-policy-report-takes-aim-at-fdas-regulation-of-autologous-stem-cell-procedures.html","display_url":"fdalawblog.net/fda_law_blog_h…"}],"annotations":{}},"conversation_id":"384670973704028160","possibly_sensitive":false,"created_at":"2013-09-30T13:28:01.000Z","referenced_tweets":[{"type":"retweeted","id":"384669977631928320"}],"id":"384670973704028160","text":"RT @sailinsomnia: Center for #LegalPolicy Report Takes Aim at #FDA’s Regulation of Autologous Stem Cell Procedures http://t.co/5OV8a1eDit","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":123,"end":130,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":100,"end":122,"url":"http://t.co/huUhbNWQbH","expanded_url":"http://shar.es/Kw2Yo","display_url":"shar.es/Kw2Yo"}],"annotations":[{"start":37,"end":39,"probability":0.5188,"type":"Organization","normalized_text":"EMA"},{"start":89,"end":98,"probability":0.627,"type":"Organization","normalized_text":"All Trials"}]},"conversation_id":"384667620487991297","possibly_sensitive":false,"created_at":"2013-09-30T13:14:42.000Z","referenced_tweets":{},"id":"384667620487991297","text":"RT @EAHPtweet: AllTrials response to EMA consultation on access to clinical trial data | All Trials http://t.co/huUhbNWQbH #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":56,"end":60,"tag":"HIV"}],"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/wTeED8Knzv","expanded_url":"http://bit.ly/16D1ruT","display_url":"bit.ly/16D1ruT"}],"annotations":{}},"conversation_id":"384667178068611072","possibly_sensitive":false,"created_at":"2013-09-30T13:12:56.000Z","referenced_tweets":{},"id":"384667178068611072","text":"We've released an update to our guideline on developing #HIV medicines for public consultation: http://t.co/wTeED8Knzv","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":29,"end":40,"tag":"paediatric"},{"start":96,"end":109,"tag":"hypertension"}],"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/PBQFUElqPk","expanded_url":"http://bit.ly/1heo3Ba","display_url":"bit.ly/1heo3Ba"}],"annotations":{}},"conversation_id":"384633888317792259","possibly_sensitive":false,"created_at":"2013-09-30T11:00:39.000Z","referenced_tweets":{},"id":"384633888317792259","text":"Send us your comments on the #paediatric addendum on our note on investigation of medicines for #hypertension: http://t.co/PBQFUElqPk","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":58,"end":80,"url":"http://t.co/ry431LWaBZ","expanded_url":"http://bit.ly/17i6min","display_url":"bit.ly/17i6min"}],"annotations":{}},"conversation_id":"384622758090772480","possibly_sensitive":false,"created_at":"2013-09-30T10:16:26.000Z","referenced_tweets":{},"id":"384622758090772480","text":"RT @LV_MPA: Monthly report from the CHMP (September 2013) http://t.co/ry431LWaBZ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":65,"end":87,"url":"http://t.co/YnJzskEVZi","expanded_url":"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62008-5/fulltext?elsca1=ETOC-LANCET&elsca2=email&elsca3=E24A35F","display_url":"thelancet.com/journals/lance…"}],"annotations":[{"start":54,"end":63,"probability":0.4959,"type":"Organization","normalized_text":"The Lancet"}]},"conversation_id":"384618535886282752","possibly_sensitive":false,"created_at":"2013-09-30T09:59:39.000Z","referenced_tweets":[{"type":"retweeted","id":"384618438175772672"}],"id":"384618535886282752","text":"RT @GCessak: Antibiotic resistance: a final warning | The Lancet http://t.co/YnJzskEVZi","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":73,"end":87,"tag":"clinicaltrial"},{"start":88,"end":101,"tag":"transparency"},{"start":133,"end":140,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":[{"start":110,"end":132,"url":"http://t.co/tn3fA5cQ8d","expanded_url":"http://bit.ly/1dREXpq","display_url":"bit.ly/1dREXpq"}],"annotations":{}},"conversation_id":"384613133266194432","possibly_sensitive":false,"created_at":"2013-09-30T09:38:11.000Z","referenced_tweets":{},"id":"384613133266194432","text":"RT @HAIEurope: We just published our joint Press Release on EMA proposed #clinicaltrial #transparency policy: http://t.co/tn3fA5cQ8d #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":95,"end":117,"url":"http://t.co/RsOxKD12r4","expanded_url":"http://bit.ly/1aDSMWr","display_url":"bit.ly/1aDSMWr"}],"annotations":[{"start":46,"end":69,"probability":0.4399,"type":"Organization","normalized_text":"Swedish Medicines Agency"}]},"conversation_id":"384611912983777280","possibly_sensitive":false,"created_at":"2013-09-30T09:33:20.000Z","referenced_tweets":{},"id":"384611912983777280","text":"RT @LV_MPA: New issue of Information from the Swedish Medicines Agency - veterinary supplement http://t.co/RsOxKD12r4","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":19,"end":30,"tag":"paediatric"},{"start":86,"end":99,"tag":"hypertension"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/jLJ3VJLDRa","expanded_url":"http://bit.ly/1heo3Ba","display_url":"bit.ly/1heo3Ba"}],"annotations":{}},"conversation_id":"384598219680124928","possibly_sensitive":false,"created_at":"2013-09-30T08:38:55.000Z","referenced_tweets":{},"id":"384598219680124928","text":"We've released the #paediatric addendum on our note on investigation of medicines for #hypertension for consultation: http://t.co/jLJ3VJLDRa","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":27,"tag":"WorldHeartDay"}],"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/QrUWOtikAr","expanded_url":"http://bit.ly/1bMe0oP","display_url":"bit.ly/1bMe0oP"}],"annotations":{}},"conversation_id":"384590774035173376","possibly_sensitive":false,"created_at":"2013-09-30T08:09:20.000Z","referenced_tweets":{},"id":"384590774035173376","text":"We supported #WorldHeartDay yesterday - we're working to provide more guidance for medicines developers: http://t.co/QrUWOtikAr","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":26,"end":40,"tag":"WorldHeartDay"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":75,"end":89,"username":"worldheartfed","id":"83809282"}],"urls":[{"start":90,"end":112,"url":"http://t.co/iILyOXleOe","expanded_url":"http://bit.ly/17nN5di","display_url":"bit.ly/17nN5di"}],"annotations":{}},"conversation_id":"383627795605512192","possibly_sensitive":false,"created_at":"2013-09-27T16:22:48.000Z","referenced_tweets":[{"type":"retweeted","id":"383627739715997696"}],"id":"383627795605512192","text":"RT @EFPIA: This Sunday is #WorldHeartDay ! Get more info on the website of @worldheartfed http://t.co/iILyOXleOe","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":43,"end":52,"tag":"westnile"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":74,"end":96,"url":"http://t.co/mirD2Yo2yv","expanded_url":"http://bit.ly/16PkDQq","display_url":"bit.ly/16PkDQq"}],"annotations":{}},"conversation_id":"383627016589033472","possibly_sensitive":false,"created_at":"2013-09-27T16:19:42.000Z","referenced_tweets":[{"type":"retweeted","id":"383622877607518210"}],"id":"383627016589033472","text":"RT @ECDC_EU: All the latest on this week's #westnile fever cases is here: http://t.co/mirD2Yo2yv. See also infographic: http://t.co/vFG4cmA…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":92,"end":109,"tag":"GlobalAIDSreport"}],"mentions":[{"start":3,"end":10,"username":"UNAIDS","id":"19177501"},{"start":37,"end":50,"username":"HuffPostLive","id":"849960753566232576"},{"start":84,"end":91,"username":"UNAIDS","id":"19177501"}],"urls":[{"start":110,"end":132,"url":"http://t.co/SiJG1g1Olw","expanded_url":"http://huff.lv/1ateFYr","display_url":"huff.lv/1ateFYr"}],"annotations":{}},"conversation_id":"383626707061964801","possibly_sensitive":false,"created_at":"2013-09-27T16:18:29.000Z","referenced_tweets":[{"type":"retweeted","id":"383622771865321472"}],"id":"383626707061964801","text":"RT @UNAIDS: Join the conversation as @Huffpostlive looks at the findings of the new @UNAIDS #GlobalAIDSreport http://t.co/SiJG1g1Olw","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":74,"end":96,"url":"http://t.co/WtyC0YjeO6","expanded_url":"http://www.polityka.pl/nauka/zdrowie/1556701,1,szczepionki-fakty-i-mity.read#.UkVO3SQyEcY.twitter","display_url":"polityka.pl/nauka/zdrowie/…"}],"annotations":{}},"conversation_id":"383626634274029568","possibly_sensitive":false,"created_at":"2013-09-27T16:18:11.000Z","referenced_tweets":{},"id":"383626634274029568","text":"RT @GCessak: Vaccines: Facts and myths | Polish vaccine war - Polityka.pl http://t.co/WtyC0YjeO6","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":17,"end":31,"tag":"WorldHeartDay"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/iFvsSlNYxU","expanded_url":"http://bit.ly/1bMe0oP","display_url":"bit.ly/1bMe0oP"}],"annotations":{}},"conversation_id":"383626245285904384","possibly_sensitive":false,"created_at":"2013-09-27T16:16:38.000Z","referenced_tweets":{},"id":"383626245285904384","text":"We're supporting #WorldHeartDay on Sunday - we're working to provide more guidance for medicines developers: http://t.co/iFvsSlNYxU","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"urls":{},"annotations":{}},"conversation_id":"383619815296204800","possibly_sensitive":false,"created_at":"2013-09-27T15:51:05.000Z","referenced_tweets":[{"type":"retweeted","id":"383619515570872320"}],"id":"383619815296204800","text":"RT @FDAMedWatch: The Compounding Shop: Lack of Sterility Assurance of Drug Products UPDATED: Do Not Use Budesonide Solution http://t.co/qJ9…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":115,"end":119,"tag":"FDA"}],"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"urls":[{"start":92,"end":114,"url":"http://t.co/Lu1fzVlbCI","expanded_url":"http://go.usa.gov/DGJB","display_url":"go.usa.gov/DGJB"}],"annotations":{}},"conversation_id":"383617697030111233","possibly_sensitive":false,"created_at":"2013-09-27T15:42:40.000Z","referenced_tweets":[{"type":"retweeted","id":"383617590062366721"}],"id":"383617697030111233","text":"RT @FDAMedWatch: Tygacil (tigecycline): Drug Safety Communication - Increased Risk of Death http://t.co/Lu1fzVlbCI #FDA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":33,"end":36,"tag":"EU"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"conversation_id":"383610861174398976","possibly_sensitive":false,"created_at":"2013-09-27T15:15:31.000Z","referenced_tweets":[{"type":"retweeted","id":"383609758361452544"}],"id":"383610861174398976","text":"RT @innovationunion: Harmonising #EU research on traditional Chinese medicines: Traditional Chinese medicine is based on an individual... h…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":54,"end":76,"url":"http://t.co/LU8wlH3Ibv","expanded_url":"http://bit.ly/1bcZaVF","display_url":"bit.ly/1bcZaVF"}],"annotations":{}},"conversation_id":"383610044547612673","possibly_sensitive":false,"created_at":"2013-09-27T15:12:16.000Z","referenced_tweets":[{"type":"retweeted","id":"383609490240581632"}],"id":"383610044547612673","text":"RT @EFPIA: \"Antibiotic resistance: a final warning\" - http://t.co/LU8wlH3Ibv","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":79,"end":87,"tag":"Tygacil"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"annotations":{}},"conversation_id":"383595318883143681","possibly_sensitive":false,"created_at":"2013-09-27T14:13:45.000Z","referenced_tweets":[{"type":"retweeted","id":"383595130386542592"}],"id":"383595318883143681","text":"RT @FDA_Drug_Info: #FDA warns of increased risk of death with IV antibacterial #Tygacil and approves new Boxed Warning http://t.co/lfUGlyqh…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":73,"end":78,"tag":"COPD"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":37,"end":46,"username":"EU2013LT","id":"2484749870"},{"start":93,"end":101,"username":"EU_COPD","id":"886504362"}],"urls":{},"annotations":[{"start":120,"end":127,"probability":0.9548,"type":"Place","normalized_text":"Brussels"}]},"conversation_id":"383582855559147520","possibly_sensitive":false,"created_at":"2013-09-27T13:24:14.000Z","referenced_tweets":[{"type":"retweeted","id":"383574652855283712"}],"id":"383582855559147520","text":"RT @EFA_Patients: Under patronage of @EU2013LT we invite you to event on #COPD prepared with @EU_COPD on 28 November in Brussels http://t.c…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":37,"tag":"HeartDisease"},{"start":44,"end":51,"tag":"stroke"}],"mentions":[{"start":3,"end":17,"username":"worldheartfed","id":"83809282"}],"urls":{},"annotations":{}},"conversation_id":"383582469586690048","possibly_sensitive":false,"created_at":"2013-09-27T13:22:42.000Z","referenced_tweets":[{"type":"retweeted","id":"383565044568444928"}],"id":"383582469586690048","text":"RT @worldheartfed: Most #HeartDisease &amp; #stroke can be prevented by making healthy changes: eating healthy, being active &amp; stopping #smokin…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":44,"end":49,"tag":"MERS"},{"start":50,"end":62,"tag":"coronavirus"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":106,"end":122,"username":"Eurosurveillanc","id":"455839750"}],"urls":{},"annotations":{}},"conversation_id":"383582336098779136","possibly_sensitive":false,"created_at":"2013-09-27T13:22:10.000Z","referenced_tweets":[{"type":"retweeted","id":"383564852309917696"}],"id":"383582336098779136","text":"RT @ECDC_Flu: Taking stock of the first 133 #MERS #coronavirus cases globally – Is the epidemic changing? @Eurosurveillanc http://t.co/pCz2…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":51,"end":59,"tag":"welfare"},{"start":63,"end":68,"tag":"dogs"},{"start":73,"end":78,"tag":"cats"},{"start":86,"end":89,"tag":"EU"},{"start":91,"end":100,"tag":"Brussels"}],"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"urls":[{"start":108,"end":130,"url":"http://t.co/7Hqg1U3UTV","expanded_url":"http://bit.ly/13t7s8M","display_url":"bit.ly/13t7s8M"}],"annotations":{}},"conversation_id":"383563885540040704","possibly_sensitive":false,"created_at":"2013-09-27T12:08:51.000Z","referenced_tweets":[{"type":"retweeted","id":"383560585054408704"}],"id":"383563885540040704","text":"RT @EU_Consumer: Join us for the 1st conference on #welfare of #dogs and #cats in the #EU, #Brussels, 28.10 http://t.co/7Hqg1U3UTV Registra…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":49,"end":57,"tag":"welfare"},{"start":61,"end":66,"tag":"dogs"},{"start":71,"end":76,"tag":"cats"},{"start":84,"end":87,"tag":"EU"},{"start":89,"end":98,"tag":"Brussels"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":106,"end":128,"url":"http://t.co/EhC2uBB7XJ","expanded_url":"http://bit.ly/13t7s8M","display_url":"bit.ly/13t7s8M"}],"annotations":{}},"conversation_id":"383563860663607296","possibly_sensitive":false,"created_at":"2013-09-27T12:08:45.000Z","referenced_tweets":[{"type":"retweeted","id":"383560506608336896"}],"id":"383563860663607296","text":"RT @EU_Health: Join us for the 1st conference on #welfare of #dogs and #cats in the #EU, #Brussels, 28.10 http://t.co/EhC2uBB7XJ Registrati…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":111,"end":133,"url":"http://t.co/IBnfybjQmw","expanded_url":"http://ow.ly/pgHEu","display_url":"ow.ly/pgHEu"}],"annotations":{}},"conversation_id":"383563785157738496","possibly_sensitive":false,"created_at":"2013-09-27T12:08:27.000Z","referenced_tweets":[{"type":"retweeted","id":"383560192254033920"}],"id":"383563785157738496","text":"RT @myESMO: Personalised Cancer Medicine Guide for Patients. Download a copy or pick it up from the ESMO booth http://t.co/IBnfybjQmw #ECC2…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":96,"end":111,"tag":"bioequivalence"}],"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/2lqZfQ5tzI","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"annotations":{}},"conversation_id":"383547826891800576","possibly_sensitive":false,"created_at":"2013-09-27T11:05:02.000Z","referenced_tweets":{},"id":"383547826891800576","text":"Just a few more days to comment on our paper on the development of product-specific guidance on #bioequivalence: http://t.co/2lqZfQ5tzI","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":48,"end":60,"tag":"statistical"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"annotations":{}},"conversation_id":"383547702224510977","possibly_sensitive":false,"created_at":"2013-09-27T11:04:32.000Z","referenced_tweets":{},"id":"383547702224510977","text":"Just a few more days to comment on our paper on #statistical methodology for the comparative assessment of quality: http://t.co/cPzrMeq9Ln","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/ufeWlImn7k","expanded_url":"http://bit.ly/19LGtF9","display_url":"bit.ly/19LGtF9"}],"annotations":{}},"conversation_id":"383547101356904448","possibly_sensitive":false,"created_at":"2013-09-27T11:02:09.000Z","referenced_tweets":{},"id":"383547101356904448","text":"We're holding our next Management Board meeting on Thursday. We'll publish the main outcomes after the meeting: http://t.co/ufeWlImn7k","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":125,"end":132,"tag":"ctdata"}],"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/4kxT5eqwZi","expanded_url":"http://bit.ly/1642OCB","display_url":"bit.ly/1642OCB"}],"annotations":{}},"conversation_id":"383546898260307969","possibly_sensitive":false,"created_at":"2013-09-27T11:01:21.000Z","referenced_tweets":{},"id":"383546898260307969","text":"Just a few more days to comment on our draft policy on publication and access to clinical-trial data: http://t.co/4kxT5eqwZi #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":74,"end":79,"tag":"MERS"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":84,"end":106,"url":"http://t.co/yoo1mUuWGo","expanded_url":"http://bit.ly/1dLuJH0","display_url":"bit.ly/1dLuJH0"}],"annotations":{}},"conversation_id":"383541924080406528","possibly_sensitive":false,"created_at":"2013-09-27T10:41:35.000Z","referenced_tweets":[{"type":"retweeted","id":"383536340102422528"}],"id":"383541924080406528","text":"RT @ECDC_Flu: EU/EEA countries report good capacity to detect and confirm #MERS-CoV http://t.co/yoo1mUuWGo","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":43,"end":48,"tag":"MERS"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"annotations":{}},"conversation_id":"383534865620406272","possibly_sensitive":false,"created_at":"2013-09-27T10:13:32.000Z","referenced_tweets":[{"type":"retweeted","id":"383533734051332096"}],"id":"383534865620406272","text":"RT @ECDC_Flu: Gender and age balance among #MERS-CoV cases becomes less skewed, as more mild &amp; asymptomatic cases are reported http://t.co/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":16,"end":33,"tag":"AIDSAwarenessDay"},{"start":57,"end":61,"tag":"HIV"}],"mentions":[{"start":34,"end":42,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":{}},"conversation_id":"383532353257500672","possibly_sensitive":false,"created_at":"2013-09-27T10:03:33.000Z","referenced_tweets":[{"type":"retweeted","id":"383532090689867777"}],"id":"383532353257500672","text":"RT @eubookshop: #AIDSAwarenessDay @ECDC_EU learn more on #HIV treatment, care and support # antiretroviral therapy (ART) http://t.co/UqDILG…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":26,"end":31,"tag":"MERS"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":90,"end":112,"url":"http://t.co/yoo1mUuWGo","expanded_url":"http://bit.ly/1dLuJH0","display_url":"bit.ly/1dLuJH0"}],"annotations":[{"start":45,"end":50,"probability":0.9949,"type":"Place","normalized_text":"Europe"},{"start":74,"end":77,"probability":0.5013,"type":"Place","normalized_text":"Hajj"}]},"conversation_id":"383532266204704768","possibly_sensitive":false,"created_at":"2013-09-27T10:03:12.000Z","referenced_tweets":[{"type":"retweeted","id":"383532087992524801"}],"id":"383532266204704768","text":"RT @ECDC_Flu: Low risk of #MERS-CoV cases in Europe but may increase with Hajj pilgrimage http://t.co/yoo1mUuWGo","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":34,"end":39,"tag":"MERS"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":103,"end":125,"url":"http://t.co/fL2iv5tx9q","expanded_url":"http://bit.ly/1dLuJH0","display_url":"bit.ly/1dLuJH0"}],"annotations":[{"start":53,"end":58,"probability":0.9922,"type":"Place","normalized_text":"Europe"}]},"conversation_id":"383532230955794432","possibly_sensitive":false,"created_at":"2013-09-27T10:03:04.000Z","referenced_tweets":[{"type":"retweeted","id":"383531616964190208"}],"id":"383532230955794432","text":"RT @ECDC_EU: Low risk of sporadic #MERS-CoV cases in Europe persists, see latest Rapid Risk Assessment http://t.co/fL2iv5tx9q","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":43,"end":57,"tag":"antimicrobial"},{"start":58,"end":69,"tag":"resistance"}],"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/WiJqQEnWlm","expanded_url":"http://bit.ly/1h5d2Sq","display_url":"bit.ly/1h5d2Sq"}],"annotations":{}},"conversation_id":"383521871322304512","possibly_sensitive":false,"created_at":"2013-09-27T09:21:54.000Z","referenced_tweets":{},"id":"383521871322304512","text":"On 8 November, we're hosting a workshop on #antimicrobial #resistance - there will be a live broadcast: http://t.co/WiJqQEnWlm","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":[{"start":17,"end":41,"probability":0.3679,"type":"Organization","normalized_text":"81st EMA Management Board"}]},"conversation_id":"383521622654996480","possibly_sensitive":false,"created_at":"2013-09-27T09:20:55.000Z","referenced_tweets":[{"type":"retweeted","id":"383521524390457344"}],"id":"383521622654996480","text":"RT @GCessak: The 81st EMA Management Board meeting will be held next Thursday. Main outcomes will be published after the meeting: http://t.…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":125,"end":130,"tag":"jobs"},{"start":131,"end":134,"tag":"EU"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":102,"end":124,"url":"http://t.co/fZlbqZKiS0","expanded_url":"http://bit.ly/15xbvBD","display_url":"bit.ly/15xbvBD"}],"annotations":[{"start":24,"end":31,"probability":0.9875,"type":"Place","normalized_text":"Helsinki"},{"start":34,"end":37,"probability":0.5291,"type":"Organization","normalized_text":"ECHA"},{"start":53,"end":78,"probability":0.438,"type":"Organization","normalized_text":"Junior Regulatory Officers"}]},"conversation_id":"383518685161590784","possibly_sensitive":false,"created_at":"2013-09-27T09:09:14.000Z","referenced_tweets":[{"type":"retweeted","id":"383517413393719296"}],"id":"383518685161590784","text":"RT @EU_ECHA: Join us in Helsinki! ECHA is recruiting Junior Regulatory Officers. Apply by 28 October. http://t.co/fZlbqZKiS0 #jobs #EU","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":15,"end":27,"tag":"EUombudsman"},{"start":61,"end":64,"tag":"EU"},{"start":116,"end":125,"tag":"11rtkdEO"}],"mentions":[{"start":3,"end":13,"username":"EUCouncil","id":"206717989"}],"urls":{},"annotations":{}},"conversation_id":"383518478864773120","possibly_sensitive":false,"created_at":"2013-09-27T09:08:25.000Z","referenced_tweets":[{"type":"retweeted","id":"383516050865680384"}],"id":"383518478864773120","text":"RT @EUCouncil: #EUombudsman will investigate how transparent #EU was in decision making in the last decade, for the #11rtkdEO, http://t.co/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":4,"end":22,"tag":"advancedtherapies"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/6NTwU4WFiR","expanded_url":"http://bit.ly/1fqLhIw","display_url":"bit.ly/1fqLhIw"}],"annotations":{}},"conversation_id":"383506032338563072","possibly_sensitive":false,"created_at":"2013-09-27T08:18:57.000Z","referenced_tweets":{},"id":"383506032338563072","text":"Our #advancedtherapies committee has issued its first recommendation for certification of non-clinical data: http://t.co/6NTwU4WFiR","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":97,"end":112,"tag":"bioequivalence"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/2lqZfQ5tzI","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"annotations":{}},"conversation_id":"383505413921964032","possibly_sensitive":false,"created_at":"2013-09-27T08:16:30.000Z","referenced_tweets":{},"id":"383505413921964032","text":"Last few days to comment on our concept paper on the development of product-specific guidance on #bioequivalence: http://t.co/2lqZfQ5tzI","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":49,"end":61,"tag":"statistical"}],"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"annotations":{}},"conversation_id":"383505233478836224","possibly_sensitive":false,"created_at":"2013-09-27T08:15:47.000Z","referenced_tweets":{},"id":"383505233478836224","text":"Last few days to comment on our concept paper on #statistical methodology for the comparative assessment of quality: http://t.co/cPzrMeq9Ln","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":97,"end":106,"tag":"11rtkdEO"}],"mentions":[{"start":3,"end":11,"username":"EU_EDPS","id":"596377986"},{"start":84,"end":96,"username":"EUombudsman","id":"873777758"}],"urls":{},"annotations":{}},"conversation_id":"383505149865758720","possibly_sensitive":false,"created_at":"2013-09-27T08:15:27.000Z","referenced_tweets":[{"type":"retweeted","id":"383504619932250112"}],"id":"383505149865758720","text":"RT @EU_EDPS: International Right to Know Day 2013 EU transparency Where are we now? @EUombudsman #11rtkdEO","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":49,"end":59,"tag":"Parkinson"},{"start":62,"end":70,"tag":"Disease"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Q352Vog3Z9","expanded_url":"http://bit.ly/O15CaG","display_url":"bit.ly/O15CaG"}],"annotations":{}},"conversation_id":"383505077727928320","possibly_sensitive":false,"created_at":"2013-09-27T08:15:10.000Z","referenced_tweets":[{"type":"retweeted","id":"383504014140116992"}],"id":"383505077727928320","text":"RT @euparkinsons: Stay up-2-date with the latest #Parkinson's #Disease research articles: http://t.co/Q352Vog3Z9","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/buUR6HkooS","expanded_url":"http://bit.ly/19LGtF9","display_url":"bit.ly/19LGtF9"}],"annotations":{}},"conversation_id":"383504862241370112","possibly_sensitive":false,"created_at":"2013-09-27T08:14:19.000Z","referenced_tweets":{},"id":"383504862241370112","text":"Our Management Board is meeting next Thursday. Main outcomes will be published after the meeting: http://t.co/buUR6HkooS","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":119,"end":126,"tag":"ctdata"}],"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/4kxT5eqwZi","expanded_url":"http://bit.ly/1642OCB","display_url":"bit.ly/1642OCB"}],"annotations":{}},"conversation_id":"383502929291784192","possibly_sensitive":false,"created_at":"2013-09-27T08:06:38.000Z","referenced_tweets":{},"id":"383502929291784192","text":"Last few days to comment on our draft policy on publication and access to clinical-trial data: http://t.co/4kxT5eqwZi  #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":38,"tag":"Polio"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":70,"end":92,"url":"http://t.co/091gTM9ocm","expanded_url":"http://bloom.bg/1eHajSy","display_url":"bloom.bg/1eHajSy"}],"annotations":[{"start":12,"end":17,"probability":0.9547,"type":"Place","normalized_text":"Europe"},{"start":60,"end":65,"probability":0.898,"type":"Place","normalized_text":"Israel"}]},"conversation_id":"383263314744463360","possibly_sensitive":false,"created_at":"2013-09-26T16:14:29.000Z","referenced_tweets":[{"type":"retweeted","id":"383260047070863361"}],"id":"383263314744463360","text":"RT @EFPIA: \"Europe Sees Risk of #Polio Re-Introduction From Israel\" - http://t.co/091gTM9ocm","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter for iPhone","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":12,"end":16,"tag":"Flu"},{"start":81,"end":91,"tag":"influenza"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":110,"end":132,"url":"http://t.co/8JHRkYZz6j","expanded_url":"http://go.usa.gov/DwwR","display_url":"go.usa.gov/DwwR"}],"annotations":{}},"conversation_id":"383254343673458688","possibly_sensitive":false,"created_at":"2013-09-26T15:38:50.000Z","referenced_tweets":[{"type":"retweeted","id":"383251177074212864"}],"id":"383254343673458688","text":"RT @US_FDA: #Flu Vaccine - New technologies are providing additional and diverse #influenza vaccines. More at http://t.co/8JHRkYZz6j.","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":68,"end":82,"tag":"antimicrobial"},{"start":83,"end":94,"tag":"resistance"}],"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/UsqCAkFWuS","expanded_url":"http://bit.ly/1h5d2Sq","display_url":"bit.ly/1h5d2Sq"}],"annotations":{}},"conversation_id":"383248459585040384","possibly_sensitive":false,"created_at":"2013-09-26T15:15:27.000Z","referenced_tweets":{},"id":"383248459585040384","text":"We're hosting a workshop on regulatory options in the fight against #antimicrobial #resistance on 8 November: http://t.co/UsqCAkFWuS","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":29,"end":34,"tag":"EFSA"},{"start":63,"end":76,"tag":"transparency"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"annotations":{}},"conversation_id":"383247817969778688","possibly_sensitive":false,"created_at":"2013-09-26T15:12:54.000Z","referenced_tweets":[{"type":"retweeted","id":"383245868079398912"}],"id":"383247817969778688","text":"RT @EFSA_EU: One week to go: #EFSA’s stakeholder conference on #transparency in risk assessment on 3 October. More info: http://t.co/VKOPuw…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":74,"end":83,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":55,"end":60,"probability":0.9968,"type":"Place","normalized_text":"London"}]},"conversation_id":"383247762999214080","possibly_sensitive":false,"created_at":"2013-09-26T15:12:41.000Z","referenced_tweets":[{"type":"retweeted","id":"383245012009361408"}],"id":"383247762999214080","text":"RT @JeanGeorgesAE: Interesting two days of meetings in London. Hat off to @EMA_News for their comprehensive strategy of involving patient o…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"annotations":{}},"conversation_id":"383247740337410048","possibly_sensitive":false,"created_at":"2013-09-26T15:12:36.000Z","referenced_tweets":[{"type":"retweeted","id":"383244494360944640"}],"id":"383247740337410048","text":"RT @FDACBER: Subscribe to Biologics Mailing Lists. E-mail distribution lists notify subscribers when a key page is updated. http://t.co/7Tr…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":68,"end":78,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":{},"annotations":{}},"conversation_id":"383240348396691456","possibly_sensitive":false,"created_at":"2013-09-26T14:43:13.000Z","referenced_tweets":[{"type":"retweeted","id":"383239728314593280"}],"id":"383240348396691456","text":"RT @euparkinsons: Mitochondria-targeted antioxidants 4 treatment of #Parkinson's disease: Preclinical &amp; clinical outcomes - http://t.co/WEi…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":115,"end":137,"url":"http://t.co/oziS6qE1tp","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/09/news_detail_001898.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{}},"conversation_id":"383235112076582913","possibly_sensitive":false,"created_at":"2013-09-26T14:22:25.000Z","referenced_tweets":[{"type":"retweeted","id":"383235037292142592"}],"id":"383235112076582913","text":"RT @GCessak: EMA | CAT issued first recommendation for certification of non-clinical data for an advanced therapy: http://t.co/oziS6qE1tp","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/Wqt93ezNtY","expanded_url":"http://bit.ly/1fqLhIw","display_url":"bit.ly/1fqLhIw"}],"annotations":[{"start":18,"end":35,"probability":0.5174,"type":"Organization","normalized_text":"Advanced Therapies"}]},"conversation_id":"383228145673179136","possibly_sensitive":false,"created_at":"2013-09-26T13:54:44.000Z","referenced_tweets":{},"id":"383228145673179136","text":"Our Committee for Advanced Therapies has issued first recommendation for certification of non-clinical data: http://t.co/Wqt93ezNtY","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"conversation_id":"383216690584354816","possibly_sensitive":false,"created_at":"2013-09-26T13:09:13.000Z","referenced_tweets":[{"type":"retweeted","id":"383215276424450048"}],"id":"383216690584354816","text":"RT @myESMO: @EMA_News recommends change to everolimus marketing auth. indic. for SEGA assoc.w/ tuberous sclerosis complex (TSC) http://t.co…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"annotations":{}},"conversation_id":"383214076803153920","possibly_sensitive":false,"created_at":"2013-09-26T12:58:50.000Z","referenced_tweets":[{"type":"retweeted","id":"383213636346335233"}],"id":"383214076803153920","text":"RT @MHRAmedicines: Drug Alerts: Class 2 Medicines Recall (action within 48 hours): Natzon 0.4mg Sublingual Tablets - Morningside ... http:/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"urls":[{"start":98,"end":120,"url":"http://t.co/oTBJ6J6EWf","expanded_url":"http://www.ilae.org/Visitors/Centre/Definition.cfm","display_url":"ilae.org/Visitors/Centr…"}],"annotations":{}},"conversation_id":"383207302872186880","possibly_sensitive":false,"created_at":"2013-09-26T12:31:55.000Z","referenced_tweets":[{"type":"retweeted","id":"383205011833884672"}],"id":"383207302872186880","text":"RT @IlaeWeb: Comment now on proposed definition of epilepsy. Deadline October 1. Read definition: http://t.co/oTBJ6J6EWf","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/lUjNOWP4Dn","expanded_url":"http://bit.ly/1b8jqaL","display_url":"bit.ly/1b8jqaL"}],"annotations":[{"start":92,"end":97,"probability":0.7819,"type":"Place","normalized_text":"London"}]},"conversation_id":"383202746280603648","possibly_sensitive":false,"created_at":"2013-09-26T12:13:48.000Z","referenced_tweets":{},"id":"383202746280603648","text":"This Saturday, our website and other online tools will be unavailable from 9.00am to 6.00pm London time: http://t.co/lUjNOWP4Dn","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":22,"tag":"Lemtrada"},{"start":24,"end":36,"tag":"alemtuzumab"},{"start":59,"end":77,"tag":"multiplesclerosis"}],"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/62HptD6qEI","expanded_url":"http://bit.ly/1be3fwf","display_url":"bit.ly/1be3fwf"}],"annotations":{}},"conversation_id":"383202632023564289","possibly_sensitive":false,"created_at":"2013-09-26T12:13:21.000Z","referenced_tweets":{},"id":"383202632023564289","text":"The EPAR for #Lemtrada (#alemtuzumab) for the treatment of #multiplesclerosis is available on our website: http://t.co/62HptD6qEI","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"urls":[{"start":100,"end":122,"url":"http://t.co/Gseudgdmt1","expanded_url":"http://www.esmo.org/Oncology-News/European-Medicines-Agency-Recommends-to-Extend-the-Indications-for-Ipilimumab#.UkQeBcJXeHk.twitter","display_url":"esmo.org/Oncology-News/…"}],"annotations":{}},"conversation_id":"383202123716235264","possibly_sensitive":false,"created_at":"2013-09-26T12:11:20.000Z","referenced_tweets":[{"type":"retweeted","id":"383195302754148354"}],"id":"383202123716235264","text":"RT @EAHPtweet: European Medicines Agency Recommends to Extend the Indications for Ipilimumab | ESMO http://t.co/Gseudgdmt1","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":115,"end":137,"url":"http://t.co/wUu0RHkchD","expanded_url":"http://fb.me/2uxAJbKCe","display_url":"fb.me/2uxAJbKCe"}],"annotations":{}},"conversation_id":"383201607330324480","possibly_sensitive":false,"created_at":"2013-09-26T12:09:17.000Z","referenced_tweets":{},"id":"383201607330324480","text":"RT @Aifa_ufficiale: Vedolizumab as induction and maintenance therapy for Crohn's disease A study just published... http://t.co/wUu0RHkchD","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":30,"end":42,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":[{"start":66,"end":88,"url":"http://t.co/zcwESkuUwz","expanded_url":"http://www.eurordis.org/news-and-events/","display_url":"eurordis.org/news-and-event…"}],"annotations":{}},"conversation_id":"383201349028282368","possibly_sensitive":false,"created_at":"2013-09-26T12:08:15.000Z","referenced_tweets":[{"type":"retweeted","id":"383191856085229568"}],"id":"383201349028282368","text":"RT @eurordis: All of our past #raredisease eNEWS is archived here http://t.co/zcwESkuUwz","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":183,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":28,"tag":"HPV"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{}},"conversation_id":"383201332775366656","possibly_sensitive":false,"created_at":"2013-09-26T12:08:12.000Z","referenced_tweets":[{"type":"retweeted","id":"383191619492528128"}],"id":"383201332775366656","text":"RT @WHO: WHO recommends #HPV vaccination for girls aged 9-13 years as this is the most cost-effective public health measure against cervica…","attachments":{"media_keys":{}}},{"lang":"und","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":20,"end":42,"url":"http://t.co/6XCqtNRAfy","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/vedolizumab-come-induzione-e-terapia-di-mantenimento-la-malattia-di-crohn","display_url":"agenziafarmaco.gov.it/it/content/ved…"},{"start":43,"end":65,"url":"http://t.co/L98CsbaWxw","expanded_url":"http://fb.me/2scrL0qlo","display_url":"fb.me/2scrL0qlo"}],"annotations":{}},"conversation_id":"383201317092872192","possibly_sensitive":false,"created_at":"2013-09-26T12:08:08.000Z","referenced_tweets":[{"type":"retweeted","id":"383191036001910784"}],"id":"383201317092872192","text":"RT @Aifa_ufficiale: http://t.co/6XCqtNRAfy http://t.co/L98CsbaWxw","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":100,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":64,"end":68,"tag":"HPV"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{}},"conversation_id":"383201216521830400","possibly_sensitive":false,"created_at":"2013-09-26T12:07:44.000Z","referenced_tweets":[{"type":"retweeted","id":"383189275807719425"}],"id":"383201216521830400","text":"RT @WHO: There are currently two vaccines which protect against #HPV types 16 and 18 which are known to cause 70% of cervical cancers","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":138,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":51,"end":58,"tag":"cancer"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":116,"end":138,"url":"http://t.co/3DUyhOq2jA","expanded_url":"http://goo.gl/Cu6mhO","display_url":"goo.gl/Cu6mhO"}],"annotations":{}},"conversation_id":"383200895812792320","possibly_sensitive":false,"created_at":"2013-09-26T12:06:27.000Z","referenced_tweets":[{"type":"retweeted","id":"383179591092686848"}],"id":"383200895812792320","text":"RT @WHO: Cervical cancer is the second most common #cancer in women, with an estimated 530,000 new cases every year http://t.co/3DUyhOq2jA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":29,"tag":"Rasagiline"},{"start":38,"end":53,"tag":"hypersexuality"},{"start":57,"end":67,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":79,"end":101,"url":"http://t.co/KU7PGbvCMa","expanded_url":"http://bit.ly/1eGBbSD","display_url":"bit.ly/1eGBbSD"}],"annotations":{}},"conversation_id":"383200857518772224","possibly_sensitive":false,"created_at":"2013-09-26T12:06:18.000Z","referenced_tweets":[{"type":"retweeted","id":"383179328239845376"}],"id":"383200857518772224","text":"RT @euparkinsons: #Rasagiline induced #hypersexuality in #Parkinson’s disease: http://t.co/KU7PGbvCMa","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":65,"end":74,"tag":"medicine"},{"start":86,"end":99,"tag":"neurological"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/t6XgZbPYWi","expanded_url":"http://www.sdu.dk/en/Om_SDU/Fakulteterne/Naturvidenskab/Nyheder/2013_09_25_sheepmucosa","display_url":"sdu.dk/en/Om_SDU/Faku…"}],"annotations":{}},"conversation_id":"383200730632691712","possibly_sensitive":false,"created_at":"2013-09-26T12:05:48.000Z","referenced_tweets":[{"type":"retweeted","id":"383179100669485056"}],"id":"383200730632691712","text":"RT @sailinsomnia: Sheep’s mucosa shows the way to more effective #medicine for severe #neurological diseases http://t.co/t6XgZbPYWi #resear…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":66,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":40,"end":44,"tag":"HPV"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":95,"end":117,"url":"http://t.co/3DUyhOq2jA","expanded_url":"http://goo.gl/Cu6mhO","display_url":"goo.gl/Cu6mhO"}],"annotations":{}},"conversation_id":"383200196249010176","possibly_sensitive":false,"created_at":"2013-09-26T12:03:40.000Z","referenced_tweets":[{"type":"retweeted","id":"383174530262265858"}],"id":"383200196249010176","text":"RT @WHO: There is also evidence linking #HPV with cancers of the anus, vulva, vagina and penis http://t.co/3DUyhOq2jA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":98,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":88,"end":92,"tag":"HPV"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":93,"end":115,"url":"http://t.co/3DUyhOq2jA","expanded_url":"http://goo.gl/Cu6mhO","display_url":"goo.gl/Cu6mhO"}],"annotations":{}},"conversation_id":"383200125671469056","possibly_sensitive":false,"created_at":"2013-09-26T12:03:24.000Z","referenced_tweets":[{"type":"retweeted","id":"383172088560771072"}],"id":"383200125671469056","text":"RT @WHO: Cervical cancer is caused by sexually acquired infection with certain types of #HPV http://t.co/3DUyhOq2jA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":83,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":46,"tag":"HPV"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":105,"end":127,"url":"http://t.co/3DUyhOq2jA","expanded_url":"http://goo.gl/Cu6mhO","display_url":"goo.gl/Cu6mhO"}],"annotations":{}},"conversation_id":"383199705012117504","possibly_sensitive":false,"created_at":"2013-09-26T12:01:43.000Z","referenced_tweets":[{"type":"retweeted","id":"383166707402956800"}],"id":"383199705012117504","text":"RT @WHO: There are more than 100 types of #HPV, of which at least 13 are cancer-causing (high risk type) http://t.co/3DUyhOq2jA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":80,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":39,"end":43,"tag":"HPV"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":46,"end":68,"url":"http://t.co/3DUyhOq2jA","expanded_url":"http://goo.gl/Cu6mhO","display_url":"goo.gl/Cu6mhO"}],"annotations":{}},"conversation_id":"383199684971753474","possibly_sensitive":false,"created_at":"2013-09-26T12:01:39.000Z","referenced_tweets":[{"type":"retweeted","id":"383164974945685505"}],"id":"383199684971753474","text":"RT @WHO: What is human papillomavirus (#HPV)? http://t.co/3DUyhOq2jA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":113,"end":122,"tag":"dementia"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":[{"start":12,"end":26,"probability":0.4359,"type":"Person","normalized_text":"Geoghegan-Quinn"}]},"conversation_id":"383199559713034240","possibly_sensitive":false,"created_at":"2013-09-26T12:01:09.000Z","referenced_tweets":[{"type":"retweeted","id":"383165322166931456"}],"id":"383199559713034240","text":"RT @IMI_JU: Geoghegan-Quinn cites IMI project EMIF (Eur Medical Info Framework) in article calling for action on #dementia http://t.co/4P3T…","attachments":{"media_keys":{}}},{"lang":"ca","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":114,"end":121,"tag":"health"},{"start":122,"end":133,"tag":"EUresearch"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":91,"end":113,"url":"http://t.co/bQjPJboZvc","expanded_url":"http://www.theparliament.com/latest-news/article/newsarticle/commissioner-calls-for-more-action-on-dementia/#.UkP93RCa9Do","display_url":"theparliament.com/latest-news/ar…"}],"annotations":{}},"conversation_id":"383199194892484608","possibly_sensitive":false,"created_at":"2013-09-26T11:59:42.000Z","referenced_tweets":[{"type":"retweeted","id":"383161112515997698"}],"id":"383199194892484608","text":"RT @innovationunion: Commissioner  Máire Geoghegan-Quinn calls for more action on dementia http://t.co/bQjPJboZvc #health #EUresearch","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":68,"end":90,"url":"http://t.co/W3bgZlM3q1","expanded_url":"http://bit.ly/1b8jqaL","display_url":"bit.ly/1b8jqaL"}],"annotations":{}},"conversation_id":"383159507557548032","possibly_sensitive":false,"created_at":"2013-09-26T09:22:00.000Z","referenced_tweets":{},"id":"383159507557548032","text":"Our website and other online tools will be unavailable on Saturday: http://t.co/W3bgZlM3q1","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":85,"end":108,"tag":"livingwellwithdementia"}],"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"urls":[{"start":109,"end":131,"url":"http://t.co/2QAwxnvzcP","expanded_url":"http://tinyurl.com/m56sqp8","display_url":"tinyurl.com/m56sqp8"}],"annotations":[{"start":25,"end":40,"probability":0.9097,"type":"Person","normalized_text":"Dr Martin Prince"},{"start":57,"end":83,"probability":0.3552,"type":"Other","normalized_text":"World Alzheimer Report 2013"}]},"conversation_id":"383158409534898176","possibly_sensitive":false,"created_at":"2013-09-26T09:17:38.000Z","referenced_tweets":[{"type":"retweeted","id":"383156748074225664"}],"id":"383158409534898176","text":"RT @AlzDisInt: Listen to Dr Martin Prince talk about the World Alzheimer Report 2013 #livingwellwithdementia http://t.co/2QAwxnvzcP","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":51,"tag":"Lemtrada"},{"start":53,"end":65,"tag":"alemtuzumab"},{"start":88,"end":106,"tag":"multiplesclerosis"}],"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/ZbfHnyT0F9","expanded_url":"http://bit.ly/1be3fwf","display_url":"bit.ly/1be3fwf"}],"annotations":{}},"conversation_id":"383148983629398016","possibly_sensitive":false,"created_at":"2013-09-26T08:40:10.000Z","referenced_tweets":{},"id":"383148983629398016","text":"We've published the assessment report for #Lemtrada (#alemtuzumab) for the treatment of #multiplesclerosis: http://t.co/ZbfHnyT0F9","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"entities":{"hashtags":[{"start":28,"end":40,"tag":"biosimilars"}],"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/Wb5YqNPTTs","expanded_url":"http://bit.ly/15TYTpE","display_url":"bit.ly/15TYTpE"}],"annotations":{}},"conversation_id":"383141810156998656","possibly_sensitive":false,"created_at":"2013-09-26T08:11:40.000Z","referenced_tweets":{},"id":"383141810156998656","text":"We're holding a workshop on #biosimilars on 31 October. A few places are available: http://t.co/Wb5YqNPTTs","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":48,"tag":"healthcareprofessionals"},{"start":57,"end":66,"tag":"patients"},{"start":71,"end":81,"tag":"consumers"}],"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/qcJppnjBle","expanded_url":"http://bit.ly/18WH4sB","display_url":"bit.ly/18WH4sB"}],"annotations":{}},"conversation_id":"383141704527667200","possibly_sensitive":false,"created_at":"2013-09-26T08:11:15.000Z","referenced_tweets":{},"id":"383141704527667200","text":"Our working parties for #healthcareprofessionals and for #patients and #consumers now have new co-chairs: http://t.co/qcJppnjBle","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":90,"end":106,"tag":"carcinogenicity"}],"mentions":[{"start":23,"end":32,"username":"ICH_news","id":"305434870"}],"urls":[{"start":116,"end":138,"url":"http://t.co/3CNhm4VV2Y","expanded_url":"http://bit.ly/1dJ2yZ8","display_url":"bit.ly/1dJ2yZ8"}],"annotations":{}},"conversation_id":"383141462608588800","possibly_sensitive":false,"created_at":"2013-09-26T08:10:17.000Z","referenced_tweets":{},"id":"383141462608588800","text":"Yesterday we published @ICH_news regulatory notice on changes to core guideline on rodent #carcinogenicity testing: http://t.co/3CNhm4VV2Y","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":58,"end":69,"tag":"compliance"},{"start":126,"end":138,"tag":"recruitment"}],"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/EE0sywjNYa","expanded_url":"http://bit.ly/1gZOrP7","display_url":"bit.ly/1gZOrP7"}],"annotations":{}},"conversation_id":"383140856363884544","possibly_sensitive":false,"created_at":"2013-09-26T08:07:53.000Z","referenced_tweets":{},"id":"383140856363884544","text":"Apply now for our vacancy for a clinical and non-clinical #compliance officer. Deadline is 25 October: http://t.co/EE0sywjNYa #recruitment","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":32,"end":38,"tag":"legal"},{"start":112,"end":124,"tag":"recruitment"}],"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/JwtLUu05F8","expanded_url":"http://bit.ly/19DXfGq","display_url":"bit.ly/19DXfGq"}],"annotations":{}},"conversation_id":"383140726176903168","possibly_sensitive":false,"created_at":"2013-09-26T08:07:22.000Z","referenced_tweets":{},"id":"383140726176903168","text":"Apply now for our vacancy for a #legal officer. Deadline for applications is 25 October: http://t.co/JwtLUu05F8 #recruitment","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":31,"end":43,"tag":"biosimilars"}],"mentions":{},"urls":[{"start":59,"end":81,"url":"http://t.co/sTwbmf855w","expanded_url":"http://bit.ly/15TYTpE","display_url":"bit.ly/15TYTpE"}],"annotations":{}},"conversation_id":"382902466805006336","possibly_sensitive":false,"created_at":"2013-09-25T16:20:36.000Z","referenced_tweets":{},"id":"382902466805006336","text":"We're organising a workshop on #biosimilars on 31 October: http://t.co/sTwbmf855w","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":48,"tag":"healthcareprofessionals"},{"start":57,"end":66,"tag":"patients"},{"start":71,"end":81,"tag":"consumers"}],"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/b4DDBAehst","expanded_url":"http://bit.ly/18WH4sB","display_url":"bit.ly/18WH4sB"}],"annotations":{}},"conversation_id":"382898339765039104","possibly_sensitive":false,"created_at":"2013-09-25T16:04:12.000Z","referenced_tweets":{},"id":"382898339765039104","text":"Our working parties for #healthcareprofessionals and for #patients and #consumers have elected new co-chairs: http://t.co/b4DDBAehst","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"annotations":{}},"conversation_id":"382892384809680896","possibly_sensitive":false,"created_at":"2013-09-25T15:40:33.000Z","referenced_tweets":[{"type":"retweeted","id":"382892130164699137"}],"id":"382892384809680896","text":"RT @FDA_Drug_Info: Safety Comm:Boxed Warning and new recommendations to decrease risk of hep B reactivation with Arzerra and Rituxan. http:…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":54,"end":68,"tag":"EUHealthPrize"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":{}},"conversation_id":"382892308779515904","possibly_sensitive":false,"created_at":"2013-09-25T15:40:14.000Z","referenced_tweets":[{"type":"retweeted","id":"382891653326835712"}],"id":"382892308779515904","text":"RT @EU_Health: 5 days left to submit your articles to #EUHealthPrize! 1st prize: € 6,500, 2nd prize: € 4,000, 3rd prize: € 2,500. http://t.…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":51,"end":62,"tag":"poliovirus"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":115,"end":137,"url":"http://t.co/k3KNDqvvuO","expanded_url":"http://bit.ly/18ZnZQu","display_url":"bit.ly/18ZnZQu"}],"annotations":[{"start":83,"end":84,"probability":0.7064,"type":"Place","normalized_text":"EU"}]},"conversation_id":"382885748107919360","possibly_sensitive":false,"created_at":"2013-09-25T15:14:10.000Z","referenced_tweets":[{"type":"retweeted","id":"382885232518909952"}],"id":"382885748107919360","text":"RT @ECDC_EU: ECDC risk assessment: threat posed by #poliovirus re-establishment in EU is very low in OPV vaccinees http://t.co/k3KNDqvvuO","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":37,"end":57,"tag":"WorldAlzheimerMonth"}],"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"urls":{},"annotations":{}},"conversation_id":"382885654713344000","possibly_sensitive":false,"created_at":"2013-09-25T15:13:48.000Z","referenced_tweets":[{"type":"retweeted","id":"382885124078964738"}],"id":"382885654713344000","text":"RT @AlzDisInt: Just one week left of #WorldAlzheimerMonth but enough to speak up and make our voices heard. Use the hashtag and spread the …","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":92,"end":108,"tag":"carcinogenicity"}],"mentions":[{"start":25,"end":34,"username":"ICH_news","id":"305434870"}],"urls":[{"start":118,"end":140,"url":"http://t.co/qEficqYxd4","expanded_url":"http://bit.ly/1dJ2yZ8","display_url":"bit.ly/1dJ2yZ8"}],"annotations":{}},"conversation_id":"382885040067473409","possibly_sensitive":false,"created_at":"2013-09-25T15:11:21.000Z","referenced_tweets":{},"id":"382885040067473409","text":"We've just published the @ICH_news regulatory notice on changes to core guideline on rodent #carcinogenicity testing: http://t.co/qEficqYxd4","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":105,"end":127,"url":"http://t.co/3r2sffR6qw","expanded_url":"http://1.usa.gov/14H8MGq","display_url":"1.usa.gov/14H8MGq"}],"annotations":[{"start":21,"end":23,"probability":0.8412,"type":"Organization","normalized_text":"FDA"}]},"conversation_id":"382884056356380672","possibly_sensitive":false,"created_at":"2013-09-25T15:07:27.000Z","referenced_tweets":[{"type":"retweeted","id":"382883157575344129"}],"id":"382884056356380672","text":"RT @FDAanimalhealth: FDA Proposes Revision to Annual Report on Antimicrobials for Food-Producing Animals http://t.co/3r2sffR6qw","attachments":{"media_keys":{}}},{"lang":"fr","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":68,"end":75,"tag":"newjob"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":45,"end":67,"url":"http://t.co/klbygaKJEP","expanded_url":"http://bit.ly/1b5ICPo","display_url":"bit.ly/1b5ICPo"}],"annotations":{}},"conversation_id":"382883933232578560","possibly_sensitive":false,"created_at":"2013-09-25T15:06:57.000Z","referenced_tweets":{},"id":"382883933232578560","text":"RT @LV_MPA: Medicines information providers: http://t.co/klbygaKJEP #newjob","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":23,"tag":"MHRA"},{"start":42,"end":59,"tag":"ReportingSystems"}],"mentions":{},"urls":[{"start":60,"end":82,"url":"http://t.co/U6R028WK0x","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Whatsnew/CON316309","display_url":"mhra.gov.uk/NewsCentre/Wha…"}],"annotations":{}},"conversation_id":"382860251420442625","possibly_sensitive":false,"created_at":"2013-09-25T13:32:51.000Z","referenced_tweets":[{"type":"retweeted","id":"382856205791555584"}],"id":"382860251420442625","text":"RT @sailinsomnia: #MHRA seeks to simplify #ReportingSystems http://t.co/U6R028WK0x","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":78,"end":100,"url":"http://t.co/nRyaeeN7xP","expanded_url":"http://bit.ly/16qO0rX","display_url":"bit.ly/16qO0rX"}],"annotations":{}},"conversation_id":"382859290199199744","possibly_sensitive":false,"created_at":"2013-09-25T13:29:02.000Z","referenced_tweets":[{"type":"retweeted","id":"382846998501531648"}],"id":"382859290199199744","text":"RT @EFPIA: Nanoscale cork used for 'message in a bottle' drug delivery system http://t.co/nRyaeeN7xP","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":110,"end":119,"tag":"melanoma"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"conversation_id":"382832015986667520","possibly_sensitive":false,"created_at":"2013-09-25T11:40:39.000Z","referenced_tweets":[{"type":"retweeted","id":"382831759299452928"}],"id":"382832015986667520","text":"RT @myESMO: @EMA_News recommends ext. of Ipilimumab indic,.to previously untreated unresectable or metastatic #melanoma http://t.co/x7XNih4…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":17,"end":25,"tag":"recruit"},{"start":54,"end":65,"tag":"compliance"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/KEORzBo9La","expanded_url":"http://bit.ly/1gZOrP7","display_url":"bit.ly/1gZOrP7"}],"annotations":{}},"conversation_id":"382827401274998784","possibly_sensitive":false,"created_at":"2013-09-25T11:22:19.000Z","referenced_tweets":{},"id":"382827401274998784","text":"We're looking to #recruit a clinical and non-clinical #compliance officer. Deadline for applications is 25 October: http://t.co/KEORzBo9La","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":17,"end":25,"tag":"recruit"},{"start":28,"end":34,"tag":"Legal"}],"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/gIA5VC6mYb","expanded_url":"http://bit.ly/19DXfGq","display_url":"bit.ly/19DXfGq"}],"annotations":{}},"conversation_id":"382826957236600832","possibly_sensitive":false,"created_at":"2013-09-25T11:20:33.000Z","referenced_tweets":{},"id":"382826957236600832","text":"We're looking to #recruit a #Legal Officer. Deadline for applications is 25 October: http://t.co/gIA5VC6mYb","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":91,"end":113,"url":"http://t.co/FkZOZXAE4y","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/09/news_detail_001894.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":13,"end":37,"probability":0.5271,"type":"Organization","normalized_text":"European Medicines Agency"},{"start":49,"end":51,"probability":0.6169,"type":"Organization","normalized_text":"CVs"}]},"conversation_id":"382824174739550208","possibly_sensitive":false,"created_at":"2013-09-25T11:09:30.000Z","referenced_tweets":[{"type":"retweeted","id":"382814804442120192"}],"id":"382824174739550208","text":"RT @GCessak: European Medicines Agency published CVs of experts involved in its activities\nhttp://t.co/FkZOZXAE4y","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":96,"end":107,"tag":"Innovation"},{"start":108,"end":113,"tag":"xray"},{"start":114,"end":124,"tag":"molecules"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":73,"end":95,"url":"http://t.co/YQECrxQ67W","expanded_url":"http://bit.ly/16Hvlsa","display_url":"bit.ly/16Hvlsa"}],"annotations":{}},"conversation_id":"382823810732662784","possibly_sensitive":false,"created_at":"2013-09-25T11:08:03.000Z","referenced_tweets":[{"type":"retweeted","id":"382806846634860544"}],"id":"382823810732662784","text":"RT @EFPIA: Revolutionary method for probing molecular structure unravels http://t.co/YQECrxQ67W #Innovation #xray #molecules","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":110,"end":132,"url":"http://t.co/uAOLpMbVmh","expanded_url":"http://www.urpl.gov.pl/system/files/_linkonly/Bior_wnowa_no_-_Terapia.pdf?1380100725","display_url":"urpl.gov.pl/system/files/_…"}],"annotations":{}},"conversation_id":"382823627055718400","possibly_sensitive":false,"created_at":"2013-09-25T11:07:19.000Z","referenced_tweets":{},"id":"382823627055718400","text":"RT @GCessak: Bioequivalence - one of the basic conditions for the authorisation of generic medicinal products http://t.co/uAOLpMbVmh","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":56,"end":62,"username":"EATGx","id":"273916420"},{"start":90,"end":99,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":[{"start":38,"end":49,"probability":0.99,"type":"Person","normalized_text":"David Haerry"}]},"conversation_id":"382788092614418432","possibly_sensitive":false,"created_at":"2013-09-25T08:46:07.000Z","referenced_tweets":[{"type":"retweeted","id":"382787806440857601"}],"id":"382788092614418432","text":"RT @JeanGeorgesAE: Congratulations to David Haerry from @eatgx on election as co-chair of @EMA_News Patients' and Consumers' Working Party","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":26,"end":34,"tag":"experts"},{"start":126,"end":139,"tag":"transparency"}],"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/CLYNUnJ2Ny","expanded_url":"http://bit.ly/1altpsl","display_url":"bit.ly/1altpsl"}],"annotations":{}},"conversation_id":"382782641767841792","possibly_sensitive":false,"created_at":"2013-09-25T08:24:28.000Z","referenced_tweets":{},"id":"382782641767841792","text":"The CVs of the scientific #experts involved in our activities are now being published on our website: http://t.co/CLYNUnJ2Ny  #transparency","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":0,"end":8,"tag":"Patient"},{"start":13,"end":37,"tag":"healthcareprofessionals"},{"start":93,"end":104,"tag":"Paediatric"}],"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/gxpkItIxMw","expanded_url":"http://bit.ly/15RzTzu","display_url":"bit.ly/15RzTzu"}],"annotations":{}},"conversation_id":"382782471151968256","possibly_sensitive":false,"created_at":"2013-09-25T08:23:47.000Z","referenced_tweets":{},"id":"382782471151968256","text":"#Patient and #healthcareprofessionals organisation reps: apply now to become a member of our #Paediatric Committee: http://t.co/gxpkItIxMw","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":118,"end":127,"tag":"research"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":58,"end":69,"username":"MagdaEfpia","id":"301066342"},{"start":73,"end":80,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":[{"start":28,"end":56,"probability":0.2079,"type":"Organization","normalized_text":"EFPIA Director Science Policy"}]},"conversation_id":"382781575697801216","possibly_sensitive":false,"created_at":"2013-09-25T08:20:14.000Z","referenced_tweets":[{"type":"retweeted","id":"382778344007155713"}],"id":"382781575697801216","text":"RT @EFPIA: NEW!!! BLOG from EFPIA Director Science Policy @MagdaEfpia on @IMI_JU 9th Call - Still Open for Proposals! #research http://t.co…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":12,"end":20,"tag":"Vacancy"},{"start":92,"end":96,"tag":"job"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":24,"end":33,"username":"EMA_News","id":"116716199"}],"urls":[{"start":69,"end":91,"url":"http://t.co/5YmxVb6l2c","expanded_url":"http://goo.gl/fw8JwR","display_url":"goo.gl/fw8JwR"}],"annotations":[{"start":37,"end":42,"probability":0.9915,"type":"Place","normalized_text":"London"}]},"conversation_id":"382781402724700160","possibly_sensitive":false,"created_at":"2013-09-25T08:19:32.000Z","referenced_tweets":[{"type":"retweeted","id":"382777989982744576"}],"id":"382781402724700160","text":"RT @EURLex: #Vacancy in @EMA_News in London. Published in eOJ C 276A http://t.co/5YmxVb6l2c #job","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":51,"end":59,"tag":"experts"},{"start":111,"end":124,"tag":"transparency"}],"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/8hgXGr6X6R","expanded_url":"http://bit.ly/1altpsl","display_url":"bit.ly/1altpsl"}],"annotations":{}},"conversation_id":"382544689586765825","possibly_sensitive":false,"created_at":"2013-09-24T16:38:55.000Z","referenced_tweets":{},"id":"382544689586765825","text":"We've started publishing the CVs of the scientific #experts involved in our activities: http://t.co/8hgXGr6X6R #transparency","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":15,"end":24,"tag":"patients"},{"start":29,"end":53,"tag":"healthcareprofessionals"},{"start":66,"end":77,"tag":"Paediatric"}],"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/lk3nJeO9em","expanded_url":"http://bit.ly/15RzTzu","display_url":"bit.ly/15RzTzu"}],"annotations":{}},"conversation_id":"382543219827171328","possibly_sensitive":false,"created_at":"2013-09-24T16:33:05.000Z","referenced_tweets":{},"id":"382543219827171328","text":"A new call for #patients and #healthcareprofessionals to join our #Paediatric Committee is now open: http://t.co/lk3nJeO9em","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":110,"end":132,"url":"http://t.co/pwoZaJj4XK","expanded_url":"http://www.agenziafarmaco.gov.it/sites/default/files/Rapporto_OsMed_2012_0.pdf","display_url":"agenziafarmaco.gov.it/sites/default/…"}],"annotations":[{"start":102,"end":106,"probability":0.9894,"type":"Place","normalized_text":"Italy"}]},"conversation_id":"382539691234705408","possibly_sensitive":false,"created_at":"2013-09-24T16:19:04.000Z","referenced_tweets":{},"id":"382539691234705408","text":"RT @Aifa_ufficiale: The Italian medicines agency's 2012 report is available: \"The use of medicines in Italy\": http://t.co/pwoZaJj4XK","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"},{"start":38,"end":47,"username":"marcwort","id":"284577403"}],"urls":[{"start":101,"end":123,"url":"http://t.co/OViGRYfkJv","expanded_url":"http://www.youtube.com/watch?v=_608mIu54_E","display_url":"youtube.com/watch?v=_608mI…"}],"annotations":{}},"conversation_id":"382539184827011072","possibly_sensitive":false,"created_at":"2013-09-24T16:17:03.000Z","referenced_tweets":[{"type":"retweeted","id":"382530066258743297"}],"id":"382539184827011072","text":"RT @AlzDisInt: ADI Executive Director @marcwort on the current challenges faced by the Alz community http://t.co/OViGRYfkJv","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":31,"end":39,"tag":"Podcast"},{"start":41,"end":45,"tag":"FDA"},{"start":73,"end":83,"tag":"Duragesic"},{"start":104,"end":111,"tag":"safety"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":112,"end":134,"url":"http://t.co/M6ZDPu8yLC","expanded_url":"http://1.usa.gov/1eE7otG","display_url":"1.usa.gov/1eE7otG"}],"annotations":{}},"conversation_id":"382519378346250241","possibly_sensitive":false,"created_at":"2013-09-24T14:58:21.000Z","referenced_tweets":[{"type":"retweeted","id":"382519220753281025"}],"id":"382519378346250241","text":"RT @FDA_Drug_Info: Drug Safety #Podcast: #FDA requiring color changes to #Duragesic pain patches to aid #safety http://t.co/M6ZDPu8yLC","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":17,"tag":"WDD"},{"start":59,"end":68,"tag":"Diabetes"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"urls":[{"start":74,"end":96,"url":"http://t.co/6epjviXAQh","expanded_url":"http://bit.ly/1bDtA5X","display_url":"bit.ly/1bDtA5X"}],"annotations":{}},"conversation_id":"382519356431028224","possibly_sensitive":false,"created_at":"2013-09-24T14:58:16.000Z","referenced_tweets":[{"type":"retweeted","id":"382518942574448641"}],"id":"382519356431028224","text":"RT @WDD: The #WDD newlsetter is out! Only 50 days to World #Diabetes Day! http://t.co/6epjviXAQh","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"urls":[{"start":116,"end":138,"url":"http://t.co/WvJh2C65nP","expanded_url":"http://bit.ly/18SM3KL","display_url":"bit.ly/18SM3KL"}],"annotations":{}},"conversation_id":"382507122249830401","possibly_sensitive":false,"created_at":"2013-09-24T14:52:27.000Z","referenced_tweets":[{"type":"replied_to","id":"382507122249830401"}],"id":"382517893243887616","text":"@HJF29088181 Our what's new page already distinguishes between human and veterinary medicines. You can also filter: http://t.co/WvJh2C65nP","in_reply_to_user_id":"1007144522","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":59,"end":81,"url":"http://t.co/dTpZz5TCvz","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/medIlegales/2013/ICM_MI_09-2013-episdrol-epistane.htm","display_url":"aemps.gob.es/informa/notasI…"}],"annotations":{}},"conversation_id":"382516945280860160","possibly_sensitive":false,"created_at":"2013-09-24T14:48:41.000Z","referenced_tweets":{},"id":"382516945280860160","text":"RT @AEMPSGOB: Withdrawal of products Episdrol and Epistane http://t.co/dTpZz5TCvz","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":51,"end":73,"url":"http://t.co/vPxKBuP852","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON316314","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"annotations":{}},"conversation_id":"382516516690092032","possibly_sensitive":false,"created_at":"2013-09-24T14:46:59.000Z","referenced_tweets":[{"type":"retweeted","id":"382505815401177088"}],"id":"382516516690092032","text":"RT @MHRApress: New appointments to MHRA committees http://t.co/vPxKBuP852","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":28,"end":41,"tag":"tuberculosis"},{"start":46,"end":50,"tag":"HIV"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":65,"end":76,"username":"WHO_Europe","id":"125403342"}],"urls":{},"annotations":{}},"conversation_id":"382516129383862272","possibly_sensitive":false,"created_at":"2013-09-24T14:45:26.000Z","referenced_tweets":[{"type":"retweeted","id":"382497377418223616"}],"id":"382516129383862272","text":"RT @ECDC_TB: \"Management of #tuberculosis and #HIV coinfection\". @WHO_Europe  publishes revision of clinical protocol 4: http://t.co/5fZAwJ…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"hashtags":[{"start":133,"end":140,"tag":"ctdata"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":110,"end":132,"url":"http://t.co/iqErVQ8UdB","expanded_url":"http://bit.ly/1642OCB","display_url":"bit.ly/1642OCB"}],"annotations":{}},"conversation_id":"382497071229853696","possibly_sensitive":false,"created_at":"2013-09-24T13:29:42.000Z","referenced_tweets":{},"id":"382497071229853696","text":"RT @GCessak: EMA | One more week to comment on draft policy on publication and access to clinical-trial data: http://t.co/iqErVQ8UdB #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":111,"end":121,"tag":"hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":{},"annotations":[{"start":18,"end":27,"probability":0.7233,"type":"Person","normalized_text":"Tonio Borg"},{"start":89,"end":90,"probability":0.6011,"type":"Organization","normalized_text":"EU"}]},"conversation_id":"382496656052473856","possibly_sensitive":false,"created_at":"2013-09-24T13:28:03.000Z","referenced_tweets":[{"type":"retweeted","id":"382493819645612032"}],"id":"382496656052473856","text":"RT @Hep_Alliance: Tonio Borg, European Commissioner for Health, speak\nse on the work the EU is doing to tackle #hepatitis http://t.co/lHIjW…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":47,"end":50,"tag":"EU"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":[{"start":111,"end":116,"probability":0.915,"type":"Place","normalized_text":"Prague"}]},"conversation_id":"382496510405279744","possibly_sensitive":false,"created_at":"2013-09-24T13:27:29.000Z","referenced_tweets":[{"type":"retweeted","id":"382491790135160832"}],"id":"382496510405279744","text":"RT @innovationunion: 25 years of bright minds: #EU rewards young scientists: European Commission Press release Prague, 24 September... http…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":53,"end":56,"tag":"EU"},{"start":88,"end":94,"tag":"EUCYS"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":[{"start":122,"end":129,"probability":0.5713,"type":"Place","normalized_text":"Brussels"}]},"conversation_id":"382496493963595779","possibly_sensitive":false,"created_at":"2013-09-24T13:27:25.000Z","referenced_tweets":[{"type":"retweeted","id":"382491782082068480"}],"id":"382496493963595779","text":"RT @innovationunion: 25 years of the European Union (#EU) Contest for Young Scientists (#EUCYS): European Commission MEMO Brussels, 24... h…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":38,"end":48,"tag":"Alzheimer"}],"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/niruuJJKVA","expanded_url":"http://www.forbes.com/sites/alicegwalton/2013/09/19/new-brain-imaging-for-alzheimers-disease-may-kickstart-early-treatment-diagnosis/","display_url":"forbes.com/sites/alicegwa…"}],"annotations":{}},"conversation_id":"382487745572397056","possibly_sensitive":false,"created_at":"2013-09-24T12:52:39.000Z","referenced_tweets":[{"type":"retweeted","id":"382486488153202688"}],"id":"382487745572397056","text":"RT @sailinsomnia: New Brain Scans For #Alzheimer's May Mean Earlier Diagnosis http://t.co/niruuJJKVA","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":21,"end":25,"tag":"FDA"},{"start":114,"end":122,"tag":"FDAApps"},{"start":123,"end":137,"tag":"medicaldevice"}],"mentions":[{"start":3,"end":19,"username":"FDAcdrhIndustry","id":"66367559"}],"urls":{},"annotations":{}},"conversation_id":"382483584822833152","possibly_sensitive":false,"created_at":"2013-09-24T12:36:07.000Z","referenced_tweets":[{"type":"retweeted","id":"382483453071335424"}],"id":"382483584822833152","text":"RT @FDAcdrhIndustry: #FDA has info to share about mobile medical apps. Join us for an online chat 3:30 PM ET 9/26 #FDAApps #medicaldevice P…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":23,"end":27,"tag":"FDA"},{"start":57,"end":70,"tag":"medical_apps"}],"mentions":[{"start":98,"end":106,"username":"Reuters","id":"1652541"}],"urls":[{"start":71,"end":93,"url":"http://t.co/a0HX1Op5F2","expanded_url":"http://reut.rs/18l5QQQ","display_url":"reut.rs/18l5QQQ"}],"annotations":[{"start":18,"end":21,"probability":0.9528,"type":"Place","normalized_text":"U.S."}]},"conversation_id":"382482197892308992","possibly_sensitive":false,"created_at":"2013-09-24T12:30:36.000Z","referenced_tweets":[{"type":"retweeted","id":"382481946002997248"}],"id":"382482197892308992","text":"RT @sailinsomnia: U.S. #FDA issues final rules on mobile #medical_apps http://t.co/a0HX1Op5F2 via @reuters","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":96,"end":109,"tag":"breastcancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/xXeyBukhrw","expanded_url":"http://ow.ly/p9Oms","display_url":"ow.ly/p9Oms"}],"annotations":{}},"conversation_id":"382476177912655872","possibly_sensitive":false,"created_at":"2013-09-24T12:06:41.000Z","referenced_tweets":[{"type":"retweeted","id":"382476030055047168"}],"id":"382476177912655872","text":"RT @myESMO: @EMA_News recommends granting mkting auth. for Trastuzumab Emtansine for metastatic #breastcancer http://t.co/xXeyBukhrw","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":11,"username":"ciarakirke","id":"515837126"}],"urls":[{"start":69,"end":91,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{}},"conversation_id":"382154088173289472","possibly_sensitive":false,"created_at":"2013-09-24T08:17:33.000Z","referenced_tweets":[{"type":"replied_to","id":"382244370621411328"}],"id":"382418515766284288","text":"@ciarakirke Thanks for your message. Please send your query to us at http://t.co/81mvfkEvbJ so that we can reply to you directly.","in_reply_to_user_id":"515837126","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"conversation_id":"382160077937197056","possibly_sensitive":false,"created_at":"2013-09-23T15:10:37.000Z","referenced_tweets":[{"type":"retweeted","id":"382159828518313984"}],"id":"382160077937197056","text":"RT @innovationunion: Scientists track the genes behind hearing loss: Tens of millions of Europeans suffer from a hearing impairment of... h…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"conversation_id":"382160014041186305","possibly_sensitive":false,"created_at":"2013-09-23T15:10:22.000Z","referenced_tweets":[{"type":"retweeted","id":"382159824168816640"}],"id":"382160014041186305","text":"RT @innovationunion: Spotlight on nanoparticles' imperceptible effects: From the clothes and make-up we wear to the electronic devices... h…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":132,"end":139,"tag":"ctdata"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":109,"end":131,"url":"http://t.co/ZxIK6NUBkG","expanded_url":"http://bit.ly/16hYJny","display_url":"bit.ly/16hYJny"}],"annotations":{}},"conversation_id":"382135717927079936","possibly_sensitive":false,"created_at":"2013-09-23T13:33:49.000Z","referenced_tweets":{},"id":"382135717927079936","text":"RT @EFPIA: Take a break &amp; read FULL report from Aug27 event \"A Road Map for Sharing Clinical Trial Data\" http://t.co/ZxIK6NUBkG #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":54,"end":67,"tag":"transparency"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"urls":{},"annotations":{}},"conversation_id":"382135470802862080","possibly_sensitive":false,"created_at":"2013-09-23T13:32:50.000Z","referenced_tweets":[{"type":"retweeted","id":"382122528526716929"}],"id":"382135470802862080","text":"RT @EUombudsman: We have reached max capacity for the #transparency event 27/9. You can watch and participate online via http://t.co/lXEzwx…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":{},"annotations":{}},"conversation_id":"382134684236668928","possibly_sensitive":false,"created_at":"2013-09-23T13:29:43.000Z","referenced_tweets":[{"type":"retweeted","id":"382117466194731009"}],"id":"382134684236668928","text":"RT @GCessak: EMA | One week left to comment on our concept paper on the development of product-specific guidance on bioequivalence http://t…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":71,"end":81,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":93,"end":115,"url":"http://t.co/QbSmq3a65Z","expanded_url":"http://bit.ly/19vZprz","display_url":"bit.ly/19vZprz"}],"annotations":{}},"conversation_id":"382105442694201344","possibly_sensitive":false,"created_at":"2013-09-23T11:33:31.000Z","referenced_tweets":[{"type":"retweeted","id":"382104722351464448"}],"id":"382105442694201344","text":"RT @euparkinsons: Subcutaneous apomorphine &amp; non-motor symptoms in #Parkinson's disease: http://t.co/QbSmq3a65Z","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":118,"end":140,"url":"http://t.co/iMQzm5OCqw","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/master-%E2%80%9Cscienze-regolatorie-del-farmaco%E2%80%9D-aifa-%E2%80%93-la-sapienza-al-la-seconda-edizione","display_url":"agenziafarmaco.gov.it/it/content/mas…"}],"annotations":{}},"conversation_id":"382105315468394497","possibly_sensitive":false,"created_at":"2013-09-23T11:33:01.000Z","referenced_tweets":{},"id":"382105315468394497","text":"RT @Aifa_ufficiale: Start of the 2nd edition of the masters in science of drug regulatory affairs: AIFA / La Sapienza http://t.co/iMQzm5OCqw","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":97,"end":112,"tag":"bioequivalence"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/2lqZfQ5tzI","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"annotations":{}},"conversation_id":"382098905946550272","possibly_sensitive":false,"created_at":"2013-09-23T11:07:32.000Z","referenced_tweets":{},"id":"382098905946550272","text":"One week left to comment on our concept paper on the development of product-specific guidance on #bioequivalence: http://t.co/2lqZfQ5tzI","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"annotations":{}},"conversation_id":"382098843052941312","possibly_sensitive":false,"created_at":"2013-09-23T11:07:17.000Z","referenced_tweets":{},"id":"382098843052941312","text":"One week left to comment on our concept paper on statistical methodology for the comparative assessment of quality: http://t.co/cPzrMeq9Ln","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":119,"end":126,"tag":"ctdata"}],"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/4kxT5eqwZi","expanded_url":"http://bit.ly/1642OCB","display_url":"bit.ly/1642OCB"}],"annotations":{}},"conversation_id":"382098764690771968","possibly_sensitive":false,"created_at":"2013-09-23T11:06:59.000Z","referenced_tweets":{},"id":"382098764690771968","text":"One week left to comment on our draft policy on publication and access to clinical-trial data: http://t.co/4kxT5eqwZi  #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"conversation_id":"382098021267554304","possibly_sensitive":false,"created_at":"2013-09-23T11:04:01.000Z","referenced_tweets":[{"type":"retweeted","id":"382097281706520576"}],"id":"382098021267554304","text":"RT @innovationunion: ERA progress report: 'single market' for research closer, not yet a reality: The report provides a factual base... htt…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":37,"end":44,"tag":"Numeta"},{"start":58,"end":65,"tag":"Numeta"}],"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/pxR8voB0Qm","expanded_url":"http://bit.ly/15b8BAg","display_url":"bit.ly/15b8BAg"}],"annotations":{}},"conversation_id":"382092075669266432","possibly_sensitive":false,"created_at":"2013-09-23T10:40:24.000Z","referenced_tweets":{},"id":"382092075669266432","text":"CMDh endorsed PRAC recommendation on #Numeta G13%E and on #Numeta G16%E: http://t.co/pxR8voB0Qm","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":98,"end":120,"url":"http://t.co/ve80Sd7ReM","expanded_url":"http://bbc.in/1aWAeS2","display_url":"bbc.in/1aWAeS2"}],"annotations":{}},"conversation_id":"382091765349875712","possibly_sensitive":false,"created_at":"2013-09-23T10:39:10.000Z","referenced_tweets":[{"type":"retweeted","id":"382091295751012352"}],"id":"382091765349875712","text":"RT @EFPIA: \"Scientists take big step towards universal flu vaccine\" - No more flu in our future?! http://t.co/ve80Sd7ReM","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":52,"end":74,"url":"http://t.co/pGYo1NP8TP","expanded_url":"http://bit.ly/18fpSwm","display_url":"bit.ly/18fpSwm"}],"annotations":{}},"conversation_id":"382091632339730432","possibly_sensitive":false,"created_at":"2013-09-23T10:38:38.000Z","referenced_tweets":{},"id":"382091632339730432","text":"We published the CHMP meeting highlights on Friday: http://t.co/pGYo1NP8TP","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":{},"annotations":[{"start":15,"end":27,"probability":0.906,"type":"Person","normalized_text":"Dr Ian Hudson"},{"start":81,"end":117,"probability":0.3277,"type":"Organization","normalized_text":"Healthcare Products Regulatory Agency"}]},"conversation_id":"382090956558053376","possibly_sensitive":false,"created_at":"2013-09-23T10:35:57.000Z","referenced_tweets":[{"type":"retweeted","id":"382090883962650624"}],"id":"382090956558053376","text":"RT @MHRApress: Dr Ian Hudson starts as new Chief Executive for the Medicines and Healthcare Products Regulatory Agency http://t.co/Smyx1Kus…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":{},"annotations":[{"start":15,"end":27,"probability":0.906,"type":"Person","normalized_text":"Dr Ian Hudson"},{"start":81,"end":117,"probability":0.3277,"type":"Organization","normalized_text":"Healthcare Products Regulatory Agency"}]},"conversation_id":"382090699594027008","possibly_sensitive":false,"created_at":"2013-09-23T10:34:56.000Z","referenced_tweets":[{"type":"retweeted","id":"382090654563590144"}],"id":"382090699594027008","text":"RT @MHRAgovuk: Dr Ian Hudson starts as new Chief Executive for the Medicines and Healthcare Products Regulatory Agency http://t.co/ojBvzleS…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":51,"tag":"European"},{"start":52,"end":61,"tag":"research"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":26,"end":40,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{}},"conversation_id":"382090131228073984","possibly_sensitive":false,"created_at":"2013-09-23T10:32:40.000Z","referenced_tweets":[{"type":"retweeted","id":"382090024340045824"}],"id":"382090131228073984","text":"RT @EURLex: Report by the @EU_Commission: #European #research area progress report 2013 @ERA_for_2014 @myCORDIS @EU_H2020 http://t.co/B0Er6…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":40,"end":53,"tag":"singlemarket"},{"start":58,"end":67,"tag":"research"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":95,"end":117,"url":"http://t.co/GIfu3bedht","expanded_url":"http://ow.ly/p7aOo","display_url":"ow.ly/p7aOo"}],"annotations":{}},"conversation_id":"382090115751088128","possibly_sensitive":false,"created_at":"2013-09-23T10:32:37.000Z","referenced_tweets":[{"type":"retweeted","id":"382089669871403008"}],"id":"382090115751088128","text":"RT @EU_Commission: ERA progress report: #singlemarket for #research closer, not yet a reality: http://t.co/GIfu3bedht","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"annotations":{}},"conversation_id":"382087449905987584","possibly_sensitive":false,"created_at":"2013-09-23T10:22:01.000Z","referenced_tweets":[{"type":"retweeted","id":"382084963387981824"}],"id":"382087449905987584","text":"RT @innovationunion: ERA progress report: 'single market' for research closer, not yet a reality: European Commission Press release... http…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":40,"end":46,"tag":"media"},{"start":60,"end":71,"tag":"healthcare"},{"start":78,"end":87,"tag":"patients"},{"start":99,"end":113,"tag":"EUHealthPrize"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"annotations":{}},"conversation_id":"382078223255076864","possibly_sensitive":false,"created_at":"2013-09-23T09:45:21.000Z","referenced_tweets":[{"type":"retweeted","id":"382071334643040256"}],"id":"382078223255076864","text":"RT @EU_Health: 1 week left! Submit your #media materials on #healthcare &amp; #patients' rights to #EUHealthPrize by 30.09 http://t.co/JC0QY7I9…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":17,"end":38,"tag":"WorldAlzheimersMonth"},{"start":104,"end":115,"tag":"biomarkers"}],"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/EZz6kQA3Qn","expanded_url":"http://bit.ly/1bvNZtI","display_url":"bit.ly/1bvNZtI"}],"annotations":{}},"conversation_id":"382067404005593088","possibly_sensitive":false,"created_at":"2013-09-23T09:02:22.000Z","referenced_tweets":{},"id":"382067404005593088","text":"We're supporting #WorldAlzheimersMonth - our work supports development of medicines by qualification of #biomarkers: http://t.co/EZz6kQA3Qn","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":27,"tag":"NexiumControl"},{"start":29,"end":42,"tag":"esomeprazole"},{"start":76,"end":87,"tag":"acidreflux"}],"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/GKxGRwaRrb","expanded_url":"http://bit.ly/1aQZwRy","display_url":"bit.ly/1aQZwRy"}],"annotations":{}},"conversation_id":"382067165412593664","possibly_sensitive":false,"created_at":"2013-09-23T09:01:25.000Z","referenced_tweets":{},"id":"382067165412593664","text":"The EPAR for #NexiumControl (#esomeprazole) for the short-term treatment of #acidreflux is available on our website: http://t.co/GKxGRwaRrb","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":97,"end":112,"tag":"bioequivalence"}],"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/2lqZfQ5tzI","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"annotations":{}},"conversation_id":"382066775531065344","possibly_sensitive":false,"created_at":"2013-09-23T08:59:52.000Z","referenced_tweets":{},"id":"382066775531065344","text":"One more week to comment on our concept paper on the development of product-specific guidance on #bioequivalence: http://t.co/2lqZfQ5tzI","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":104,"end":119,"tag":"prostatecancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"urls":{},"annotations":{}},"conversation_id":"382066224181833728","possibly_sensitive":false,"created_at":"2013-09-23T08:57:40.000Z","referenced_tweets":[{"type":"retweeted","id":"382065709360373760"}],"id":"382066224181833728","text":"RT @myESMO: @EMA_News recommends granting mkting auth. for Radium-223 Chloride for castration-resistant #prostatecancer http://t.co/Vp0DawU…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"annotations":{}},"conversation_id":"382065374662889472","possibly_sensitive":false,"created_at":"2013-09-23T08:54:18.000Z","referenced_tweets":{},"id":"382065374662889472","text":"One more week to comment on our concept paper on statistical methodology for the comparative assessment of quality: http://t.co/cPzrMeq9Ln","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":119,"end":126,"tag":"ctdata"}],"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/4kxT5eqwZi","expanded_url":"http://bit.ly/1642OCB","display_url":"bit.ly/1642OCB"}],"annotations":{}},"conversation_id":"382064785967177729","possibly_sensitive":false,"created_at":"2013-09-23T08:51:58.000Z","referenced_tweets":{},"id":"382064785967177729","text":"One more week to comment on our draft policy on publication and access to clinical-trial data: http://t.co/4kxT5eqwZi  #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"urls":{},"annotations":[{"start":104,"end":130,"probability":0.3942,"type":"Other","normalized_text":"World Alzheimer Report 2013"}]},"conversation_id":"382064429040697345","possibly_sensitive":false,"created_at":"2013-09-23T08:50:32.000Z","referenced_tweets":[{"type":"retweeted","id":"382064325042532352"}],"id":"382064429040697345","text":"RT @AlzDisInt: There will be 277 million dependent adults by 2050 and half of them will have dementia - World Alzheimer Report 2013 http://…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":16,"end":25,"tag":"diabetes"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"annotations":{}},"conversation_id":"382064006779125760","possibly_sensitive":false,"created_at":"2013-09-23T08:48:52.000Z","referenced_tweets":[{"type":"retweeted","id":"382061494881353728"}],"id":"382064006779125760","text":"RT @IMI_JU: IMI #diabetes projects open new chapter in research by signing Memorandum of Understanding to improve collaboration http://t.co…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":33,"end":44,"tag":"antibiotic"},{"start":96,"end":100,"tag":"hai"},{"start":107,"end":121,"tag":"antimicrobial"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"urls":{},"annotations":[{"start":52,"end":59,"probability":0.5401,"type":"Place","normalized_text":"European"}]},"conversation_id":"382063869902192640","possibly_sensitive":false,"created_at":"2013-09-23T08:48:19.000Z","referenced_tweets":[{"type":"retweeted","id":"382060008281620480"}],"id":"382063869902192640","text":"RT @EAAD_EU: Looking for data on #antibiotic use in European hospitals? Interactive database on #hai &amp; #antimicrobial use http://t.co/sAHx0…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":52,"end":66,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":88,"end":110,"url":"http://t.co/MaxNF3ugp7","expanded_url":"http://bit.ly/17r9vdH","display_url":"bit.ly/17r9vdH"}],"annotations":{}},"conversation_id":"381095870093332480","possibly_sensitive":false,"created_at":"2013-09-23T08:44:42.000Z","referenced_tweets":[{"type":"replied_to","id":"381095870093332480"}],"id":"382062957729161216","text":"@PinkyG123 We aim to publish with 15 days after the @EU_Commission issues its decision: http://t.co/MaxNF3ugp7","in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":17,"end":38,"tag":"WorldAlzheimersMonth"},{"start":97,"end":108,"tag":"biomarkers"}],"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/RwbhpxdEoe","expanded_url":"http://bit.ly/1bvNZtI","display_url":"bit.ly/1bvNZtI"}],"annotations":{}},"conversation_id":"381090232827117568","possibly_sensitive":false,"created_at":"2013-09-20T16:19:26.000Z","referenced_tweets":{},"id":"381090232827117568","text":"We're supporting #WorldAlzheimersMonth - we support development of medicines by qualification of #biomarkers: http://t.co/RwbhpxdEoe","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":56,"tag":"NexiumControl"},{"start":58,"end":71,"tag":"esomeprazole"},{"start":105,"end":116,"tag":"acidreflux"}],"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/VulLJ0gLxB","expanded_url":"http://bit.ly/1aQZwRy","display_url":"bit.ly/1aQZwRy"}],"annotations":{}},"conversation_id":"381082008547782656","possibly_sensitive":false,"created_at":"2013-09-20T15:46:45.000Z","referenced_tweets":{},"id":"381082008547782656","text":"We've published the assessment report for #NexiumControl (#esomeprazole) for the short-term treatment of #acidreflux: http://t.co/VulLJ0gLxB","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":117,"end":139,"url":"http://t.co/8CIWgk4aPL","expanded_url":"http://www.ages.at/ages/ueber-uns/das-unternehmen/organisation/jobs/","display_url":"ages.at/ages/ueber-uns…"}],"annotations":[{"start":44,"end":77,"probability":0.7781,"type":"Organization","normalized_text":"Plant Product Protection Institute"}]},"conversation_id":"381069498847334400","possibly_sensitive":false,"created_at":"2013-09-20T14:57:03.000Z","referenced_tweets":{},"id":"381069498847334400","text":"RT @agesnews: Jobs - Ecotoxicologist at the Plant Product Protection Institute, inspector in drug-market supervision http://t.co/8CIWgk4aPL","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":109,"end":131,"url":"http://t.co/rRhPsx0fD3","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-20-09-2013-r-dotyczaca-stanowiska-cmdh-w-sprawie-zawieszenia-pozwolenia-dla-produktu-leczniczego-numeta-g13-e-oraz-wp","display_url":"urpl.gov.pl/aktualnosci/in…"}],"annotations":{}},"conversation_id":"381066458970992640","possibly_sensitive":false,"created_at":"2013-09-20T14:44:58.000Z","referenced_tweets":{},"id":"381066458970992640","text":"RT @URPLWMiPB: Information regarding the CMDh position on the suspension of the license for Numeta G13% E... http://t.co/rRhPsx0fD3","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":46,"end":68,"url":"http://t.co/VjjNdv1DqW","expanded_url":"http://bit.ly/1eXiVWa","display_url":"bit.ly/1eXiVWa"}],"annotations":{}},"conversation_id":"381062773729669120","possibly_sensitive":false,"created_at":"2013-09-20T14:30:19.000Z","referenced_tweets":[{"type":"retweeted","id":"381062682339602433"}],"id":"381062773729669120","text":"RT @EFPIA: TODAY's FRESH : Efpia's Newsletter http://t.co/VjjNdv1DqW","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":116,"end":138,"url":"http://t.co/rRhPsx0fD3","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-20-09-2013-r-dotyczaca-stanowiska-cmdh-w-sprawie-zawieszenia-pozwolenia-dla-produktu-leczniczego-numeta-g13-e-oraz-wp","display_url":"urpl.gov.pl/aktualnosci/in…"}],"annotations":{}},"conversation_id":"381059287709413376","possibly_sensitive":false,"created_at":"2013-09-20T14:16:28.000Z","referenced_tweets":{},"id":"381059287709413376","text":"RT @GCessak:Information regarding the CMDh position on the suspension of the license for the medicine Numeta G13% E http://t.co/rRhPsx0fD3","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":123,"end":130,"tag":"ctdata"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"urls":[{"start":42,"end":64,"url":"http://t.co/DTNyTBeIhF","expanded_url":"http://bit.ly/1aQyVEg","display_url":"bit.ly/1aQyVEg"}],"annotations":[{"start":21,"end":28,"probability":0.4607,"type":"Organization","normalized_text":"EU Court"}]},"conversation_id":"381055265602551808","possibly_sensitive":false,"created_at":"2013-09-20T14:00:29.000Z","referenced_tweets":[{"type":"retweeted","id":"381055187269337090"}],"id":"381055265602551808","text":"RT @IlariaPassarani: EU Court allows BEUC http://t.co/DTNyTBeIhF to voice people views in the cases EMA vs pharma industry #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":8,"username":"IASO_US","id":"1755284676"}],"urls":[{"start":80,"end":102,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{}},"conversation_id":"381052565841928192","possibly_sensitive":false,"created_at":"2013-09-20T13:59:28.000Z","referenced_tweets":[{"type":"replied_to","id":"381054726680231936"}],"id":"381055011150901248","text":"@IASO_US @sailinsomnia Thanks for your message. Please send your query to us at http://t.co/81mvfkEvbJ so that we can reply to you directly.","in_reply_to_user_id":"1755284676","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":133,"end":140,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"beuctweet","id":"3061421219"},{"start":38,"end":51,"username":"EUCourtPress","id":"1343714233"}],"urls":[{"start":110,"end":132,"url":"http://t.co/6uvxiVrVwC","expanded_url":"http://bit.ly/1aQyVEg","display_url":"bit.ly/1aQyVEg"}],"annotations":{}},"conversation_id":"381054190736654336","possibly_sensitive":false,"created_at":"2013-09-20T13:56:13.000Z","referenced_tweets":{},"id":"381054190736654336","text":"RT @beuctweet: BEUC given standing by @EUCourtPress to support drug trial publication/voice consumer concerns http://t.co/6uvxiVrVwC #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":43,"end":51,"tag":"Ranbaxy"},{"start":60,"end":64,"tag":"FDA"}],"mentions":{},"urls":{},"annotations":[{"start":106,"end":131,"probability":0.2196,"type":"Organization","normalized_text":"Ranbaxy - BioSpectrum Asia"}]},"conversation_id":"381053475180007425","possibly_sensitive":false,"created_at":"2013-09-20T13:53:22.000Z","referenced_tweets":[{"type":"retweeted","id":"381052565841928192"}],"id":"381053475180007425","text":"RT @sailinsomnia: Further to my post about #Ranbaxy: Unlike #FDA, Indian regulators find no violations at Ranbaxy - BioSpectrum Asia http:/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":88,"end":110,"url":"http://t.co/oFkxl4GLpH","expanded_url":"http://bit.ly/17ODFsP","display_url":"bit.ly/17ODFsP"}],"annotations":{}},"conversation_id":"381051928173879296","possibly_sensitive":false,"created_at":"2013-09-20T13:47:13.000Z","referenced_tweets":{},"id":"381051928173879296","text":"RT @Legemiddelinfo: Norwegian medicines agency has approved flu vaccines for 2013-2014: http://t.co/oFkxl4GLpH","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":110,"end":132,"url":"http://t.co/gwbkLDYoGR","expanded_url":"http://www.urpl.gov.pl/pl-komunikaty-bezp/ryzyko-wystapienia-srodoperacyjnego-zespolu-wiotkiej-teczowki-zwiazane-z-leczeniem-rysperydonem-lub-paliperydonem-u-pacjentow-poddawanych-zabiegowi-ch","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"annotations":{}},"conversation_id":"381051735516917760","possibly_sensitive":false,"created_at":"2013-09-20T13:46:28.000Z","referenced_tweets":{},"id":"381051735516917760","text":"RT @URPLWMiPB: Risk of intraoperative floppy iris associated with treatment with risperidone and paliperidone http://t.co/gwbkLDYoGR","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":[{"start":100,"end":107,"tag":"ctdata"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"urls":{},"annotations":[{"start":21,"end":28,"probability":0.5593,"type":"Organization","normalized_text":"EU Court"}]},"conversation_id":"381051210117427200","possibly_sensitive":false,"created_at":"2013-09-20T13:44:22.000Z","referenced_tweets":{},"id":"381051210117427200","text":"RT @IlariaPassarani: EU Court allows BEUC to voice people views in the cases EMA vs pharma industry #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":22,"tag":"Westnile"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":76,"end":98,"url":"http://t.co/UWKpvidcrC","expanded_url":"http://bit.ly/QijONt","display_url":"bit.ly/QijONt"},{"start":116,"end":138,"url":"http://t.co/wJvRuzDO0I","expanded_url":"https://twitter.com/ECDC_EU/status/381037976999833600/photo/1","display_url":"pic.twitter.com/wJvRuzDO0I"}],"annotations":[{"start":62,"end":63,"probability":0.8482,"type":"Place","normalized_text":"EU"}]},"conversation_id":"381039581866774528","possibly_sensitive":false,"created_at":"2013-09-20T12:58:10.000Z","referenced_tweets":[{"type":"retweeted","id":"381037976999833600"}],"id":"381039581866774528","text":"RT @ECDC_EU: #Westnile fever update: 28 new cases reported in EU. See maps: http://t.co/UWKpvidcrC and infographic: http://t.co/wJvRuzDO0I","attachments":{"media_keys":["3_381037977004027905"]}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":16,"end":23,"tag":"EPRUMA"},{"start":54,"end":69,"tag":"ResponsibleUse"},{"start":88,"end":99,"tag":"antibiotic"}],"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/oKCZ4sB4n3","expanded_url":"http://bit.ly/1eYjW05","display_url":"bit.ly/1eYjW05"}],"annotations":[{"start":29,"end":45,"probability":0.7891,"type":"Person","normalized_text":"Commissioner Borg"}]},"conversation_id":"381039545812533249","possibly_sensitive":false,"created_at":"2013-09-20T12:58:01.000Z","referenced_tweets":[{"type":"retweeted","id":"381034760501329920"}],"id":"381039545812533249","text":"RT @IFAHEurope: #EPRUMA asks Commissioner Borg to put #ResponsibleUse at the core of EU #antibiotic strategy http://t.co/oKCZ4sB4n3 http://…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":29,"end":39,"tag":"Alzheimer"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":46,"end":68,"url":"http://t.co/KVOS59GQMj","expanded_url":"http://bit.ly/1aYDfF3","display_url":"bit.ly/1aYDfF3"}],"annotations":{}},"conversation_id":"381027396620931072","possibly_sensitive":false,"created_at":"2013-09-20T12:09:45.000Z","referenced_tweets":[{"type":"retweeted","id":"381027290877927424"}],"id":"381027396620931072","text":"RT @EFPIA: Tomorrow is World #Alzheimer's Day http://t.co/KVOS59GQMj","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":121,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{}},"conversation_id":"381026283947585536","possibly_sensitive":false,"created_at":"2013-09-20T12:05:19.000Z","referenced_tweets":[{"type":"retweeted","id":"381024849457467392"}],"id":"381026283947585536","text":"RT @WHO: Alzheimer's disease is most common cause of dementia. Data, policy, caregiving, a way forward in 2012 dementia report http://t.co/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":3,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/8mSUDahGIt","expanded_url":"http://bit.ly/16dRdRD","display_url":"bit.ly/16dRdRD"},{"start":113,"end":135,"url":"http://t.co/CCjJny8Cc9","expanded_url":"http://bit.ly/18Hk4rE","display_url":"bit.ly/18Hk4rE"}],"annotations":{}},"conversation_id":"381015199429689345","possibly_sensitive":false,"created_at":"2013-09-20T11:53:14.000Z","referenced_tweets":[{"type":"replied_to","id":"381021746985730049"}],"id":"381023242011815936","text":"@PinkyG123 We don't include new routes of administration in highlights. Keep an eye on http://t.co/8mSUDahGIt or http://t.co/CCjJny8Cc9.","in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":15,"username":"MarvinOLicious","id":"595127053"},{"start":16,"end":29,"username":"fezziwig2008","id":"376154503"}],"urls":[{"start":84,"end":106,"url":"http://t.co/CCjJny8Cc9","expanded_url":"http://bit.ly/18Hk4rE","display_url":"bit.ly/18Hk4rE"}],"annotations":{}},"conversation_id":"381022536055934976","possibly_sensitive":false,"created_at":"2013-09-20T11:51:10.000Z","referenced_tweets":[{"type":"replied_to","id":"381022536055934976"}],"id":"381022721930694656","text":"@MarvinOLicious @fezziwig2008 Alternatively you can follow the MabThera RSS feed at http://t.co/CCjJny8Cc9.","in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":15,"username":"MarvinOLicious","id":"595127053"},{"start":16,"end":29,"username":"fezziwig2008","id":"376154503"}],"urls":[{"start":113,"end":135,"url":"http://t.co/8mSUDahGIt","expanded_url":"http://bit.ly/16dRdRD","display_url":"bit.ly/16dRdRD"}],"annotations":{}},"conversation_id":"381022536055934976","possibly_sensitive":false,"created_at":"2013-09-20T11:50:26.000Z","referenced_tweets":{},"id":"381022536055934976","text":"@MarvinOLicious @fezziwig2008 We don't include new routes of administration in highlights. Please keep an eye on http://t.co/8mSUDahGIt.","in_reply_to_user_id":"595127053","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":321,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":44,"end":54,"tag":"Alzheimer"},{"start":76,"end":83,"tag":"memory"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":21,"end":41,"probability":0.3399,"type":"Other","normalized_text":"World Alzheimer’s Day"}]},"conversation_id":"381020850876850176","possibly_sensitive":false,"created_at":"2013-09-20T11:43:44.000Z","referenced_tweets":[{"type":"retweeted","id":"381020204681015296"}],"id":"381020850876850176","text":"RT @WHO: Tomorrow is World Alzheimer’s Day. #Alzheimer's disease may affect #memory, thinking, behaviour, daily activities http://t.co/UoPg…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":41,"end":48,"tag":"Numeta"},{"start":62,"end":69,"tag":"Numeta"}],"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/zV0CTLF3Cy","expanded_url":"http://bit.ly/15b8BAg","display_url":"bit.ly/15b8BAg"}],"annotations":{}},"conversation_id":"381019906906787840","possibly_sensitive":false,"created_at":"2013-09-20T11:39:59.000Z","referenced_tweets":{},"id":"381019906906787840","text":"CMDh has endorsed PRAC recommendation on #Numeta G13%E and on #Numeta G16%E: http://t.co/zV0CTLF3Cy","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":11,"end":24,"username":"fezziwig2008","id":"376154503"}],"urls":{},"annotations":{}},"conversation_id":"381015199429689345","possibly_sensitive":false,"created_at":"2013-09-20T11:38:26.000Z","referenced_tweets":[{"type":"replied_to","id":"381018066962108416"}],"id":"381019517562130432","text":"@PinkyG123 @fezziwig2008 The page is live. Are you still having difficulty seeing it?","in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":0,"end":15,"username":"xOneStepBehind","id":"40722651"},{"start":41,"end":55,"username":"EU_Commission","id":"157981564"}],"urls":{},"annotations":{}},"conversation_id":"381015199429689345","possibly_sensitive":false,"created_at":"2013-09-20T11:30:10.000Z","referenced_tweets":[{"type":"replied_to","id":"381016584208142337"}],"id":"381017437917159424","text":"@xOneStepBehind We've recommended to the @EU_Commission that it authorises Xofigo for marketing. We only issue opinions; the EC authorises.","in_reply_to_user_id":"40722651","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":105,"end":112,"tag":"ctdata"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"urls":[{"start":82,"end":104,"url":"http://t.co/DKuprGZawQ","expanded_url":"http://gu.com/p/3tzzh/tw","display_url":"gu.com/p/3tzzh/tw"}],"annotations":{}},"conversation_id":"381016067268947969","possibly_sensitive":false,"created_at":"2013-09-20T11:24:44.000Z","referenced_tweets":{},"id":"381016067268947969","text":"RT @IlariaPassarani: Why the data on all drug trials must be released | Síle Lane http://t.co/DKuprGZawQ #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"bitly bitlink","public_metrics":{"retweet_count":7,"reply_count":2,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":50,"end":72,"url":"http://t.co/NVZGPQitu1","expanded_url":"http://bit.ly/18fpSwm","display_url":"bit.ly/18fpSwm"}],"annotations":{}},"conversation_id":"381015199429689345","possibly_sensitive":false,"created_at":"2013-09-20T11:21:17.000Z","referenced_tweets":{},"id":"381015199429689345","text":"We've just published the CHMP meeting highlights: http://t.co/NVZGPQitu1","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":132,"end":139,"tag":"ctdata"}],"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"}],"urls":[{"start":108,"end":130,"url":"http://t.co/OsR60n0fzw","expanded_url":"http://tinyurl.com/kly7pa4","display_url":"tinyurl.com/kly7pa4"}],"annotations":{}},"conversation_id":"381001408826187776","possibly_sensitive":false,"created_at":"2013-09-20T10:26:29.000Z","referenced_tweets":{},"id":"381001408826187776","text":"RT @IlariaPassarani: Surreal: Pharma co rep argues info on adverse effects of drugs should be confidential. http://t.co/OsR60n0fzw  #ctdata","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":97,"end":102,"tag":"MERS"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":59,"end":81,"url":"http://t.co/5jnzbY8IC3","expanded_url":"http://goo.gl/I8oSvo","display_url":"goo.gl/I8oSvo"}],"annotations":[{"start":26,"end":36,"probability":0.3307,"type":"Place","normalized_text":"Middle East"}]},"conversation_id":"380996237723729920","possibly_sensitive":false,"created_at":"2013-09-20T10:05:56.000Z","referenced_tweets":[{"type":"retweeted","id":"380986837113659394"}],"id":"380996237723729920","text":"RT @WHO: Latest update on Middle East respiratory syndrome http://t.co/5jnzbY8IC3 (20 Sept 2013) #MERS","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":77,"end":99,"url":"http://t.co/jzM4iYXHAH","expanded_url":"http://bit.ly/14peKLS","display_url":"bit.ly/14peKLS"}],"annotations":{}},"conversation_id":"380979214264303616","possibly_sensitive":false,"created_at":"2013-09-20T08:58:17.000Z","referenced_tweets":{},"id":"380979214264303616","text":"RT @LV_MPA: New recommendation for dosing of antibiotics to cattle and sheep http://t.co/jzM4iYXHAH","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":54,"end":63,"tag":"11rtkdEO"}],"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"}],"urls":{},"annotations":{}},"conversation_id":"380978957551951872","possibly_sensitive":false,"created_at":"2013-09-20T08:57:16.000Z","referenced_tweets":[{"type":"retweeted","id":"380976667729997824"}],"id":"380978957551951872","text":"RT @EUombudsman: We have reached max capacity for the #11rtkdEO event. If you are interested you can follow the event online via http://t.c…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":116,"end":126,"tag":"RC63Izmir"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":93,"end":115,"url":"http://t.co/l7vmyC7lBA","expanded_url":"http://goo.gl/paZPC8","display_url":"goo.gl/paZPC8"}],"annotations":[{"start":36,"end":53,"probability":0.4613,"type":"Organization","normalized_text":"Regional Committee"},{"start":86,"end":91,"probability":0.97,"type":"Place","normalized_text":"Europe"}]},"conversation_id":"380978880812941312","possibly_sensitive":false,"created_at":"2013-09-20T08:56:58.000Z","referenced_tweets":[{"type":"retweeted","id":"380971425151991809"}],"id":"380978880812941312","text":"RT @WHO: Highlights of day 4 of the Regional Committee of the WHO Regional Office for Europe http://t.co/l7vmyC7lBA #RC63Izmir","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":56,"end":71,"tag":"ClinicalTrials"}],"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/H0tjGCOklg","expanded_url":"http://blog.pharmexec.com/2013/09/18/europe-still-an-attractive-place-for-clinical-trials/#.UjwF_RQFF1s.twitter","display_url":"blog.pharmexec.com/2013/09/18/eur…"}],"annotations":[{"start":18,"end":23,"probability":0.9836,"type":"Place","normalized_text":"Europe"}]},"conversation_id":"380977908501999616","possibly_sensitive":false,"created_at":"2013-09-20T08:53:06.000Z","referenced_tweets":[{"type":"retweeted","id":"380971187456573440"}],"id":"380977908501999616","text":"RT @sailinsomnia: Europe: Still An Attractive Place for #ClinicalTrials? http://t.co/H0tjGCOklg","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":13,"end":20,"tag":"Cholib"},{"start":22,"end":34,"tag":"fenofibrate"},{"start":37,"end":49,"tag":"simvastatin"},{"start":71,"end":75,"tag":"fat"}],"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/50Ln3iTLiD","expanded_url":"http://bit.ly/18bF2T2","display_url":"bit.ly/18bF2T2"}],"annotations":{}},"conversation_id":"380967117962506240","possibly_sensitive":false,"created_at":"2013-09-20T08:10:13.000Z","referenced_tweets":{},"id":"380967117962506240","text":"The EPAR for #Cholib (#fenofibrate / #simvastatin) for improving blood #fat levels is available on our website: http://t.co/50Ln3iTLiD","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":26,"end":31,"tag":"H7N7"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":100,"end":108,"username":"ECDC_EU","id":"204752573"}],"urls":{},"annotations":[{"start":93,"end":97,"probability":0.9929,"type":"Place","normalized_text":"Italy"}]},"conversation_id":"380725365016395776","possibly_sensitive":false,"created_at":"2013-09-19T16:09:35.000Z","referenced_tweets":[{"type":"retweeted","id":"380725133238759425"}],"id":"380725365016395776","text":"RT @ECDC_Flu: Low risk of #H7N7 transmission to general population following latest cases in Italy, @ECDC_EU assessment concludes http://t.…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":75,"end":85,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":98,"end":120,"url":"http://t.co/f5010IJhOR","expanded_url":"http://bit.ly/15EHj9c","display_url":"bit.ly/15EHj9c"}],"annotations":{}},"conversation_id":"380723707339350017","possibly_sensitive":false,"created_at":"2013-09-19T16:03:00.000Z","referenced_tweets":[{"type":"retweeted","id":"380723081863368704"}],"id":"380723707339350017","text":"RT @euparkinsons: MAO-B inhibitors: Implications 4 disease-modification in #Parkinson’s disease - http://t.co/f5010IJhOR","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":110,"end":123,"tag":"globalhealth"},{"start":124,"end":132,"tag":"cgi2013"}],"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"},{"start":105,"end":109,"username":"WHO","id":"14499829"}],"urls":{},"annotations":{}},"conversation_id":"380721051728355328","possibly_sensitive":false,"created_at":"2013-09-19T15:52:26.000Z","referenced_tweets":[{"type":"retweeted","id":"380718670491574272"}],"id":"380721051728355328","text":"RT @USPharmacopeia: Fact: Combined, counterfeit and substandard drugs constitute a $431 billion market. –@WHO #globalhealth #cgi2013","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":53,"end":75,"url":"http://t.co/yVbrpR2c5J","expanded_url":"http://bit.ly/16hoTGF","display_url":"bit.ly/16hoTGF"}],"annotations":[{"start":27,"end":50,"probability":0.5848,"type":"Other","normalized_text":"Anatomy of the HIV Virus"}]},"conversation_id":"380719985049751552","possibly_sensitive":false,"created_at":"2013-09-19T15:48:12.000Z","referenced_tweets":[{"type":"retweeted","id":"380716327289507840"}],"id":"380719985049751552","text":"RT @GCessak: WATCH VIDEO - Anatomy of the HIV Virus: http://t.co/yVbrpR2c5J","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":24,"end":28,"tag":"FDA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":95,"end":117,"url":"http://t.co/x1hah5auy2","expanded_url":"http://1.usa.gov/1fco9uT","display_url":"1.usa.gov/1fco9uT"}],"annotations":[{"start":56,"end":71,"probability":0.4511,"type":"Other","normalized_text":"Drug Name Review"}]},"conversation_id":"380719583457734656","possibly_sensitive":false,"created_at":"2013-09-19T15:46:36.000Z","referenced_tweets":[{"type":"retweeted","id":"380715487769796610"}],"id":"380719583457734656","text":"RT @FDA_Drug_Info: New! #FDA Drug Info Rounds video on \"Drug Name Review\". Watch the video at: http://t.co/x1hah5auy2.","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":50,"end":54,"tag":"HIV"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":56,"end":78,"url":"http://t.co/qEqB9NGAKZ","expanded_url":"http://bit.ly/16hoTGF","display_url":"bit.ly/16hoTGF"}],"annotations":[{"start":25,"end":48,"probability":0.5415,"type":"Other","normalized_text":"Anatomy of the HIV Virus"}]},"conversation_id":"380718924272508928","possibly_sensitive":false,"created_at":"2013-09-19T15:43:59.000Z","referenced_tweets":[{"type":"retweeted","id":"380712095068602368"}],"id":"380718924272508928","text":"RT @EFPIA: WATCH VIDEO - Anatomy of the HIV Virus #HIV  http://t.co/qEqB9NGAKZ","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"annotations":[{"start":9,"end":15,"probability":0.8194,"type":"Person","normalized_text":"Dr Chan"}]},"conversation_id":"380700642672934912","possibly_sensitive":false,"created_at":"2013-09-19T14:31:20.000Z","referenced_tweets":[{"type":"retweeted","id":"380696051516063745"}],"id":"380700642672934912","text":"RT @WHO: Dr Chan: The use of massive amounts of antimicrobials, usually at sub-therapeutic doses, in animal husbandry is another problem","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":92,"end":99,"tag":"ctdata"},{"start":100,"end":115,"tag":"clinicaltrials"},{"start":116,"end":122,"tag":"efpia"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":{},"annotations":{}},"conversation_id":"380700601510027264","possibly_sensitive":false,"created_at":"2013-09-19T14:31:11.000Z","referenced_tweets":[{"type":"retweeted","id":"380695862118072320"}],"id":"380700601510027264","text":"RT @EFPIA: A Roadmap for Sharing Clinical Trial Data - Aug. 27 workshop event - Full Report #ctdata #clinicaltrials #efpia http://t.co/HEmM…","attachments":{"media_keys":{}}},{"lang":"tl","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"annotations":{}},"conversation_id":"380687993969078272","possibly_sensitive":false,"created_at":"2013-09-19T13:41:05.000Z","referenced_tweets":[{"type":"retweeted","id":"380684131199242240"}],"id":"380687993969078272","text":"RT @FDA_Drug_Info: FDA: \"Instant Slim\" aka “Shou Fu Ti Tun Guo Xiang Xing Jian Fei Jiao Nang”  Contains Hidden Drug Ingredient http://t.co/…","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":28,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":89,"end":111,"url":"http://t.co/xlUTxRHct8","expanded_url":"http://bit.ly/18cKTpB","display_url":"bit.ly/18cKTpB"}],"annotations":{}},"conversation_id":"380677926838353920","possibly_sensitive":false,"created_at":"2013-09-19T13:01:05.000Z","referenced_tweets":[{"type":"retweeted","id":"380677799339507712"}],"id":"380677926838353920","text":"RT @euparkinsons: #Parkinson's disease in a dish – using stem cells as a molecular tool: http://t.co/xlUTxRHct8","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":114,"end":136,"url":"http://t.co/ozCO8eKVn5","expanded_url":"http://patientnetwork.fda.gov/current-patient-network-newsletter","display_url":"patientnetwork.fda.gov/current-patien…"}],"annotations":[{"start":82,"end":84,"probability":0.8154,"type":"Organization","normalized_text":"FDA"}]},"conversation_id":"380676566583640064","possibly_sensitive":false,"created_at":"2013-09-19T12:55:40.000Z","referenced_tweets":[{"type":"retweeted","id":"380676444671582208"}],"id":"380676566583640064","text":"RT @US_FDA: Here is the current bi-weekly Patient Network Newsletter with all the FDA news from the past 2 weeks. http://t.co/ozCO8eKVn5","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":127,"end":134,"tag":"cancer"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":104,"end":126,"url":"http://t.co/QJF8f4uej4","expanded_url":"http://ow.ly/p0YLT","display_url":"ow.ly/p0YLT"}],"annotations":{}},"conversation_id":"380667381309526017","possibly_sensitive":false,"created_at":"2013-09-19T12:19:10.000Z","referenced_tweets":[{"type":"retweeted","id":"380667226304823297"}],"id":"380667381309526017","text":"RT @myESMO: Clinical Tool Accurately Classifies Benign &amp; Malignant Nodules on Lung Scans of Smokers http://t.co/QJF8f4uej4 #cancer","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":22,"tag":"FDA"},{"start":52,"end":60,"tag":"Ranbaxy"}],"mentions":{},"urls":[{"start":86,"end":108,"url":"http://t.co/r1azmAEZai","expanded_url":"http://shar.es/iSVHk","display_url":"shar.es/iSVHk"}],"annotations":[{"start":69,"end":84,"probability":0.3984,"type":"Place","normalized_text":"BioSpectrum Asia"}]},"conversation_id":"380666960931221504","possibly_sensitive":false,"created_at":"2013-09-19T12:17:30.000Z","referenced_tweets":[{"type":"retweeted","id":"380666865975967744"}],"id":"380666960931221504","text":"RT @sailinsomnia: #FDA finds hair from human arm in #Ranbaxy drugs - BioSpectrum Asia http://t.co/r1azmAEZai","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":18,"end":31,"tag":"Homocysteine"},{"start":38,"end":48,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":84,"end":106,"url":"http://t.co/oG0eRhZN6K","expanded_url":"http://bit.ly/18cKJOW","display_url":"bit.ly/18cKJOW"}],"annotations":{}},"conversation_id":"380663029471674368","possibly_sensitive":false,"created_at":"2013-09-19T12:01:53.000Z","referenced_tweets":[{"type":"retweeted","id":"380662689854275585"}],"id":"380663029471674368","text":"RT @euparkinsons: #Homocysteine &amp; #Parkinson’s disease: a complex relationship: http://t.co/oG0eRhZN6K","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":42,"end":49,"tag":"Cholib"},{"start":51,"end":63,"tag":"fenofibrate"},{"start":66,"end":78,"tag":"simvastatin"},{"start":100,"end":104,"tag":"fat"}],"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/50Ln3iTLiD","expanded_url":"http://bit.ly/18bF2T2","display_url":"bit.ly/18bF2T2"}],"annotations":{}},"conversation_id":"380662662293487616","possibly_sensitive":false,"created_at":"2013-09-19T12:00:25.000Z","referenced_tweets":{},"id":"380662662293487616","text":"We've published the assessment report for #Cholib (#fenofibrate / #simvastatin) for improving blood #fat levels: http://t.co/50Ln3iTLiD","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":45,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":[{"start":102,"end":107,"tag":"MERS"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":59,"end":81,"url":"http://t.co/afIRXLC2Dr","expanded_url":"http://goo.gl/4bpEsE","display_url":"goo.gl/4bpEsE"}],"annotations":[{"start":26,"end":36,"probability":0.3056,"type":"Place","normalized_text":"Middle East"}]},"conversation_id":"380661635331145728","possibly_sensitive":false,"created_at":"2013-09-19T11:56:20.000Z","referenced_tweets":[{"type":"retweeted","id":"380661556779814913"}],"id":"380661635331145728","text":"RT @WHO: Latest update on Middle East respiratory syndrome http://t.co/afIRXLC2Dr (19 September 2013) #MERS","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":84,"end":106,"url":"http://t.co/OSizytb4vr","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&DOC=11&CAT=NEWS&QUERY=014135fe0fa3:9b51:20bced92&RCN=36070","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"annotations":{}},"conversation_id":"380658565633310720","possibly_sensitive":false,"created_at":"2013-09-19T11:44:09.000Z","referenced_tweets":[{"type":"retweeted","id":"380655994755227649"}],"id":"380658565633310720","text":"RT @GCessak: New approach to early diagnosis of chronic renal diseases in children: http://t.co/OSizytb4vr","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":85,"end":107,"url":"http://t.co/fnIEe9eKP1","expanded_url":"http://cordis.europa.eu/fetch?CALLER=PL_NEWS&ACTION=D&DOC=2&CAT=NEWS&QUERY=0140cdf6aa0c:c668:202f86ac&RCN=36070","display_url":"cordis.europa.eu/fetch?CALLER=P…"}],"annotations":{}},"conversation_id":"380658552450596864","possibly_sensitive":false,"created_at":"2013-09-19T11:44:05.000Z","referenced_tweets":{},"id":"380658552450596864","text":"RT @GCessak: New approach to early diagnosis of chronic kidney diseases in children: http://t.co/fnIEe9eKP1","attachments":{"media_keys":{}}},{"lang":"en","author_id":"116716199","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"hashtags":{},"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/WyC0u6Gyxb","expanded_url":"http://bit.ly/155UOjL","display_url":"bit.ly/155UOjL"}],"annotations":[{"start":77,"end":82,"probability":0.9413,"type":"Place","normalized_text":"London"}]},"conversation_id":"380648022536753152","possibly_sensitive":false,"created_at":"2013-09-19T11:02:15.000Z","referenced_tweets":{},"id":"380648022536753152","text":"Our websites and other online tools will be unavailable from 5.30pm tomorrow London time until Monday morning: http://t.co/WyC0u6Gyxb","attachments":{"media_keys":{}}}]
